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Abstract
Traumatic spinal cord injury arises from varied primary mechanisms, leaving individuals
with significant long-term disability. Mechanically distinct secondary damage patterns
have been observed in vivo; however, there remains a lack of consensus on how
biomechanical parameters, such as displacement and velocity, influences secondary
pathology. Astrocytes are key responders to mechanical insult, thus the aim of this
project was to evaluate the effects of varied displacement and velocity parameters of
contusion and distraction injury on primary astrocyte reactivity in vitro.
A 3D culture model with astrocytes embedded in a collagen hydrogel (5 x 105
cells.ml−1) was used to simulate the CNS environment. Using the BOSE Electroforce
BioDynamic 5110, contusion was modelled at 100 and 1000 mm.s−1 to depths of 25, 50,
and 75% gel thickness. Distraction was simulated at 100 mm.s−1 to 10, 20, and 30% of
the gauge length. Increasing displacement and velocity resulted in an increase in energy
applied, resulting in astrogliotic alterations: hypertrophy, ramification, loss of individual
domains, increased glial fibrillary acidic protein volume, and increased chondroitin
sulfate proteoglycan deposition. Increased astrocyte reactivity was observed with
increasing contusion depth at 100, but not 1000 mm.s−1. Distraction injury also induced
astrogliotic changes, but with temporal differences in GFAP volume and CSPG
expression. Further, distraction length had no effect on injury severity from Day 7
onwards, suggesting injury mechanism influences astrocyte reactivity in different ways.
In vitro models of contusion and distraction injury were developed, but with scope
for adapting them to use different neural cell types and increase cellular complexity in a
controlled manner. This may enable the user to evaluate the biomechanical thresholds of
different cell populations and the influence of cell-cell interactions on secondary
pathophysiology. These preclinical models may also be useful for early stage testing of
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Traumatic spinal cord injury (TSCI) refers to damage to the spinal cord which results
from high energy events, such as motor vehicle accidents or falls from a height. TSCI
arises from failure of the vertebral column, the structure which houses and protects the
spinal cord. These injuries create a large long-term physical, financial and socioeconomic
burden on those affected. The current state of TSCI research has provided a toolbox of
experimental techniques and models both in vitro and in vivo, which have contributed
greatly to our understanding of the mechanisms of injury and pathophysiological events
which follow. In silico models are increasingly useful supplementary models for providing
predictions of the evolution of injury and resultant strain and stress patterns, which are
difficult to measure instantaneously due to the unexpected nature of injury and
timeframe in the order of milliseconds (Wilcox et al., 2002).
Despite this wealth of knowledge, which has led to the development of numerous
clinical trials, an effective treatment has yet to be developed which leads to a robust and
complete functional recovery for the patient. Heterogeneity exists due not only to the
mechanism, severity, and level of vertebral column failure leading to spinal cord damage
but also heterogeneity in the population who receive the injury. The age, gender, health,
and socioeconomic status of an individual also influences their recovery. This diversity is
not reflected in the preclinical models and clinical trials which may be impeding the
search for effective treatment(s).
More recent research has highlighted the importance of injury mechanism in
determining the progression of primary and secondary injury, thus influencing the
behavioural outcomes in vivo. The injury mechanism, encompassing the mechanism of
vertebral column failure and spinal cord damage, is also defined by the extent of cord
displacement and velocity. Researchers at the University of British Columbia have
provided evidence for mechanism-specific distinct strain and biological damage patterns
through developing a custom electromagnetic injury device - The University of British
Columbia (UBC) multimechanism device - which is capable of modelling contusion,
distraction and dislocation SCI with independent control of displacement and velocity
(Chen et al., 2016; Choo et al., 2008, 2007).
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However, how injury biomechanics, such as displacement and velocity, influences the
pathophysiological outcomes of individual populations of cells, and what the biomechanical
thresholds for injury activation are for these populations has been difficult to elucidate in
vivo due to the complexity of the native CNS. There is also a lack of consensus on which
biomechanical parameter(s) is/are dominant in determining the severity of injury in vivo.
Therefore, three-dimensional in vitro models provide a useful tool for which these questions
can be probed. Further, the tailorability of these models provides scope to better reflect
the heterogeneity of TSCI. The work in this thesis explores the effects of contusion and
distraction injury with independent control of displacement and velocity in an in vitro
three-dimensional model, composed of primary neonatal cortical astrocytes seeded into
collagen hydrogels. The motivation for this research is to determine whether and how
these parameters influence astrocyte reactivity at a single cell population level.
1.2 Anatomy of the Spine and Spinal Cord
The vertebral column is the central support structure of the body, providing structural
support, stability and flexibility alongside soft tissues, such as ligaments and
intervertebral discs. The vertebral column is divided into vertebral segments, of which
there are 24 in humans: seven cervical (C1 – C7), twelve thoracic (T1 – T12), and five
lumbar (L1 – L5). Below the lumbar spine is the sacrum and coccyx, each of which are
formed through the fusing of five sacral (S1 – S5) and three to five coccygeal vertebrae,
respectively (Figure 1.1).
One of the main functions of the spine is to protect the spinal cord, which runs through
its central canal. As one of two structurally distinct nervous systems in the human body,
the central nervous system (CNS) comprises the brain and the spinal cord. The spinal
cord receives, integrates, and relays information to and from the brain and spinal cord
to the rest of the body, via tracts of neurons and glial cells organised throughout the
spinal cord. In humans, the spinal cord occupies the upper two-thirds of the spinal canal,
typically ending between the L1 and L2 vertebra; although it can end anywhere between
T12 and L3 (Barson, 1970). The spinal cord is ovoid in shape and is typically wider in the
transverse plane (5 – 13 mm) compared to the anteroposterior plane (4 – 8 mm) (Frostell
et al., 2016).
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Figure 1.1: Anatomy of the human vertebral column and vertebrae. The
human vertebral column can be divided into cervical, thoracic, lumbar, sacral, and
coccygeal regions (left). A typical vertebra comprises several structures as annotated
(right). Through the vertebral foramen is where the spinal cord runs. Image adapted and
modified from Gray (1985).
Similar to the vertebral column, the spinal cord is divided into segments based on the
pairs of spinal nerves which are located on each side of the cord, and each spinal nerve is
formed from two pairs of nerve roots (Figure 1.2). Spinal nerves conduct motor, sensory,
and autonomic information between the spinal cord and the body, with each individual
spinal nerve innervating a specific area of the body, called a dermatome (de Campos et
al., 2017; Greenberg, 2003). There are 31 pairs of spinal nerves in humans, which are
numbered according to the vertebrae above which they emerge: eight cervical (C1 – C8),
twelve thoracic (T1 – T12), five lumbar (L1 – L5), five sacral (S1 – S5) and one
coccygeal nerve (Co1). There are two major enlargements of the spinal cord: a cervical
enlargement associated with the origin of spinal nerves C5-T1 innervating the upper
limbs; and a lumbosacral enlargement associated with the origins of spinal nerves L2-S3
innervating the lower limbs (Purves et al., 2001).
The protective meninges of the spinal cord extends from the foramen magnum, at the
base of the skull, to approximately the level of the intervertebral disc between L1 and L2,
and comprises the outer dura mater, arachnoid mater, and inner pia mater (Figure 1.2)
(Nógrádi and Vrbová, 2006). Cerebrospinal fluid (CSF) bathes the inner and outer
surfaces of the spinal cord to biomechanically protect the spinal cord, through
supporting the weight of the tissue and absorbing shock (Sakka et al., 2011). CSF also
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provides immunological support and enables the transport of nutrients and removal of
waste products from CNS metabolism. Experimental studies on bovine cord and finite
element studies have demonstrated the protective role of CSF against SCI, by reducing
cord deformation during impact (Persson et al., 2009).
Figure 1.2: Anatomy of the human spinal cord. The spinal cord is housed in the
vertebral foramen of the spine and is protected by three layers of membranous tissue (dura
mater, arachnoid mater, pia mater) which form the meninges. Additional mechanical and
immunological protection is provided by the cerebrospinal fluid (CSF) which occupies the
subarachnoid space, between the arachnoid mater and pia mater, and central spinal cord
canal. Image adapted and modified from Shutterstock.
A transverse section of the spinal cord reveals the grey and white matter of the spinal
cord, with white matter surrounding the grey matter and forming a characteristic butterfly
shape (Figure 1.2). The grey matter is predominantly comprised of nerve cell bodies, glial
cells, dendrites, and unmyelinated axons, forming longitudinal columns along the cord
(Purves et al., 2001). The white matter is rich in myelinated nerve cell processes, with few
nerve cell bodies, hence its white-like colour. These nerves form large bundles, or tracts,
that ascend and descend throughout the spinal cord, connecting cell bodies from the grey
matter and transmitting electrical signals to and from the brain (Watson et al., 2009).
1.2.1 Spinal Cord Cytoarchitecture
The vertebrate spinal cord is comprised of two major classes of cells: neurons and glia
(Table 1.1). Neurons are electrically excitable cells responsible for transmitting all signals
to and from the brain to the rest of the body. As highly specialized nerve cells, neurons
can relay different types of information depending on their specific function. Neurons
can be functionally classified into three types: sensory, motor, or interneurons (Mancall
and Brock, 2011).
Collectively termed neuroglia or glial cells, non-neuronal cells exist alongside neuronal
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cells in the CNS but do not directly facilitate signal transmission. Glia were historically
described as the support cells, or glue, holding nervous tissue together. However, research
has since revealed the cellular complexity and functions of glial cells in the CNS (Purves
et al., 2001; Sofroniew and Vinters, 2010). Glia are the most abundant cells within the
spinal cord, outnumbering neurons by approximately 3:1 (Simons and Trajkovic, 2006).
In general, there are three main types of glia: astrocytes, microglia, and oligodendrocytes.
Ependymal cells are a fourth minor type of glial cell. Glia and neurons are highly organised
within the spinal cord from the developmental program that begins with the neural plate
in the embryo (Watson et al., 2009).
Table 1.1: Cell types of the central nervous system. The cells which comprise the
CNS and thus spinal cord encompass neuronal and neuroglial subtypes, each of which
possess distinct functions. CNS = central nervous system; CSF = cerebrospinal fluid.
Cell Type Functions
Neurons
Sensory Receive sensory signals from sensory organs and transmit them
to the CNS (afferent).
Motor Conduct motor signals from the cortex to the spinal cord, or
from the spinal cord to the effector organs, such as muscles
(efferent).
Interneuron Residing entirely within the CNS, interneurons receive and
integrate information from sensory neurons, and generate a
response via the motor neuron.
Neuroglia
Astrocytes Maintain homeostatic activities, such as synaptic function and
metabolism; respond to pathological insults through numerous
repair activities.
Microglia Resident macrophage cells of the CNS acting to clear cellular
debris and dead and/or damaged neurons; respond to infectious
agents.
Oligodendrocytes Myelinating cells of the CNS, producing the myelin sheath that
envelops and provides insulation and support to axons.
Ependymal cells Located in the central canal of the spinal cord and involved in
the production of CSF.
Astrocytes, also known as astroglia, are the most abundant cells in the CNS and have
been proposed to perform many functions: they are the support cells that regulate the
formation of new synapses, with the absence of astrocytes being reported to limit the
ability of neurons to form mature and functional synapses (Ullian et al., 2001).
Astrocytes also regulate the functions of endothelial cells at the blood brain barrier,
provide nutrients, and maintain a wide range of homeostatic activities due to the broad
range of neurotransmitter receptors and ion channels that they possess, which can
remove molecules from the synaptic cleft (Kerstetter and Miller, 2012; Miller, 2002).
Astrocytes have historically been categorised into two main subtypes: fibrous and
protoplasmic astrocytes, based on their morphology and anatomical location, as depicted
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in Figure 1.3 (Cajal, 1909). However, heterogeneity in astrocytes extends beyond just
morphological differences, and increasing evidence is being presented for genetic and
functional astrocyte heterogeneity (Miller, 2018).
Figure 1.3: Morphology of fibrous and protoplasmic astrocytes. Fibrous
astrocytes are predominantly located in the white matter and are characterised by their
sparse and long processes which are thicker and less finely branched. Protoplasmic
astrocytes are located in the grey matter and possess many finely branched processes
which extend radially, giving it a ’brush’ like structure. Figure created using Biorender.
Under physiological conditions, astrocytes are said to be in a resting, or ‘non-reactive’
state. Exposure to an injury stimulus, such as cellular perturbation via a spinal cord
injury, results in the release of a variety of molecules. These molecules include
inflammatory mediators like TNF-α, reactive oxygen species (ROS), and glutamate and
can be released by multiple cell types within the CNS (Sofroniew, 2009). These
molecules trigger astrogliosis, the process whereby astrocytes respond to damage in a
graded manner by increasing in number and size (hypertrophy), upregulating glial
fibrillary acid protein (GFAP) expression, extending their processes, and altering their
gene expression (Eng and Ghirnikar, 1994; Faulkner et al., 2004; Sofroniew, 2009). One
major consequence of astrogliosis is the formation of a mechanical and chemical barrier
to axon regeneration called the glial scar, of which reactive astrocytes contribute.
Examples of genes upregulated during astrogliosis include, GFAP, vimentin, and nestin.
Typical immunohistochemical identification of astrocytes utilises the expression of GFAP,
a cytoskeletal intermediate filament element; although it has been reported that some
healthy astrocytes may not express detectable levels of GFAP, compared to injured
astrocytes undergoing astrogliosis (Sofroniew, 2009; Sofroniew and Vinters, 2010).
Microglia are the resident immunocompetent cells of the CNS, acting as the primary
form of immune defence against injury and infection (Aloisi, 2001). Resting microglia
exhibit small cell bodies and are highly ramified, with elaborate thin processes extending
in all directions. Their processes continuously scan the surrounding microenvironment
thus are able to detect and respond to insults rapidly (Zhou et al., 2014). Damage or
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infection induces microglia to exhibit a reactive ‘macrophage’ phenotype, characterised
by the retraction of processes and transition from a ramified to a rod-like morphology.
This enables them to perform phagocytic functions by migrating to areas of injury and
expressing inflammatory molecules.
Oligodendrocytes are the myelinating glia of the CNS, ensheathing axons in
compacted spirals of lipid-rich plasma membrane (Miller, 2002; Simons and Trajkovic,
2006). This enables neurons to conduct action potentials rapidly, and also support their
survival through the production of trophic molecules, such as brain-derived neurotrophic
factor (BDNF) (Kassmann and Nave, 2008; Lappe-Siefke et al., 2003). Demyelination of
axons, as a result of SCI, typically results in remyelination by the generation of new
mature oligodendrocytes from the OPC pool distributed throughout the CNS (Malas
and Panayiotou, 2013). Remyelination appears to be triggered by factors derived from
activated microglia and astrocytes, such as IL-1α, and IFNγ (Rhodes et al., 2006).
A fourth, often less discussed type of neuroglial cell are ependymal cells. Ependymal
cells line the central canal of the spinal cord and are thought to be involved in the directed
movement of cerebrospinal fluid (CSF) throughout the CNS (Barnabé-Heider et al., 2010).
Movement of CSF allows nutrient delivery to neurons, and removal of waste substances
(Sakka et al., 2011). Ependymal cells have been demonstrated to exhibit stem cell-like
behaviour in vitro, resulting in interest in isolating these cells for regenerative purposes
(Barnabé-Heider et al., 2010; Meletis et al., 2008).
1.2.2 The Extracellular Matrix Environment of the Spinal Cord
Extracellular matrix (ECM) is a bioactive scaffold comprised of a complex network of
numerous proteins, such as fibrous proteins (collagen, elastin, fibronectin), adhesion
proteins (integrin), growth factors (FGF, VEGF), cytokines, chemokines, and
proteoglycans (aggrecan) expressed by cells (Frantz et al., 2010). The mature CNS ECM
consists of the basement membrane (BM), interstitial space (IS), and specialised ECM
called perineuronal nets (PNNs) (Carulli et al., 2006; Haggerty et al., 2017). ECM
composition differs between different tissues, offering tissue-specific regulation of
structure, biological and biomechanical behaviour, and is reported to contribute to 20%
of the total volume of the adult CNS (Sobel, 1998).
Whereas fibrous proteins, such as collagen, laminin and fibronectin are enriched in
the ECM of peripheral tissue, the opposite is the case in CNS tissue. The ECM of the
spinal cord comprises mostly of glycosaminoglycans (GAGs) and proteoglycans
(DeQuach et al., 2011; Rauch, 2007). GAGs are long unbranched polysaccharides of a
variable number of repeating disaccharide units, and hyaluronan (HA) is the most
abundant GAG and ECM structural component in the CNS. Due to their polyanionic
properties, HA attracts positively charged cations, such as sodium ions and water. Its
large water retaining capacity results in a highly hydrated ECM and contributes to the
low stiffness of the spinal cord. Proteoglycans are composed of a protein core with GAG
side chains. Chondroitin sulfate proteoglycans (CSPG) are an important group of
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proteoglycans within the spinal cord ECM and include aggrecan, versican, neurocan, and
brevican. In the healthy CNS, proteoglycans mediate activities, such as cell adhesion,
growth, migration, and receptor binding (Rhodes and Fawcett, 2004). The GAG chains
of proteoglycans can form a matrix of varying pore size, which can serve as a regulator of
cell migration, for instance.
In response to mechanical damage, the composition of the ECM at the lesion site and
glial scar is altered with the increased expression of matrix metalloproteinases (MMP) and
deposition of ECM molecules which are inhibitory to neurite outgrowth (Fitch and Silver,
2008; Volpato et al., 2013). For instance, increased expression of neurocan, brevican,
phosphacan, and versican has been shown to persist for up to two months after spinal
cord injury in vivo, and has been shown to inhibit axonal regeneration (Jones et al., 2003).
It is thought that the CS-GAG chains are particularly inhibitory to neurite outgrowth and
possible mechanisms of inhibition include binding to membrane-bound receptors mediating
inhibition, and blocking the functions of growth-promoting molecules such as laminins
(Sharma et al., 2012). This knowledge of ECM alterations following injury has been
exploited to develop tissue engineered constructs to enhance or deposit growth promoting
ECM factors, for instance (Volpato et al., 2013).
1.3 Biomechanical Properties of the Spinal Cord
Biomechanics is the study of the responses of the body and tissues to mechanical loading,
and defining the biomechanical properties of tissues is important for understanding their
native function and discerning their tolerance to mechanical loading. Thus, determining
the effects of different injury mechanisms on the cellular responses in the spinal cord may
provide more effective strategies for treatment. Modulus, a commonly measured
biomechanical property of tissues, is defined as the tendency of a material to deform
along an axis upon application of a force, and is typically measured in units of Pascals
(Pa). Modulus can be determined under shear, compressive, or tensile loading, which has
led to variability in reported data for the spinal cord, as reviewed by (Bartlett et al.,
2016b).
Biological tissues, such as the spinal cord exhibit viscoelastic behaviour: both viscous
and elastic properties under stress and deformation (Bilston, 2011). This behaviour is
time-dependent; thus, the moduli calculated will depend on the strain rate applied to the
tissue. Albeit not the predominant mechanism of injury in humans, uniaxial tensile testing
is the most common biomechanical test to determine the relationship between force and
tensile deformation (Cheng et al., 2008). Studies pertaining to the stress-strain response
of spinal cord tissue to tensile forces is summarised in Table 1.2. The values reported
are in fact pseudo-moduli as they are derived from the gradient of the linear region of a
stress-strain curve. The inherent cylindrical-like nature of the spinal cord makes specimen
loading onto the apparatus more convenient (Bilston, 2011). However, securing soft tissues,
such as the spinal cord, into grips proves difficult due to the risk of tissue damage at the
clamping point.
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Variables, such as tissue origin, segment of the spinal cord tested, age of the tissue,
testing environment, boundary conditions, mode of testing, and preconditioning have
contributed to variable data between groups. There is yet no consensus on the
appropriate parameters and sample preparation procedures, resulting in a lack of
standardised protocols. The lack of a standardised testing protocol is evident, resulting
in tensile modulus values ranging from 0.012 MPa to 1.98 MPa (Table 1.2). The earlier
tensile studies were performed in vivo thus the environmental conditions differed
significantly from ex vivo studies (Hung and Chang, 1981; Hung et al., 1981a,b). For
instance, the spinal cord in vivo is under tensile pre-strain and this has been suggested
to contribute to the more linear stress-strain relationship observed, compared to the
J-shaped response in ex vivo studies by Bilston and Thibault (1995), Fiford and Bilston
(2005) and Oakland et al., (2006).
Further, the presence or absence of some or all of the meningeal components have
contributed to the varied results as the meninges has been shown to contribute
significantly to the stiffness of the spinal cord (Mazuchowski, Thibault, et al., 2003;
Ozawa et al., 2004; Ramo et al., 2018). Another limitation of these studies is that the
strain rates used are not comparable to those experienced during a traumatic SCI event,
which is in the order of milliseconds. However, a study by Mazuchowski, Thibault, et al.,
(2003) showed that the spinal cord appears to be rate insensitive in the axial direction at
higher rates (0.2, 1, 10 s−1), with a reported Young’s modulus of ∼1.40 MPa which is
within the range of moduli reported by Bilston and Thibault (1995).
The compressive properties of the spinal cord has been less studied despite being a
prominent mechanism of SCI and the majority of experimental injury models utilise
compression/contusion (Sharif-Alhoseini et al., 2017). Karimi et al., (2017) performed an
ex vivo study on the compressive properties of male human cervical spinal cord and
calculated the elastic modulus to be 40.12 kPa (5 mm.min−1 to failure). This is lower
than the moduli reported for human spinal cord under tensile loading (Table 1.2)
highlighting the anisotropy of the spinal cord. Further, the spinal cord is a complex
cellular structure, with its highly organised cytoarchitecture contributing to its
viscoelastic and non-linear anisotropic properties (Koser et al., 2015; Shreiber et al.,
2009). For instance, the orientation of axons in the white matter along the craniocaudal
direction could contribute to the tensile strength of the spinal cord.
Despite a wide range of tools available to evaluate the mechanical properties of the
spinal cord (as reviewed by Bartlett et al., (2016b) and Cheng et al., (2008)) the lack of
consensus and standardised protocol for specimen acquisition, setup and testing
parameters has led to the variability in moduli reported. There is also a discrepancy in
the level of experimental detail reported, which impedes the comparison of data between
studies. However, this data has led to the development of useful in silico models for
predicting stresses and strains in response to simulated injury, and continues to inform
research into applications where the design of tissue engineered therapies requires the








Table 1.2: Tensile testing studies involving measurement of the biomechanical properties of the spinal cord. Summary of the studies
involving tensile testing of the spinal cord, including the species used, properties of the sample, and mechanical testing parameters. The region from
which the spinal cord sample was taken refers to the vertebral segments. Reported moduli values are pseudo-moduli, which is the gradient of the linear
region of the stress-strain curve. * = unless stated otherwise. Stretch ratio (λ) = L/L0, where L is the instantaneous length of the specimen and L0 is
original length of specimen hanging under its own weight. NR = Not Reported.
Reference Species Region Sample
Length
(mm)
Strain rate (s−1)* Maximum Strain (%)* Modulus (MPa)
(Luna et al., 2013) Sea lamprey Whole 30 – 50 0.5 – 2 mm at a time
using manipulator
18 0.015 – 0.5
(Oakland et al., 2006) Cow NR 130 – 180 0.24 ∼8.5 1.19
(Fiford and Bilston, 2005) Rat (∼230 g) C1 – L4 NR 0.002, 0.02, 0.2 5 1.14 – 1.98
(Mazuchowski, Thibault,
et al., 2003)
Human (59 – 81
yrs)
Whole 50 + pia mater: 0.2, 1, 10;
– pia mater: 0.1, 1, 10
+ pia mater: λ = 1.06 – 1.20;
– pia mater: λ = 1.5
+ pia mater = 1.40;
– pia mater = 0.089
(Bilston and Thibault,
1995)




30 – 45 0.048, 0.120, 0.225 ∼10 1.02, 1.17, 1.37
(Hung and Chang, 1981) Puppy (3 – 5
kg)
L1 – L2 8 0.003 1.70 0.265
(Hung et al., 1981b) Cat T8 – T11 25 0.0008 8 – 12 0.4
(Hung et al., 1981a) Cat L1 – L12 7 0.002 1, 16 0.252, 0.295
(Tunturi, 1978) Dog NR 120 Quasi-static (5 g
increments)
19 (failure) 0.012 – 0.017
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1.4 The Spinal Cord under Physiological Conditions
The spinal cord and vertebra experiences constant loading through everyday
physiological activities, such as walking and lifting objects where flexion, extension and
rotational movements occur. The vertebral column, together with associated ligaments,
muscles, and intervertebral discs (IVD) results in a structure which can support and
distribute compressive loading repetitively whilst also encasing and protecting the spinal
cord. For instance, Cappozzo (1983) predicted the L3-L4 forces during various speeds of
gait in five young males to range from 0.2 to 2.5 times body weight throughout the gait
cycle.
The spinal cord itself must also tolerate dynamic loads under physiological
conditions, particularly the cervical spinal cord due to the movements of the head and
neck. The anteroposterior diameter of the cervical spinal cord has been shown to be up
to 0.5 mm larger in extension and smaller in flexion, compared to the neutral position
(Kuwazawa et al., 2006). The spinal cord occupies up to approximately 45% of the
vertebral canal at the C2 – T1 level with little change in canal occupation under flexion
or extension; thus, the cord is able to deform in a relatively unconfined manner without
resulting in damage (Sayıt et al., 2015). Another observation in that study was that
during extension at the C4 – C6 level, the diameter of the spinal canal was at its
smallest, with maximum disc bulging and ligamentum flavum thickness. This makes this
region more susceptible to compression and this knowledge may contribute to the design
of injury risk prevention tools.
Ageing and diseases can reduce the load-bearing capacity of the vertebra, resulting in
weakened support and increased risk of fracture, exposing the spinal cord to damage. In
a society where the mean life expectancy is increasing, the population at risk of fractures
and spinal cord injuries grows, which has implications for the individual, and health and
social care services. Further, an increase in load above the physiological threshold can also
result in spinal cord injury with or without vertebral column failure, which often occurs
following high velocity and energy traumatic events.
1.5 Traumatic Spinal Cord Injury
Traumatic spinal cord injury (TSCI) results from the acute lesion of the neural
components of the spinal cord, above its physiological threshold, resulting in temporary
or permanent sensory and/or motor loss below the level of injury. Trauma may involve
failure of ligamentous support to the spinal cord, or dynamic interactions between the
spinal cord and vertebral column (Szwedowski and Walecki, 2014). Non-traumatic spinal
cord injury differs in that deformation of the cord is degenerative and occurs over a
longer time period of up to years (David et al., 2019).
Global incidences (the number of new cases per year) of TSCI vary widely, with one
systematic review reporting a range of 3.6 to 195.4 patients per million, across 41 individual
countries (Jazayeri et al., 2015). This creates an enormous burden, not only on the
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mental and physical welfare of the patient themselves, but also on the socioeconomic
environment. It is estimated that the annual cost of treating and managing spinal cord
injury is £1 billion, in the UK (McDaid et al., 2019). The severity of TSCI depends on
the level, mechanism, and extent of injury, but includes permanent locomotor and sensory
deficits, and may lead to neuropathic pain, spasticity, urinary and respiratory dysfunction,
metabolic problems as well as psychological problems (Watson et al., 2009).
1.5.1 Biomechanics of Traumatic Spinal Cord Injury
TSCI results from a number of diverse causes, including falls, motor vehicle accidents
(MVA), sports-related incidents, and violence. Globally, MVAs and falls are the most
common causes of TSCI, although the incidence of falls in the elderly is increasing due to
the increasing ageing population (Center et al., 2015; Singh et al., 2014). These events
cause a wide variety of injuries to the vertebral column and spinal cord. Common
mechanisms of TSCI involving the vertebral column include, burst fracture, distraction
or and dislocation (Oxland et al., 2010; Panjabi and White, 1990). Injuries most
frequently occur at the cervical level, which poses a larger problem due to the increased
severity and number of functional deficits at this level (Singh et al., 2014). This is likely
due to the increased range of motion around the head and neck, along with the smaller
size of the cervical vertebrae making this region more vulnerable to forces which surpass
the physiological threshold (Sekhon and Fehlings, 2001).
A burst fracture type injury may result from high speed motor vehicle accidents,
resulting in vertebral fracture and secondary retropulsion of bony fragments into the
spinal cord at high velocity. Approximately 15 – 30% of all acute SCIs arise from this
type of trauma (Denis, 1983; Sekhon and Fehlings, 2001). This leads to a contusion
and/or compression mechanism of SCI. Although velocities of burst fractures, and other
injury mechanisms, cannot be measured directly in clinical scenarios, ex vivo experiments
using bovine and human cadaveric vertebral segments have shown that velocities of 1 –
10 m.s−1 were achieved (Panjabi et al., 1994; Wilcox et al., 2003). Further, maximum
canal occlusion has been shown to be achieved during the dynamic injury, which is
under-represented in post-injury radiographs and may lead to an underestimation of the
severity of the initial injury (Wilcox et al., 2003, 2002).
Dislocation involves the relative translation of two adjacent vertebra, exerting a
combination of compressive, tensile, and shear forces on the spinal cord (Russell et al.,
2012). Thus, it is typically an unstable injury, meaning further mechanical and biological
damage is likely without appropriate intervention to stabilise the injury. Dislocation
injury may occur with or without fracture and is the most commonly observed injury
mechanism, occurring in roughly 32 – 58% of SCI cases (Sekhon and Fehlings, 2001;
Tator et al., 1987; Tator, 1983; Wilson et al., 2013). Ivancic et al., (2007) modelled a
frontal sled impact on human cadaveric vertebral segments to produce a dislocation
injury, and the mean velocity was reported to be 0.23 m.s−1.
Distraction injuries arise when adjacent vertebrae are pulled apart, with the spinal cord
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being stretched in the axial plane, and is commonly observed in motor vehicle accidents
where rapid deceleration can cause hyperflexion, or sudden backwards acceleration leads
to hyperextension leading to a combination of compressive and tensile forces acting on
the cord (Dumont et al., 2001). The role of distraction in TSCI is more difficult to define
and correlate with SCI outcomes because distraction usually occurs in concert with other
mechanisms, such as flexion (Vaccaro et al., 2005). It is important to understand the
relationship between the structure and function of the vertebral column, with respect to
the spinal cord, in order to understand how the consequent injury evolves during a TSCI.
1.6 Pathophysiology of Traumatic Spinal Cord Injury
The pathophysiological events following trauma are complex, heterogeneous, and involve
many cell types and molecules. The events following the initial trauma evolve over time
and can manifest itself in many ways depending on the location and severity of the injury,
and the cells affected. Therefore, each patient will present unique pathologies, and treating
them with the same strategy is unlikely to yield the same results.
1.6.1 Primary Injury
The primary response to injury is concurrent with the mechanical load on the cord and
occurs within the order of milliseconds. A combination of the initial impact and persistent
compression after injury (resulting commonly in burst fracture and fracture-dislocation) is
most typical of TSCI, giving rise to local cell death, ischaemia, and disruption of the blood
spinal cord barrier (BSCB) (Dumont et al., 2001). Other morphologies of primary injury
include impact alone with transient compression, distraction, and laceration/transection
(Oyinbo, 2011). The cytoarchitecture of the spinal cord is altered dramatically: damage of
nerve fibre pathways in the white and grey matter means that spinal segments below the
level of the injury cannot receive nor transmit signals to the brain, and disruption to the
blood spinal cord barrier typically occurs (Norenberg et al., 2004). Blood-borne immune
cells also begin to infiltrate the injury site to initiate the inflammatory process alongside
the activation of resident microglia and astrocytes, which evolves and becomes amplified in
the secondary phase of pathology. Downstream events following the primary injury involve
a complex cascade of cellular and immunological events- the secondary injury- culminating
in a degenerative microenvironment which is inhibitory to neuroregeneration.
1.6.2 Secondary Injury
The primary injury triggers a secondary reactive phase which comprises a cascade of
numerous systemic and cellular events initiated within minutes following the primary
injury. This process can last for days, weeks, or even years (Bareyre and Schwab, 2003;
Oyinbo, 2011). Common events occurring during this phase include, inflammation,
astrogliosis, axon degeneration, free-radical production, and formation of a glial scar and
cystic cavity (Fleming et al., 2006). A summary of common events which occur during
the secondary pathophysiological response to SCI can be seen in Table 1.3. For the scope
of this thesis, the events of astrogliosis will be described in more detail. As a result of
continued degeneration, the lesion can expand radially and longitudinally leading to
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further damage to the spinal cord in areas which were not affected by the initial impact
(Schwab et al., 2006; Zhou et al., 2014).
Table 1.3: Common characteristics of the secondary pathophysiological
response to traumatic spinal cord injury. AAD = acute axonal degeneration.
CSPG = chondroitin sulfate proteoglycan. ECM = extracellular matrix. GFAP = glial
fibrillary acidic protein. MAI = myelin associated inhibitor. MMP = matrix
metalloproteinase. NO = nitric oxide.
Characteristic Description Reference(s)
Glial scar Astrocytes undergo astrogliosis: increased
GFAP expression, hypertrophy, proliferation,
and formation of a compact glial scar- composed
predominantly of fibroblasts and inflammatory




Hypoxic conditions lead to widespread necrosis
and apoptosis, release of free radicals e.g. NO,
neurotransmitters, and calcium ions, which
signals excitotoxicity to neighbouring cells.
(Dong et al.,
2009)
Inflammation Infiltration of blood-borne immune cells and
activation of innate microglia mediate clearance
of debris and release of pro-inflammatory
cytokines e.g. IL-6, TNF-α, IL-1β and IFN-γ.
M1 macrophage response can persist for months
following initial injury resulting in an imbalance




Zhou et al., 2014)
Neurodegeneration AAD and Wallerian degeneration occurs in




ECM alterations Upregulation of MMPs and collagenases;
deposition of ECM components e.g. CSPGs,





1.6.2.1 Astrogliosis and Glial Scar Formation
One major mechanical and chemical barrier to regeneration is the formation of the glial
scar and fluid-filled cystic cavity where debris has been cleared by macrophages and
microglia (Fitch and Silver, 2008). Formation of the glial scar is primarily mediated by
reactive astrocytes, in concert with glia, neurons and other non-neuronal cells, such as
pericytes (Burda and Sofroniew, 2014). Astrocytes in particular respond to CNS insult
by triggering a gradated response to injury through the process of astrogliosis, or
reactive gliosis (Sofroniew, 2015). Astrogliosis encompasses a spectrum of molecular,
structural and functional alterations in astrocytes which are regulated in a context and
severity-dependent manner (Figure 1.4).
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Figure 1.4: Astrogliosis is a spectrum of heterogeneous molecular, cellular and
functional changes. Astrocytes in the healthy CNS express little GFAP and there is little
overlap of individual astrocyte domains. In response to a mild or moderate insult, variable
alterations in GFAP expression and cellular hypertrophy occur depending on the injury
type and severity. Astrocyte domains remain distinct and do not overlap. Severe diffuse
astrogliosis is characterised by overlapping of astrocyte processes and proliferation over
a more widespread area. Severe astrogliosis with glial scar formation sees the formation
of a glial scar composed of reactive and proliferating scar-forming astrocytes, other cell
types such as fibroblasts and meningeal cells, as well as an altered ECM microenvironment
with increased deposition of collagen and CSPGs. This creates a barrier against axons
and inflammatory cells. Adapted and modified from Sofroniew and Vinters (2010) using
Biorender.
The glial scar exhibits altered ECM with increased deposition of chondroitin sulfate
proteoglycans (CSPGs) by reactive astrocytes around the lesion site, which has been
shown to inhibit neurite outgrowth (Jones et al., 2003; Siebert et al., 2014; Snow et al.,
1990). Other components of the glial scar include myelin-associated inhibitors (MAIs), a
class of neurite growth inhibitors produced by oligodendrocytes in the CNS. Prototypical
MAIs include Nogo, myelin associated glycoprotein (MAG), Semaphorin 4D (Sema4D),
and oligodendrocyte myelin glycoprotein (OMgp) (Chen et al., 2000; Kottis et al., 2002;
McKerracher et al., 1994). Although the glial scar creates a physical barrier for
regeneration, it has also been shown to also be beneficial, limiting the spread of further
damage (Faulkner et al., 2004). Studies where glial scar formation was inhibited through
ablating reactive astrocytes showed worsening of functional outcome in animals, and it is
thought reactive astrocytes also play roles in repairing the blood-spinal cord barrier and
secretion of anti-inflammatory cytokines after injury (Faulkner et al., 2004; Sofroniew,
2005).
1.7 Treatment Strategies for Spinal Cord Injury
A complex injury brings with it complex treatment strategies. Given the unexpected
nature of TSCI and the primary injury, maintaining proper breathing and
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immobilisation of the spine typically take precedence over repairing the damage to the
cord itself. Therefore, therapeutic intervention has more commonly been directed
towards mediating the secondary pathological reactions. However, treatment strategies
also vary with the extent of secondary injury, that is the acute, subacute or chronic
stage, where major temporal differences in cellular activity, gene expression, and
inflammation exist. Despite the vast number of therapeutic targets and clinical trials
that have been identified and initiated over the years, this has not translated into
treatments which effectively restore sensorimotor function to the patients. A brief
overview of the current treatment strategies for SCI is presented in Table 1.4.
Table 1.4: Current treatment strategies for SCI.A non-exhaustive list of








Primary aim is to maintain
breathing and stabilise
the patient; uncertainty
over optimal timing of
decompressive surgery








shown to not be associated with
short- or long-term benefits
(Sultan et al., 2020)
Cell Therapies iPSC, BM-MSC, PBSC, NSC,
OEC
Directly replace or induce
repair of damaged cells
through indirect secretion
of neurotrophic factors and
cytokines (Li and Lepski, 2013)
Biomaterials NGC, NeuroRegen scaffold with




commonly used in combination
with cells, drugs, or growth
factors (Ashammakhi et al.,
2019)
BM-MSCs = bone marrow-derived mesenchymal stem cells; BMMC = bone marrow mononuclear cells;
CSF = cerebrospinal fluid; hUCB-MSCs = human umbilical cord blood-derived mesenchymal stem
cells; iPSC = induced pluripotent stem cells; NGC = nerve guidance conduit; NSAID = non-steroidal
anti-inflammatory drugs; OEC = olfactory ensheathing cells; PBSC = peripheral blood stem cells; NSC
= neural stem cells
Many factors affect the progression of secondary injury and neural regeneration,
including the glial scar, CSPGs, demyelination and inflammation; thus, a combinatorial
approach to address multiple different aspects of injury are likely to be more effective.
However, it is clear that the understanding of the pathophysiology of SCI in humans is
still limited, and increasing weight is being placed upon the appropriateness of
preclinical models to reflect injury in humans. The research in this thesis will hopefully
highlight the critical importance of modelling human injury biomechanics and how it can
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affect cellular behaviour in vitro which, in turn, may lead to the development of
preclinical models which are better informed.
1.8 Models of Traumatic Spinal Cord Injury
Spinal cord injury models have become extremely useful tools for discerning the
biomechanics and pathophysiology of traumatic spinal cord injury, and for the testing of
interventions aimed at improving functional recovery following injury. The injury
models encompass in vitro, in vivo and in silico techniques, all of which have been
designed with the aim to faithfully replicate one or more aspects of human SCI.
1.8.1 In vivo Models
Animal models provide an alternative complex system in which to study SCI since it is
practically and ethically difficult to experiment using human participants. They have
played a vital role in discerning injury mechanisms and for the development of therapies.
However, the positive effects commonly observed in these preclinical models are usually
not reflected in human trials. It has been shown that species, size, anatomical, and
pathophysiological differences in animals contribute to the significant barriers of
translation of treatments into humans (Cheriyan et al., 2014).
Rats are the most frequently utilised animal model as they are relatively inexpensive
to acquire and care for, thus can be studied in large numbers (Zhang et al., 2014).
Pathophysiologically, rats are similar to humans in that they develop glial scars and
fluid-filled cystic cavities at the injury site following SCI (Kjell and Olson, 2016).
Functional assays and endpoints are also well established for studying the effects of TSCI
in rats, such as the widespread reporting of the BBB (Basso Beattie Bresnahan)
Locomotor Rating score (Basso et al., 1995). However, it is yet unclear how these
endpoint measurements translate to humans, if possible, which is impeding clinical
translation of SCI therapies.
The biomechanics of TSCI have becoming increasingly important in understanding how
the spinal cord comes to be damaged and the influence of mechanical deformation on the
progression of secondary injury. For the scope of this thesis, it will be important to examine
the current literature for information regarding the biomechanical parameters used in SCI
models, including the output measurements in order to discuss the relationship between
injury biomechanics and biological outcomes. A summary of biomechanical studies of
TSCI with reported input and output kinetic parameters is presented in Table 1.5. Non-
biomechanical SCI models, such as chemically-induced SCI do not incorporate the element
of biomechanical control so will not be discussed here. A number of apparatus capable
of simulating any one or multiple mechanisms of injury have been developed and refined
since the first weight drop contusion model was developed in 1911 by Allen (1911). The
most commonly utilised biomechanical models of TSCI comprise contusion, compression,
dislocation, and distraction mechanisms of injury. Transection models, although frequently








Table 1.5: In vivo biomechanical models of traumatic spinal cord injury. In vivo models of TSCI.






17 – 30 wk





C4 Tip = 0.6 mm
Force = 30 kDyn
Dwell = 0 s
Displacement = 0.31 ± 0.03 mm
Peak velocity = 120 mm.s−1









Displacement = 1.1 mm
(mild); 1.8 mm (severe)
Dislocation
Displacement = 1.7 mm
(mild); 2.5 mm (severe)
Contusion
Displacement = 0.94 ± 0.24 mm (mild);
1.55 ± 0.19 mm (severe)
Dislocation
Displacement = 0.70 ± 0.08 mm (mild);











C6/7 Tip = 4 mm
Waveform:
200 ms dwell
1000 mm.s−1 ramp to 2.0, 3.0
or 4.0 mm
20 ms dwell
1000 mm.s−1 ramp to 0 mm
Displacement range = 1.71 – 3.72 mm
Peak velocity range = 270 – 580 mm.s−1
Time to peak displacement = 20 ms
Impact force range = -3.27 – -23.19 N
Force at peak displacement = -0.16 – 19.10
N
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4 – 5 mths
2.5 – 3.0 kg
Custom Uniaxial
distraction
L1 – L3 Displacement = 10, 20, 30%
1 turn = 2.5 mm; 5 mm dwell
for each turn











C5/6 Velocity = 1000 mm.s−1
Contusion
Tip = 2.0 mm
Displacement = 1.6 mm
Dislocation
Displacement = 1.8 mm
Distraction
Displacement = 5.6 mm
(All mechanisms defined as moderate)
Contusion
Displacement = 1.59 ± 0.01 mm
Peak velocity = 1206 ± 78 mm.s−1
Impact force = 2.57 ± 0.53 N
Dislocation
Displacement = 1.84 ± 0.02 mm
Peak velocity = 870 ± 11 mm.s−1
Impact force = 18.0 ± 1.9 N
Distraction
Displacement = 5.64 ± 0.10 mm
Peak velocity = 1298 ± 40 mm.s−1
Impact force = 52.2 ± 2.9 N
(Mean ± SD)
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Contusion C5/6 Tip = 2.0 mm
Displacement = 0.9, 1.5 mm
Velocity = 8, 80, 800 mm.s−1
Dwell = 0 s
Displacement range = 0.880 ± 0.003 –
0.896 ± 0.002 mm
1.459 ± 0.006 – 1.471 ± 0.032 mm
Peak velocity range = 8.263 ± 0.928 –
8.797 ± 1.003 mm.s−1
83.800 ± 1.112 – 83.868 ± 1.396 mm.s−1
838.272 ± 2.921 – 840.555 ± 1.696 mm.s−1
Impact force range = 0.637 ± 0.106–2.134
± 0.266 N











T9 Tip = 2 mm
Velocity = 700 mm.s−1
Displacement = 1 mm
Residual compression = 0, 40,
90%
Dwell = 60 min
Displacement = 1 mm
Peak velocity = 700 mm.s−1
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T12 – L1 Infant
Displacement = 1.6, 2.8, 4.0
mm
Velocity = 40, 80, 100 mm.s−1
Adult
Displacement = 4, 7, 10 mm
Velocity = 100, 200, 250
mm.s−1






20 – 25 kg
Custom weight
drop
Contusion T10 – 11 Tip = 9.53 mm
Tip mass = 50 g
Drop height = 5, 10, 20, 30,
40 cm
Dwell = 5 min (+ 100 g)
Peak velocity range = 1830 ± 20 – 2670
± 30 mm.s−1
Impact force range = 11.1 ± 1.2 – 66.6 ±
7.8 N
Dural displacement range = 2.1 ± 0.4 –





51.6 ± 2.5 kg
Custom Distraction T9 Displacement = 1 mm
intervals until TES-MEP
recordings decreased by >
80%
Dwell = 60 s every 3 mm; 90
s at SCI
NR
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300 – 350 g
IH impactor Unilateral
contusion
C5 Tip = 15 mm
Force = 150 kDyn
Displacement = 1512.72 ± 27.86 µm
Peak velocity = 120.24 ± 0.52 mm.s−1







NYU MASCIS Contusion T8 Tip = 2.0 mm
Tip mass = 10 g
Impact height = 6.25 mm
(mild); 12.50 mm (moderate);






275 – 300 g
IH Impactor Hemicontusion C5 Tip = 0.8 mm
Force = 100 kDyn (mild); 200
kDyn (moderate); 300 kDyn
(severe)
Displacement = 679.3 ± 19.0; 1226.2 ±
25.5; 1614.6 ± 23.9 µm
Peak velocity† = 118.5 ± 1.1; 124.5 ± 1.5;
118.7 ± 1.0 mm.s−1
Impact force = 103.4 ± 1.0; 213.6 ± 2.8;
312.6 ± 3.0 kDyn
(Mean ± SEM)
†Standard used with E of rodent spinal cord
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200 – 230 g
IH Impactor Contusion C5 Tip = 3.5 mm
Force = 200 kDyn (mild); 250
kDyn (moderate)
Dwell = 0 s
Impact force range = 208 – 231; 250 – 287
kDyn
Peak velocity = 113 ± 1.7; 120.3 ± 7.3
mm.s−1
(Mean ± SD)

















Velocity = 1000 mm.s−1
Contusion:
Tip = 2.0 mm
Displacement = 1.1 mm
Dislocation:
Displacement = 2.3 mm
(50%); 3.7 mm (100%)†
Distraction:
Displacement = 5.1 – 6.1 mm;
4.1 – 4.6 mm ± flexion
Dwell = 1 s
†Percentage canal occlusion
Contusion:
Displacement range = 1.1 ± 0.02 mm
Peak velocity range = 978 ± 37 mm.s−1
Impact force range = 2.1 ± 0.5 N
Dislocation:
Displacement range = 2.3 – 3.7 mm
Peak velocity range = 753 – 1026 mm.s−1
Impact force range = 13.2 – 30.9 N
Distraction:
Displacement range = 4.1 – 6.1 mm
Peak velocity range = 856 – 968 mm.s−1
Impact force range = 24.1 – 43.9 N
(Mean ± SD for contusion)
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18 – 20 g
10 wks
Custom Contusion T8/9 Tip = 1.3 mm
Displacement = 0.8 mm
Velocity = 100, 200, 400
mm.s−1
Dwell = 20 ms





Custom Contusion NR Pellet area = 78.5, 157, 314
mm2
Pellet mass = 7.0 g





210 – 320 g
Modified OSU
Impactor
Contusion T10 Tip = 2.0 mm
Displacement = 1 mm
Velocity = 3, 300 mm.s−1
Displacement = 0.90 ± 0.03; 1.03 ± 0.10
mm
Peak velocity = 2.69 ± 0.43; 307 ± 5.8
mm.s−1
Impact force = 0.54 ± 0.05; 2.37 ± 0.30 N
Energy = 2.6 x 10−4 ± 1.7 x 10−5; 1.4 x
10−3 ± 2.1 x 10−4 J
Stiffness = 0.61 ± 0.07; 2.4 ± 0.28
N.mm−1
(Mean ± SD)
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See (Choo et al., 2009) Contusion:
Displacement = 1.1 ± 0.02 mm
Peak velocity = 998 ± 37 mm.s−1
Impact force = 1.5 ± 0.4 N
Dislocation:
Displacement = 2.5 ± 0.12 mm
Peak velocity = 956 ± 32 mm.s−1
Impact force = 24.7 ± 5.7 N
Distraction:
Displacement = 4.1 ± 0.03 mm
Peak velocity = 1112 ± 35 mm.s−1
Impact force = 37.9 ± 5.4 N
(Mean ± SD)
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See (Choo et al., 2009) Contusion:
Displacement = 1.1 ± 0.06 mm
Peak velocity = 967 ± 48 mm.s−1
Impact force = 2.0 ± 0.5 N
Dislocation:
Displacement = 2.5 ± 0.16 mm
Peak velocity = 951 ± 95 mm.s−1
Impact force = 20.7 ± 6.5 N
Distraction:
Displacement = 4.1 ± 0.01 mm
Peak velocity = 919 ± 29 mm.s−1







IH Impactor Contusion T9 Tip = 1.25 mm
Force = 30 kDyn (mild); 50
kDyn (moderate); 70 kDyn
(severe)
Data represented by graphs. No raw data.
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C5 Tip = 2.0 mm
Tip mass = 10 g
Drop height = 6.25 mm
(mild); 12.5 mm (moderate)
Displacement = 2.11 ± 0.24 mm; 2.66 ±
0.24 mm
Peak velocity = 350 ± 10 mm.s−1; 490 ±
10 mm.s−1
Displacement rate = 0.28 ± 0.02 mm.s−1;






260 – 290 g
Harrington
distractor
Distraction T9/11 Displacement = 3 mm (mild);
5 mm (moderate); 7 mm
(severe)
Velocity = 1, 5, 10 mm.s−1






16 – 18 g
6 – 8 wks
IH Impactor Contusion T10 Force = 30 kDyn (mild); 50
kDyn (moderate); 70 kDyn
(severe)
Displacement range = 176 – 405 µm; 370






OSU ESCID Contusion C5 Tip = 4.0 mm
Displacement = 0.80 mm
(mild); 0.95 mm (moderate);
1.10 mm (severe)
NR
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Dislocation T12 – L2 Displacement = 1 – 20 mm
Velocity = 50 – 150 mm.s−1
Dwell = 1 s
Displacement range = 3.2 – 7.5 mm
Velocity range = 57 – 127 mm.s−1




200 – 225 g
IH Impactor Contusion T10 Tip = 2.5 mm
Force = 100 kDyn (mild); 150
kDyn (moderate); 200 kDyn
(severe)
Peak velocity = 122 ± 3.6 mm.s−1
Impact displacement and force data







Contusion T9 Displacement = 0.3, 0.5, 0.8
mm
Dwell = 12 – 14 ms





19 – 24 g
10-15 wks
OSU ESCID Contusion T9 Tip = 1.35 mm
Displacement = 0.3, 0.5, 0.8
mm
Dwell = 12 – 14 ms
Impact displacement = 0.284 ± 0.001;
0.498 ± 0.002; 0.792 ± 0.003 mm
Peak force = 51.5 ± 5.0; 102.4 ± 9.5; 185.4
± 13.9 kDyn
Impulse momentum = 0.613 ± 0.069;
1.045 ± 0.158; 1.634 ± 0.204
(Mean ± SEM)
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OSU ESCID Contusion T9 Tip = 1.3, 1.4 mm
Displacement = 0.5, 0.7, 0.9
mm
Dwell = 10 ms
Peak displacement = 0.50 ± 0.001; 0.70 ±
0.001 mm
Peak force = 100 ± 3; 143 ± 6 kDyn
Peak velocity = 14.80 ± 0.21; 17.94 ± 0.20
mm.s−1
Peak energy = 3.3 x 10−3 ± l x 10−4; 5.9
x 10−3 ± 2 x 10−4 kDyn.cm−1
(Mean ± SEM)













Contusion T8 Tip = 1.5 mm
Mass of tip = 1, 2, 3 g
Drop height = 2.5, 5.0 cm
NR
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136 – 325 g
OSU ESCID Contusion T6 Tip = 2.0 mm
Group II:
Maximum force = 12 – 147
kDyn
Dwell = 4 – 16 ms
Group III:
Displacement = 2 mm
Dwell = 10 ms
Group II:
Displacement range = 0.38 – 2.48 mm
Force range = 12 – 147 kDyn
Velocity range = 80 – 540 mm.s−1
Work range = 0.33 – 25.30 kDyn.cm−1
Group III:
Displacement range = 0.17 – 0.184 mm
Force range = 65 – 100 kDyn
Velocity range = 400 – 460 mm.s−1
Work range = 1.7 – 6.7 kDyn.cm−1
E = Young’s Modulus; NR = Not Reported; NYU MASCIS = New York University Multicenter Animal Spinal Cord Injury Study impactor; OSU ESCID = Ohio State University
Electromagnetic Spinal Cord Injury Device; SD rats = Sprague-Dawley rats; UBC = University of British Columbia; TES-MEP = Transcranial Electrical Stimulation Motor Evoked
Potential; Output data listed in order of mild, moderate, severe where indicated in the input parameters column.
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1.8.1.1 Contusion
Given velocities of up to 10 m.s−1 have been measured in ex vivo models of spinal cord
injury (Section 1.5.1), reflecting this in in vivo animal models, which are much smaller in
scale, has proved difficult due to practical limitations, including with the rigs available.
Contusion models are designed to inflict a transient bruising injury to the spinal cord.
Contusion is the most common mechanism of injury modelled in vivo, representing 43%
of animal studies (Sharif-Alhoseini et al., 2017). It is clinically relevant due to its
prevalence in human cases (Section 1.5.1). Force feedback-controlled contusion devices,
such as the Infinite Horizons Impactor, comprise a stepper motor capable of producing a
stroke length at a relatively constant velocity and the impacting tip is automatically
withdrawn once the target force is registered. Varying forces have been used to inflict
graded cervical and thoracic injuries in rats and mice, ranging from mild to moderate to
severe, as measured by various behavioural parameters (Anderson et al., 2009; Dunham
et al., 2010; Ghasemlou et al., 2005; Lee et al., 2012; Nishi et al., 2007; Scheff et al.,
2003). However, due to limited sensor feedback the velocity is restricted in order to
prevent an overshoot in force. The requirements for a greater velocity means a greater
distance is required in order to stop once the target force has been achieved with impact
velocities of less than 130 mm.s−1 being achieved in literature (Table 1.5).
The Ohio State University (OSU) Electromagnetic Spinal Cord Injury Device
(ESCID) is similar to the IH impactor in that it utilises a feedback-controlled
electromagnetic impactor; however, displacement can be controlled using this device and
does not result in bouncing as observed with other devices, such as the NYU MASCIS,
because the impactor tip is actively withdrawn from the cord. The OSU ESCID has
been used to model thoracic contusion injury in mice (Jakeman et al., 2000; Ma et al.,
2001; Stokes and Jakeman, 2002) and both cervical and thoracic contusion in rats
(Bresnahan et al., 1987; Pearse et al., 2005). Impact velocities have not been reported in
all studies, but available data shows values of up to 460 mm.s−1 being achieved.
The New York University (NYU)/Multicentre Animal Spinal Cord Injury Study
(MASCIS) impactor utilises the transfer of energy from a weight (typically a 10 g rod)
dropped from a predetermined height onto the spinal cord (Gruner, 1992). An increase
in mass of the weight and/or the height at which it is dropped results in an increase in
injury severity due to the greater energy and displacement applied to the cord. The
impact velocity is also inherently increased so these parameters cannot be decoupled
using these types of devices. One limitation with this device is the potential for
introduction of a second contusion event due to the weight bouncing off the cord from
the initial contusion (Cheriyan et al., 2014).
The University of British Columbia (UBC) multimechanism device was developed more
recently to enable the modelling of contusion, dislocation and distraction SCI in rats
(Choo et al., 2007). The advantage of this device is that both displacement and velocity
can be controlled independently and has the versatility of being able to inflict different
mechanisms of SCI, the only device currently available to do so. It has mainly been used to
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model cervical contusion injury in rats to evaluate the primary and secondary pathologies
and behavioural changes up to eight weeks post-injury (Chen et al., 2016; Choo et al.,
2008, 2007). A variety of displacement and velocities (up to 1 m.s−1) have also been
modelled to investigate the relative importance of each parameter in influencing injury
outcomes (Lam et al., 2014).
1.8.1.2 Compression
Compression models involve the persistent compression of the cord over a relatively
longer period of time, as opposed to the transient nature of contusion injuries. This
mode of injury is more commonly observed in non-traumatic SCI, where injury to the
spinal cord is not caused by a sudden high energy impact, but rather lower velocity
injury which progresses over a time period up to years in length. Examples of causes of
non-traumatic SCI include bacterial infections, spinal stenosis, and tumour compression.
Contusion-compression models, where a contusion injury is followed by sustained
compression is a more common TSCI scenario, particularly resulting from burst fractures
where bone fragments impinge on the cord and remain compressing the cord for a period
of time. Few studies have modelled contusion-compression where the acute contusion
injury has been modelled with clinically relevant impact velocities. Sjovold et al., (2013)
modelled a thoracic contusion-compression injury in rats using UBC multimechanism
device. Contusion at 700 mm.s−1 and 1 mm displacement followed by residual
compression (40 or 90%) for 60 minutes was simulated. Results showed that increased
residual compression resulted in significantly increased haemorrhage and loss of neuronal
nuclei in the grey matter, suggesting residual compression leads to more severe tissue
damage and this is not being reflected in pure contusion models.
Common tools available to inflict a compression injury include a modified aneurysm
clip, calibrated forceps and inflatable balloons (Cheriyan et al., 2014). The clip or forceps
are used to compress the exposed spinal cord to a defined force or width, respectively.
Inflatable balloons attached to catheters have been implanted into the epidural or subdural
space of multiple species, including rats and dogs (Fukuda et al., 2005; Vanický et al.,
2001). By varying inflation volume, rate of inflation and duration, graded injuries have
been produced. Despite these methods being inexpensive, relatively simple, and adaptable
for use at different spinal regions they do not reproduce the biomechanical loads that result
from an acute traumatic impact in humans.
1.8.1.3 Dislocation
Despite being the most prevalent mechanism of TSCI observed in humans, dislocation
injury is not frequently modelled in vivo, representing only 1% of animal studies when
combined with distraction model studies (Sharif-Alhoseini et al., 2017). This is likely
due to the increased complexity of the injury, requiring external clamps to grip onto
adjacent vertebrae, and increased instability of the vertebral column (Section 1.5.1).
Unlike contusion models which typically expose the spinal cord via a dorsal laminectomy,
dislocation models are typically closed column, maintaining the integrity of the spine
and spinal components. Fiford et al., (2004) developed an electromagnetic
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feedback-controlled lateral dislocation device which consisted of two horizontal beams, of
which one was fixed and the other laterally displaced the caudal vertebrae to a defined
displacement (1 – 20 mm) and maximum velocity of 150 mm.s−1. The data showed that
larger displacements resulted in an increase in injury severity, as characterised by
ligamentous failure and fracture. Choo et al., (2009) used the UBC multimechanism
device to model cervical anterior fracture-dislocation, with displacements representing 50
and 100% canal occlusion. Peak velocities ranged from 750 – 1 m.s−1, with the higher
velocities achieved at the larger displacements.
1.8.1.4 Distraction
Distraction models involve axial stretching of the spinal cord, representing the tensile
forces experienced by the spinal cord during flexion and hyperextension injuries.
Distraction injuries are infrequently modelled compared to contusion injury. As
previously mentioned distraction represents only 1% of the total proportion of in vivo
studies when combined with dislocation (Sharif-Alhoseini et al., 2017). Dabney et al.,
(2004) performed a laminectomy in order to place modified Harrington hooks under the
laminae of adjacent vertebrae in rats and inflicted injury using a computer-controlled
stepping motor. Mild, moderate, and severe injury were modelled by varying the
distraction length and velocity, which was limited to 10 mm.s−1. The UBC
multimechanism device utilises clamps which are wedged beneath the transverse
processes of the vertebrae and also has the option of incorporating flexion to better
mimic human flexion-distraction injuries (Choo et al., 2009). A uniaxial distraction was
applied to the cervical spinal cord of rats by distracting the caudal clamp to a defined
displacement.
1.8.2 In vitro Models
In vivo models remain a preferred model to many scientific communities due to their
similarities in biological complexity and (patho)physiology to humans. The requirement
for more representative animal models, particularly larger animals, is becoming
increasingly considered as an important intermediary for the translation of successful
small animal preclinical trials into humans. However, there is a push by some
communities to reduce the usage of animals in SCI research where the likelihood of
causing pain, distress, suffering and lasting harm is greater. Further, it can be difficult
to isolate specific aspects of TSCI pathology due to the high degree of biological
complexity and interactions within the CNS.
Consequently, in vitro models have been developed as an alternative to overcome issues
pertaining to the practical and ethical use of in vivo models, and support the principles
of the 3Rs (Replacement, Reduction, Refinement). They can permit the study of cell-cell
interactions and single cell population experiments in a more controlled environment and
the knowledge gained can be used to complement and/or inform animal studies (Abu-Rub
et al., 2010). In vitro models are available in the form of numerous two- (2D) and three-
(3D) dimensional formats (Table 1.6).
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Table 1.6: Two-dimensional and three-dimensional formats for modelling
spinal cord injury in vitro. A description of the most common types of models used
to investigate SCI in vitro, including their advantages and disadvantages. Figures
created using Biorender.
Model Description Advantages Disadvantages Reference(s)
Two-dimensional
Cell






































• Damage to cells
• Target innervation
lost due to axotomy
(Abu-Rub et
al., 2010)
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Two-dimensional models of SCI have involved plating dissociated cells onto the
surface of rigid materials, such as plastic, glass coverslips, membranes, or hydrogels.
Boomkamp et al., (2014) cultured astrocytes on the surface of plated dissociated mixed
spinal cord cells isolated from rats and used a scalpel to create a lesion across the culture.
They found a lack of neurite outgrowth and reactive astrocyte migration around the
lesion, which is in agreement with results from in vivo models. Neural cell gene
expression, growth, and function is greatly influenced not just by the culture conditions,
but also the microenvironment in which they reside. Cells cultured in 2D generally only
receive nutrients and support from the surface; whereas cells cultured in 3D are able to
receive nutrients in all dimensions (Cukierman et al., 2001; Pedersen and Swartz, 2005).
Further, cell-cell and cell-matrix interactions are not replicated in 2D, which are
important for a variety of functions including cell differentiation, proliferation, viability,
and responsiveness to stimuli (Baker and Chen, 2012).
Cells cultured in 3D adopt more physiological morphologies, compared to 2D, where
the cells are forced to adhere to a rigid surface and adopt a flattened morphology (Friedl
and Bröcker, 2000; Pedersen and Swartz, 2005). Astrocytes cultured in 3D in softer
collagen hydrogels exhibited small and round morphologies with few stress fibres
(Georges et al., 2006). In contrast, on stiffer surfaces, such as the edges of the hydrogel
in contact with the walls of tissue culture plastic, astrocytes exhibited highly spread
morphologies and more stress actin fibres, typical of reactive glia (East et al., 2009;
Georges et al., 2006). This makes it difficult to investigate the effects of external factors
on astrogliosis as the cells are already reactive without the experimental treatment. The
aim of developing 3D in vitro models is to better recreate this unique microenvironment
of the spinal cord and provide an intermediary between 2D monolayer cultures and in
vivo systems.
Organotypic slice culture models involve culturing slices of the spinal cord (150 – 400
µm) typically on semi-porous membranes at the air-liquid interface (Stoppini et al.,
1991). This retains the native cytoarchitecture and neural connectivity of the native
spinal cord, and does not require the dissociation of cells. Pandamooz et al., (2019)
simulated a weight drop contusion injury to 400 µm thick slices of adult lumbar rat
spinal cord slices and observed maximal cell death at Day 1, an increase in GFAP
expression and proliferation, which is in line with the pathophysiological events observed
following SCI in vivo. Weightman et al., (2014) generated 350 µm thick longitudinal
spinal cord slices from mice and applied a lesion using a scalpel. Evidence of astrogliosis
(increased GFAP expression and hypertrophy) and microglial infiltration into the lesion
was observed at 12 days post-injury, mimicking the pathological features of SCI in vivo.
Limitations of the use of organotypic slices include the loss of target innervation due to
axotomy, particularly in transverse slices, and the damage caused to cells through the
slicing process.
Hydrogels have been a popular choice of substrate for 3D cell culture and biomaterial
for tissue engineering applications. Hydrogels are highly hydrophilic 3D networks of
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crosslinked polymer chains capable of holding large amounts of water (Perale et al.,
2011). As a result, they exhibit mechanical properties similar to native soft tissues and
can support cell adhesion, survival and proliferation (Caliari and Burdick, 2016).
Hydrogels can be prepared from both natural and synthetic sources, which have their
advantages and disadvantages (Table 1.6). In the CNS, laminins and collagens have been
shown to promote neural attachment and neurite outgrowth (Barros et al., 2011).
Collagen hydrogels have been used to model SCI in vitro using mechanical and
chemical methods. Bar-Kochba et al., (2016) encapsulated primary rat cortical neurons
in type I collagen hydrogels (2.2 mg.mL−1) and applied compressive strains at strain
rates of 10.s−1 and 75.s−1 to evaluate neuronal pathology. East et al., (2009)
encapsulated primary cortical astrocytes in type I collagen hydrogels (2 mg.mL−1, First
Link UK) and modelled astrogliosis using the chemical, transforming growth factor–beta
1 (TGF-β1). Research at The University of Leeds has also utilised type I collagen (2
mg.mL−1, First Link UK) to model focal contusion injuries using the IH impactor and
BOSE Electroforce BioDynamic 5110 materials testing device (Kirk, 2018; Smith, 2016).
A disadvantage associated with natural hydrogels is that they are mechanically
unstable due to their highly hydrated nature and the loss of some structural and
chemical organisation during the extraction process (Tronci et al., 2015). A summary of
studies pertaining to the mechanical properties of collagen hydrogels is presented in
Table 1.7. These values are lower than moduli reported for the spinal cord (Table 1.2)
which has potential implications for the design of hydrogel-based scaffolds for SCI repair
and influences on cell behaviour (Perale et al., 2011). Variability exists in the mechanical
testing methods and parameters used, and even collagen source and preparation has
been shown to affect mechanical properties (Antoine et al., 2014; Parenteau-Bareil et al.,
2011). Tensile tests have been most commonly used to evaluate the mechanical
properties of SC tissues, whereas compression has been mostly used for hydrogels.
Despite this, collagen hydrogels have already been used in neural tissue engineering
applications, demonstrating successful neural cell attachment, proliferation and survival
(East et al., 2007, 2009; Georgiou et al., 2013; Phillips et al., 2005).
Many naturally-derived hydrogels utilise only one ECM component, such as collagen
or laminin. As the ECM is composed of numerous types of proteins and molecules, there
is a lack of complexity in these biomaterials, which may affect cellular behaviour.
Therefore, a number hydrogels have been developed using methods to assemble
hydrogels using multiple ECM components or prepare hydrogels from decellularised
tissues (Tukmachev et al., 2016; Uriel et al., 2009). Synthetic hydrogels have become
increasingly popular, due to their reduced immunogenicity, reduced batch-to-batch
variation, and increased mechanical tuneability. However, they lack bioactivity thus are
less conducive for cell attachment and survival and require modification to incorporate








Table 1.7: Mechanical properties of type I collagen hydrogels. Studies which evaluated the mechanical properties of collagen type I hydrogels
were summarised as they are pertinent to the hydrogels used in the research in this thesis. Ec = bulk compressive modulus. HA = aggregate modulus. *
= gels were functionalised.
Test Source Concentration Specimen dimensions Testing parameters Modulus Reference
Oscillatory
rheology
Rat tail type I
(First Link UK)
2 mg.mL−1  = 24 well plate
Volume = 500 ul
Strain = 1%
Frequency = 1 Hz
48.66 Pa (Smith, 2016)
Compression Rat tail type I
in-house
0.25 wt%  = 8 mm discs Loading rate =
3 mm.min−1 to failure
Ec = 30 – 168 kPa * (Tronci et al.,
2015)
Compression Rat tail type I
in-house
4–10 mg.mL−1  = 9.5 mm
Thickness = 8.5 mm
Strain rate = 0.1%.s−1
Strain = 0–20%
538 – 10 691 Pa (Antoine et al.,
2015)
Compression Rat tail type I
in-house
0.2–0.4 w/v  = 16 mm
Volume = 1 mL
Mean thickness = 4.79 mm
Strain rate = 0.5%.s−1
Strain = 5%




Rat tail type I
(BD Biosciences)
2 mg.mL−1  = 12 mm Strain = 0.5%
Frequency = 0.1 Hz
4 – 62 Pa (Miron-Mendoza
et al., 2010)
DMA Rat tail type I
(First Link UK)
2 mg.mL−1 Thickness = 0.1 mm
Width = 1 mm strips
Plastically Compressed
Strain = 5 – 30% 1057 – 2305 kPa (Hadjipanayi et
al., 2009)
DMA Rat tail type I
(First Link UK)
2 mg.mL−1  = 1.7 mm




200 mN.min−1 to failure
1.5 MPa (Brown et al.,
2005)
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1.8.2.1 Methods for Simulating SCI In Vitro
With the variety of culture formats available for modelling SCI, different methods for
generating the injury itself have been developed (Table 1.8). In some studies, a specific
aspect of SCI is investigated, such as formation of the glial scar or hypoxia-mediated cell
death. This is achieved by manipulating the environment through culturing samples in a
hypoxic chamber, for instance.
Table 1.8: Methods of inducing SCI or replicating specific aspects of SCI
pathophysiology in vitro. Examples of methods used to induce SCI or aspects of SCI
include chemical, mechanical, and environmental methods. TGF-β1 = transforming
growth factor-β1. H2O2 = hydrogen peroxide.




































































Transforming growth factor-β1 (TGFβ1)-mediated chemical induction of astrogliosis
has been used to develop and validate 3D culture models, (East et al., 2009). TGFβ1
has been shown to regulate the formation of the glial scar through multiple activities,
such as activation of astrocytes and microglia and promoting matrix deposition (Logan
et al., 1994). It has also been utilised as a positive control of astrogliosis alongside the
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development of biomechanical models of TSCI using novel apparatus, such as the BOSE
Electroforce BioDynamic materials testing systems (Cullen et al., 2007; Kirk, 2018).
Despite the advantages associated with chemical inducers of SCI, they lack the
important factor of incorporating the biomechanics of TSCI.
Mechanical methods encompass those with and without controllable biomechanical
parameters, such as velocity and displacement. Scratch models employ scalpels or
pipettes to scrape across the surface of cell-seeded surfaces or organotypic slices to model
a lesion devoid of cells. Astrocytes and microglia migrate towards the lesion and mediate
scar formation representing the process in vivo (Slovinska et al., 2016; Weightman et al.,
2014). However, this model does not recapitulate the primary damage associated with a
TSCI, which is caused by a high impact event and which is now known to influence the
progression of secondary injury (Mattucci et al., 2019). Mechanical models which have
implemented biomechanical characteristics of a TSCI include Cullen et al., (2007) who
utilised a custom-built electromagnetic shearing device to inflict high strain rate shear
deformation to primary rat cortical neuron-astrocyte co-cultures encapsulated in
Matrigel hydrogels. Strain and strain rate were independently controlled: up to 0.50
strain and 30.s−1 strain rate.
Materials testing machines, such as the BOSE group of machines (TA Instruments),
are capable of decoupling velocity and displacement, thus have the potential to be
adapted for inflicting high velocity contusive and/or tensile injuries in vitro. Busby et al.,
(2013) used the BOSE Electroforce 3200 Test Instrument to evaluate the mechanical
properties of rat type I collagen hydrogels, using a strain of 5% and strain rate of
0.5%.s−1 (Table 1.7). With a mean gel thickness of 4.79 ± 0.06 mm, this is equivalent to
a rate of 0.024 mm.s−1. Koivisto et al., (2017) used the BOSE Electroforce BioDynamic
5100 to evaluate the mechanical properties of bioamine crosslinked gellan gum (GG)
hydrogels for neural tissue engineering applications. Gels were tested under compression,
with a strain rate of 10 mm.min−1 to a maximum strain of 65% of the original gel height
(6.5 mm). These strain rates are not reflective of the rates used in in vivo TSCI models,
nor observed clinically but are typical for mechanical testing.
Salegio et al., (2016) used the BOSE TestBench™system apparatus in vivo to inflict
a cervical unilateral contusion injury in Macaca mulatta (non-human primates) using
an input velocity of 1000 mm.s−1 and a displacement depth range of 2.0 – 4.0 mm. A
limitation of that study was that variable output velocities were measured- 270 – 580
mm.s−1- which were below the target input. Kirk (2018) used the BOSE Electroforce
BioDynamic 5110 to model focal contusion injuries in astrocyte-seeded collagen type I
hydrogels, using an input velocity of 3000 mm.s−1 and a range of displacement depths
up 100% of the total gel thickness. The output velocity was not reported but these
parameters are within the range of velocities used in vivo and measured from biomechanical
studies of burst fracture ex vivo (Wilcox et al., 2003). This study has combined the
biomechanical aspects of modelling from in vivo studies and the simplicity of in vitro
systems to investigate a variety of research questions, including how matrix mechanical
39
Chapter 1. Introduction Section 1.10
properties affects neural cell behaviour and their responses to controlled high velocity focal
contusion at defined displacement depths. However, verification and validation of these
materials testing machines is required, particularly at the higher strain rates required to
accurately model traumatic injuries.
1.9 Therapeutic Strategies
1.10 Summary and Aims
1.10.1 Summary
Traumatic spinal cord injury is a complex and heterogeneous series of events which
affects a large and heterogeneous population. Given the complexity of human SCI, no
one model can encompass all aspects of injury. The histopathological and behavioural
differences observed across contusion, dislocation and distraction by Choo et al., (2008)
and Chen et al., (2016) highlights the importance of considering and implementing
biomechanical parameters into a model which reflects the stresses and strains observed
clinically. It also presents an area of research for the stratification of patients based on
injury mechanism and where the development and application of therapeutic
interventions could be targeted more selectively. For instance, due to the larger extent of
neuronal damage following dislocation injury, interventions which promote axon
outgrowth may be most effective for contusion injury.
Although previous studies using in vitro and in vivo models have reported robust
characteristic responses to SCI, the relationship between biomechanical inputs and
secondary responses are less well understood. In particular, it is not known whether
different neural cell populations respond to mechanical injury which is proportional to
injury severity, whether there is a dominant parameter which influences cell responses,
and what the thresholds are for injury activation in these different populations. It is
difficult to isolate cell specific responses to injury in vivo due to the complex interactions
between different neural cell types, thus an in vitro 3D model would be beneficial where
single cell populations can be isolated and studied. In order to begin investigating these
research gaps, an appropriate injury model needs to be developed which enables the
independent control of displacement and velocity, is capable of modelling velocities
reflective of traumatic injuries, and is capable of modelling multiple mechanisms of
TSCI.
The BOSE Electroforce BioDynamic 5110 (BOSE) is a commercially available
materials testing machine which possesses numerous features that make it appropriate
for simulating TSCI. Most importantly, displacement and velocity can be independently
controlled. Further, the apparatus can be configured to apply tensile strains by changing
the compression platens for tensile grips, thus two mechanisms of injury can potentially
be modelled. The BOSE group of apparatus has been used in limited TSCI contexts,
modelling contusion injuries in vivo (Salegio et al., 2016) and in vitro (Kirk, 2018).
Therefore, in depth verification of the displacement and velocity parameters will be
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evaluated under parameters which represent clinical injuries. The use of a 3D-seeded
collagen hydrogel with primary rat cortical astrocytes was selected as this hydrogel
provides a permissive environment for long-term neural cell survival which approximates
that of the spinal cord. As key contributors to astrogliosis and the glial scar, primary
astrocytes were selected to be experimented on in isolation to probe cellular thresholds.
Astrocyte viability and reactivity will be assessed following contusion and distraction
injury and discussed alongside the kinetic outputs measured: peak displacement, impact
velocity, peak velocity, load, and energy applied.
1.10.2 Aim and Objectives
The aim of this project is to evaluate the effects of varying input displacement and
velocity parameters of contusion and distraction injuries on primary rat cortical
astrocyte responses in vitro.
This is to be achieved through the following objectives:
I. To assess the suitability of utilising the BOSE 5110 Electroforce BioDynamic as a
rig capable of simulating controlled, repeatable loads representative of contusion and
distraction injury scenarios.
II. To develop a protocol for the simulation of contusion and distraction injuries using
three-dimensionally encapsulated astrocytes in collagen hydrogels.
III. To evaluate the biological responses of astrocytes to simulated contusion and
distraction injury.
IV. To investigate the relationship between the primary mechanical input and responses
of primary astrocytes cultured in isolation.
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General Materials and Methods
2.1 Equipment and Software
The equipment and software used, along with their suppliers, are listed in Appendix A,
Table 6.1.
2.2 Consumables
The consumables used, along with their suppliers, are listed in Appendix A, Table 6.2.
2.3 Chemicals and Reagents
The chemicals and reagents used, along with their suppliers, are listed in Appendix A,
Table 6.3.
2.4 Antibodies
The antibodies and nuclear stain used in this study are listed in Table 2.1. Astrocytes were
immunolabelled using an anti-GFAP (glial fibrillary acidic protein) polyclonal antibody,
which labels the cytoskeleton of the cell. GFAP is a widely used marker of astrocytes and
is also a common marker of astrocyte activation, thus immunolabelling for this component
is suitable for comparing injured and non-injured astrocytes in this study. Chondroitin
sulfate proteoglycans (CSPG) were immunolabelled using a CS-56 monoclonal antibody,
which is specific for the glycosaminoglycan (GAG) portion of CSPGs.
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Table 2.1: List of Antibodies Used





Mono IgM Mouse 1:200 Sigma-
Aldrich
C8035


























2.5.1.1 Disinfection of Surfaces
Surfaces, such as that of the Class II safety cabinet, were sterilised using 1% Trigene (v/v),
followed by 70% (v/v) ethanol, then UV light. Prior to placing equipment and reagents
into the hood, the surfaces were sprayed and cleaned with 1% (w/v) Virkon, followed by
70% (v/v) ethanol. The equipment was then sprayed with 70% (v/v) ethanol prior to
placing into the hood. Solutions containing cells were disinfected in 1% (w/v) Virkon for
20 minutes before discarding.
2.5.1.2 Dry Heat Sterilisation
Equipment to be sterilised via dry heat were wrapped in aluminium foil and placed into
an oven at 190 °C, for 4 hours. Delicate tools, such as dissection tools were sealed in a
metal tin.
2.5.1.3 Moist Heat Sterilisation
Solutions and/or equipment were placed into autoclavable receptacles and labelled with
autoclave tape. Lids on bottles were loosely screwed to enable steam to escape. The items
were autoclaved at 121 °C, 15 psi, for 20 minutes.
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2.5.1.4 Filter Sterilisation
Solutions which required filter sterilisation were done so using a syringe fitted with a 0.22
µm filter. The solution to be filter sterilised was drawn up into the syringe. The syringe
was then inverted and any air bubbles expelled. The filter was then attached to the syringe
and the solution filtered into a new sterile receptacle.
2.5.2 Measurement of pH
The pH meter was calibrated prior to use according to the manufacturer’s instructions,
using pH standard solutions at pH 4, 7, and 10. The pH of the solution being prepared
was adjusted to its required pH, using 1 M sodium hydroxide or 1 M hydrochloric acid.
2.5.3 Preparation of General Solutions
2.5.3.1 Antibody Diluent
To prepare 60 mL of antibody diluent, 6 mL sodium azide (1% w/v) was mixed with 300
µL BSA solution (5% w/v), in 40 mL of 1x TBS. The pH of the solution was measured and
adjusted to pH 7.6 where necessary, using 1 M hydrochloric acid or 1 M sodium hydroxide.
The volume of the pH adjusted solution was then made up to 60 mL using 1x TBS. The
solution was stored at 4 °C, for up to three months.
2.5.3.2 Bovine Serum Albumin
A 5% (w/v) solution of BSA was prepared by weighing out and dissolving 0.5 g BSA into
10 mL PBS.
2.5.3.3 DAPI (4’,6-diamidino-2-phenylindole)
A stock solution of DAPI at 1 mg.mL−1 was prepared using distilled water. A working
concentration of 1 µg.mL−1 was prepared for all experiments, by performing a 1:1000
dilution with the appropriate diluent.
2.5.3.4 Ethanol
A 70% (v/v) solution of ethanol was prepared by mixing together 7 L of 100% ethanol
with 3 L of distilled water.
2.5.3.5 Hydrochloric Acid
A 1 M solution of hydrochloric acid (HCl) was prepared by adding 8.212 mL of HCl
solution (37% w/w) to 25 mL deionised water, in a volumetric flask. The volume was then
adjusted to 100 mL with deionized water.
2.5.3.6 LIVE/DEAD™Viability/Cytotoxicity Assay Solution
The viability status of mammalian cells can be distinguished by specific activities, which
the LIVE/DEAD™assay exploits. Live cells can be characterised by their ubiquitous
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intracellular esterase activity and the presence of an intact plasma membrane. A dual-
stain, comprising calcein AM (CAM) and ethidium homodimer-1 (EthD-1) is applied to the
cells, whereby CAM indicates intracellular esterase activity by green fluorescence (ex/em
495/515 nm), and EthD-1 indicates loss of plasma membrane integrity by red fluorescence
(ex/em 495/635 nm). The individual reagents were stored at -20 °C protected from light.
Once thawed at room temperature, a volume of 2 µL CAM and 3 µL EthD-1 was mixed
with 3995 µL of the appropriate complete cell culture medium. The final concentration
of CAM and EthD-1 was 2 and 1.5 µm, respectively. The solution was wrapped in foil to
protect it from light, prepared fresh and used immediately.
2.5.3.7 Methanol
A 70% (v/v) solution of methanol was prepared by mixing 7 mL 100% methanol with 3
mL distilled water, and stored at room temperature for up to one month.
2.5.3.8 Phosphate Buffered Saline (PBS)
Into a clean glass Duran bottle, a solution of PBS was prepared by dissolving one PBS
tablet per 100 mL distilled water. The solution was stirred using a magnetic stirrer until
the tablet(s) completely dissolved. The solution was autoclaved using moist heat (Section
2.5.1.3).
2.5.3.9 Poly-D-Lysine
A 50 µg.mL−1 solution of PDL was prepared by dissolving 10 mg PDL powder in 200 mL
sterile PBS. The solution was filter sterilised and aliquotted into 20 mL volumes. The
solution was stored at -20 °C, for up to one year. The solution was reused up to three
times before being discarded.
2.5.3.10 Sodium Chloride Solution
A 3 M solution of sodium chloride (NaCl) was prepared by dissolving 175.32 g sodium
chloride in 1 L distilled water.
2.5.3.11 Sodium Hydroxide Solution
a 1 N solution was prepared by adding 4 g NaOH pellets to 100 mL distilled water and the
solution stirred using a magnetic stirrer. The solution was stored at room temperature,
for up to two years.
2.5.3.12 Tris Solution
A 2 M solution of Tris was prepared by dissolving 242.26 g Trizma base in 700 mL distilled
water. The pH of the solution was adjusted to pH 7.6 with 6 M HCl before making the
volume up to 1 L using distilled water.
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2.5.3.13 Tris buffered Saline
Tris buffered saline (TBS; 20 mM Tris, 150 mM NaCl, pH 7.6) was prepared by mixing
25 mL Tris solution (2 M) and 50 mL NaCl (3 M) with 700 mL distilled water. The pH
of the solution was adjusted to pH 7.6 with 6 M HCl before making the volume up to 1
L using distilled water. The solution was autoclaved by moist heat and stored at room
temperature, for up to 3 months.
2.5.3.14 Triton X-100
Into a clean duran bottle, 100 µL 100% Triton X-100 and 99.9 mL sterile PBS were
combined. The solution was stirred using a magnetic stirrer until the Triton X-100
completely dissolved. The solution was stored at room temperature, for up to 6 months.
2.5.3.15 Virkon
A 1% (w/v) solution of Virkon was prepared by dissolving 10 g Virkon powder per 1 L
distilled water. The solution was stored at room temperature.
2.5.4 Primary Cell Culture
All procedures involving the use of animal tissue and/or cells were performed in
accordance with the UK Animals (Scientific Procedures) Act, 1986. All procedures were
performed under the project license number, 70/8085.
All centrifugation steps were performed at room temperature, and all incubation steps
at 37 °C were performed in a humidified incubator at 8% CO2:92% air, unless stated
otherwise.
2.5.4.1 Poly-D-Lysine Coating
To facilitate adhesion of primary rat neural cells, tissue culture surfaces were coated with
poly-D-lysine (PDL). Frozen aliquots of PDL were thawed at room temperature, then
overlayed on the appropriate surface such as tissue culture flasks or glass coverslips. The
flasks and/or coverslips were then incubated at 37 °C for at least one hour. The PDL
solution was then aspirated and two PBS washes followed by one cell culture media wash
performed. The media was aspirated and the surfaces dried at 37 °C. PDL-coated surfaces
were stored at 4 °C for up to two weeks, sealed using parafilm.
2.5.4.2 Preparation of a Mixed Glial Culture
Primary cortical glial cells were sourced and isolated from female postnatal 2-3 day old
Wistar rats, with the protocol used being based on that developed by McCarthy and
De Vellis (1980). Rats younger than postnatal day 2 were not used as this ensures the
absence of viable neurons in the cell suspension.
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2.5.4.2.1 Mixed Glial Cell Culture Medium
Primary rat astrocyte cells were cultured and maintained in DMEM, containing 10% (v/v)
FBS, 1% (v/v) L-Glutamine, and 1% (v/v) penicillin-streptomycin (100 Units.mL−1 and
100 µg.mL−1 streptomycin, respectively). This is referred to as DMEM complete. The
medium solution was stored at 4 °C, for up to 2 weeks.
Table 2.2: Preparation of Solutions for Mixed Glial Cultures






0.1 mg.mL−1 0.05 mg.mL−1 HBSS+
Poly-D-lysine
(PDL)












Trypsin 1 mg.mL−1 1 mg.mL−1 PBS
HBSS+ denotes HBSS with magnesium and calcium. HBSS- denotes HBSS without magnesium and
calcium. All stock solutions were filter sterilised and aliquots stored at -20 °C, for up to two years.
2.5.4.2.2 Dissection and Culture
Rats were euthanised using the Schedule 1 technique of cervical dislocation. Upon
confirmation of complete dislocation, the heads were removed and sprayed with 70%
(v/v) ethanol. Using sterile springbow scissors, an incision in the skin of the head was
made along the midline, followed by the skull. Additional lateral cuts were made to the
skull to enable better access to the brain. The brain was gently removed from the skull
and placed in a petri dish filled with ice-cold HBSS. The two hemispheres were then
separated, then under a dissection microscope the cortices were dissected out, and
meninges and blood vessels removed using fine forceps. The cortices were pooled before
mincing with a scalpel blade. The tissue suspension was transferred to a 15 mL falcon
tube and centrifuged for 5 minutes at 150 g. The supernatant was discarded and the
pellet resuspended in 1 mg.mL−1 trypsin (3000 - 20,000 U.mg−1), then incubated for 20
minutes, at 37 °C, followed by the addition of 0.01 % (w/v) DNase (2000 U.mg−1) and a
further 5 minute incubation. The suspension was then centrifuged for 5 minutes at 150g.
The supernatant was discarded and the pellet resuspended in a triturating solution,
comprised of 10 mg.mL−1 BSA, 500 µg.mL−1 trypsin inhibitor, and 20 µg.mL−1 DNase
in Ca2+ and Mg2+-free HBSS. The suspension was dispensed into PDL-coated (50
µg.mL−1) 75 cm2 flasks at a density of two cortices per flask. An additional 10 mL
complete DMEM was added to each flask, and incubated in a humidified incubator at 37
°C.
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2.5.4.2.3 Preparation of an Enriched Astrocyte Culture
The cells were expanded in culture for 8 - 10 days, to allow confluency and stratification
of the different cell types to be achieved. When required, the flasks were placed on an
orbital shaker at 250 rpm for 4 hours (10 mm orbital diameter) to deplete the less
adherent cells, namely microglia. Parafilm was used to seal the vents of the lids to
prevent media spillage. Mechanical dissociation resulted in enriched cultures which were
>95% astrocytes, as determined by immunoreactivity for GFAP and CD11b. After
mechanical dissociation, the media (containing non-astrocyte cells) was discarded and
the adherent astrocytes trypsinised for 10 minutes, followed by neutralisation with
complete DMEM. The suspension was centrifuged for 10 minutes at 150 g. A Trypan
blue exclusion assay was performed to assess cell viability and determine the number of
cells required for the experiment.
2.5.4.3 Cell Maintenance and Passaging
Cell cultures were maintained in tissue culture flasks and confluency monitored. At 80%
confluency, the media was discarded and two 10 mL DPBS(-) washes were performed to
remove residual serum. A volume of 2.5 mL trypsin/EDTA was added to the cells and
incubated for 7 minutes at 37 °C. The flask was then firmly tapped against a hard surface
to aid cell detachment. The trypsin was neutralised with 10 mL cell culture medium and
a cell scraper was used to aid cell detachment. The cell suspension was then transferred to
a sterile universal and centrifuged at 150 g for 10 minutes. The supernatant was discarded
and the pellet resuspended in 2 mL fresh cell culture medium. A cell count was performed
(Section 2.5.4.4) and the desired number of cells was used for seeding into gels. Remaining
cells were replated at a density of 1 x 106 cells per T75 flask. Additional cell culture
medium was added to achieve a final volume of 10 mL in the flask and incubated at 37
°C. Primary astrocytes were not used beyond passage 2.
2.5.4.4 Cell Counting
Trypan blue is a dye which enables the visual distinction between viable and non-viable
cells: viable cells possess intact cell membranes which are impermeable to the dye.
Conversely, non-viable cells’ damaged membranes are unable to exclude the dye thus the
cell cytoplasm is visible as a blue colour. To perform this assay, the cell suspension was
trypsinised and centrifuged as for passaging cells (Section 2.5.4.3). Once the pellet was
resuspended in a volume of cell culture medium, 10 µL of cell suspension was mixed with
10 µL Trypan Blue dye. A haemocytometer was prepared by placing a moistened
coverslip over the counting grid. The haemocytometer was loaded with 10 µL cell
suspension-dye mix and cells visualised under an inverted light microscope. The total
number of cells was counted within the four outer 4x4 grids (Figure 2.1). The following
formula was then used to determine the total number of cells in the suspension and the
concentration:
Concentration (cells.mL−1) = Total no. cells4 × 2× 10, 000× V (2.1)
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where V = volume of cell suspension.
Figure 2.1: Counting grid of a haemocytometer. The red box indicates one of
the four counting areas. Cells touching the line on the bottom and right hand side were
excluded to prevent cells being double counted.
2.5.5 Preparation of Collagen Hydrogels
A commercially available rat tail type-I collagen (First Link UK Ltd.) was used throughout
this project as it was easily available, less time consuming to acquire compared to in-house
collagen production, and less batch-to batch variability. The hydrogel solution comprised
the following reagents:
• Rat tail type-I collagen (80% v/v; >2 mg.ml−1 in 0.6% (v/v) acetic acid)
• 10X MEM (10% v/v)
• Neutralising Solution (5.8% v/v)
• Cell Suspension (4.2% v/v)
To minimise titration errors using in-house preparations of sodium hydroxide, a
commercial neutralising solution was purchased from Lonza. Due to Lonza’s proprietary
rights, the only listed ingredient is sodium hydroxide. All hydrogel reagents and
consumables (well plates and universals) were kept on ice to minimise premature
gelation. Cell seeding density was calculated as the number of cells per mL gel solution.
For example, a volume of 5 mL gel, seeded at a density of 5x105 cells.mL−1, would
contain 2.5x106 cells resuspended in 210 µL cell culture medium.
The required volumes of collagen and MEM were mixed in a sterile universal. To
prevent the introduction of bubbles into the solution, a swirling motion was adopted to
mix the reagents. The yellow colour of the solution indicated an acidic pH. The solution
was then neutralised using the neutralising solution. Working swiftly, the cell suspension
was resuspended in the gel solution and then immediately plated. The gels were then
incubated for 10 minutes, at 37 °C, 8% CO2:92% air to enable gelation to complete. The
gels were then overlayed with complete cell culture medium.
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2.5.6 ATPlite™Luminescence Assay System
Adenosine triphosphate (ATP) is a molecule which stores and provides energy to drive
biological processes. It is a useful marker for metabolic activity and cell viability as
it is present only in metabolically active cells. Its concentration declines when a cell
undergoes necrosis or apoptosis. The ATPlite™Luminescence Assay is a system based on




Oxyluciferin + AMP+ PPi +CO2 + Light (2.2)
where AMP = adenosine monophosphate, and PPi = pyrophosphate.
2.5.7 Immunofluorescence Staining
All steps were performed on an orbital shaker, at 110 rpm. Volumes of solutions used were
twice that of the gel (600 µL for the contusion gels and 300 µL for the distraction gels).
Antibodies were diluted in antibody diluent (Section 2.5.3.1). Following 3 x 5 minute PBS
washes, gels were fixed with 4% (w/v) PFA for 4 hours, at 4 °C. Permeabilisation was
performed with 0.1% (v/v) Triton X-100, for 45 minutes. Following 3 x 5 minute PBS
washes, blocking of non-specific antibody binding sites was performed using powdered milk
dissolved in PBS, for 45 minutes. After 3 x 5 min PBS washes, the gels were incubated in
the primary antibody overnight, at 4 °C. Following 3 x 10 minute PBS washes, the gels
were incubated in the secondary body containing DAPI (1:1000), at room temperature for
1.5 hours. Gels were washed with PBS (3 x 10 minutes) and then stored in PBS prior to
confocal imaging. Antibodies and dilutions are detailed in Table 2.1.
2.5.8 Assembly of the BOSE 5110 Electroforce BioDynamic
The BOSE 5110 Electroforce BioDynamic Test Instrument is comprised of a main load
frame, which houses the load cell and orthopaedic chamber (Figure 2.2). The system is
controlled by the proprietary WinTest® Control System software on the attached
computer.
Figure 2.2: Setup of the BOSE 5110 Electroforce BioDynamic rig with
compression platens.
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The load frame provides mechanical stimulation to samples under sterile conditions, if
desired. The chamber parts can be sterilised (Section 2.5.8.1), and the entire frame can
be housed within a Class II Cabinet in order to operate the rig under sterile laminar air
flow. The BioDynamic load frame specifications are detailed in Table 2.3 (BOSE, 2015).




Maximum Force ±200 N
Maximum Displacement 13 mm (±6.5 mm)
Minimum Displacement Increment 0.001 mm
Maximum Deformation Rate 740 mm.s−1
2.5.8.1 Disinfection and Sterilisation of Components
All of the BioDynamic chamber components, including the manifold components, were
sterilised using moist heat autoclaving. For efficiency the chamber was autoclaved pre-
assembled, ensuring that the axial shaft locks and screw components were loosened to
allow the pressurised steam to penetrate all areas. To maintain sterility, particularly
inside the chamber and the platen fixtures which would come into direct contact with
experimental samples, sterile gloves were used for assembly.
2.5.9 Microscopy
2.5.9.1 Brightfield Microscopy
An Olympus CK-40-SLP microscope was used under Köhler illumination to monitor cell
cultures and perform cell counts.
2.5.9.2 Fluorescent Microscopy
A Zeiss Axio upright microscope was used for fluorescent imaging of two-dimensional cell
cultures with the following filters: 49 DAPI (excitation 365, beam splitter 395, emission
450 nm), 38 GFP (excitation 470/40, beam splitter 495, emission 525/50 nm), and 20
Rhodamine (excitation 546/12, beam splitter 560, emission 575-640 nm).
2.5.9.3 Confocal Microscopy
All confocal images were acquired using a Zeiss LSM880 Axio Imager.Z2 upright
microscope, equipped with an Axiocam camera, Zeiss Plan-Apochromat 20x 0.8 NA
objective, and ZEN software. The lasers used were as follows: Diode: 405, Argon: 458,
488, 514, DPSS: 561, and HeNe: 633.
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2.5.10 Statistical Analysis
2.5.10.1 Presentation of Data Variance
Numerical data was analysed using Microsoft Excel (version 1908), and presented as the
mean (where n = ≥ 3) ± standard error of the mean (SEM). The SEM was calculated











Standard Error of the Mean (SEM) = SD√
n
(2.5)
where x = data value and n = sample number.
2.5.10.2 Comparison of Means
Group means were analysed using GraphPad Prism 8.0 (version 8.4.1.676). A student’s t-
test was used for the comparison of two means. A one-way or two-way analysis of variance
(ANOVA) was used to compare the means of more than two groups. The individual
differences between means were identified by calculating the minimum significant difference
(MSD) at p = 0.05. For two-way ANOVA analyses a Tukey-Kramer post-hoc test was used
to identify the location of significant differences, where every mean is compared with every
other mean. Similarly, a Dunnett post-hoc test was used to compare group means to the
mean of a control group.
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Development of Contusion and Distraction
Traumatic Spinal Cord Injury Models In Vitro
3.1 Introduction
Traumatic spinal cord injury (TSCI) is clinically represented by a broad range of
mechanisms and many experimental models exist. The dominance of the secondary
response in the pathological process of SCI has meant that less focus has been placed on
how the mechanisms of primary injury influences pathology. Relatively little research
has been published which has attempted to perform direct comparisons of the effects of
injury mechanism on histological and functional parameters in vivo (Chen et al., 2016;
Choo et al., 2008, 2007, 2009). The results of these studies suggest that mechanism
specific patterns of pathology exist due to differences in spinal cord deformation.
Further, this was associated with differences in behavioural outcomes in rats observed up
to 8 weeks following injury (Chen et al., 2016). However, understanding of this
heterogeneity is not yet refined enough to inform how treatments can be targeted
towards mechanism-specific pathologies.
A current barrier to research investigating injury mechanics is the lack of apparatus
available which are capable of experimentally simulating multiple mechanisms of injury,
with the capability of independently controlling input biomechanical parameters, such as
displacement and velocity. The experimental displacement and velocity values are also
often unreported so there is no information on whether the values have been verified as
accurate against the inputs. Since the objective of these studies is to utilise a
standardised model to study a specific aspect of secondary injury and/or to test
therapeutic interventions, the biomechanics of primary injury are less considered. The
Infinite Horizons Impactor, for instance, is most commonly used to model contusion
injuries in vivo. This force-controlled system does not allow for user control of input
displacement or velocity. Smith (2016) used this apparatus to model contusion-type
injuries in vitro, using primary astrocyte-seeded type-I collagen hydrogels. Due to the
low elastic modulus of the gels, accurate impact force data could not be obtained as the
force sensor was not sensitive enough to detect the presence of the gel. The lack of
quality output kinetic data means associations could not be made between input
mechanics and cellular behaviour, which is the aim of this project. The University of
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British Columbia (UBC) multimechanism device is currently the only apparatus capable
of experimentally simulating multiple injury mechanisms in vivo: contusion, dislocation,
and distraction (Chen et al., 2016; Choo et al., 2008, 2007, 2009; Lam et al., 2014).
The BOSE Electroforce BioDynamic 5110 (BOSE) is a commercially available
bioreactor used to apply mechanical loads to single specimens to determine their
mechanical properties. The user can independently control either force, or displacement
and velocity. An experimental in vitro model of contusion injury was developed by Kirk
(2018) using primary neural cell-seeded synthetic hydrogels, whereby an input velocity of
3000 mm.s−1 and a range of input displacement depths- from 50 – 100% gel height- was
used to model a TSCI. Results demonstrated an increase in astrocyte and microglial
metabolism with increasing contusion displacement depth, suggesting increased cellular
reactivity. However, output biomechanical data, such as load, impact velocity and peak
displacement were not reported. Therefore, it is unknown whether those input
parameters were achieved experimentally. Additionally, characterisation of the
apparatus was not performed, thus its capabilities remain unknown under conditions
simulating a contusion injury.
With the availability of the BOSE and the potential to model at least two
mechanisms of TSCI this apparatus was selected for this project. The BOSE is equipped
for generating both uniaxial compressive and tensile loads. Contusion and distraction
mechanisms were selected as these are clinically prevalent (Katsuura et al., 2016; Wood
et al., 2014). Characterisation of the BOSE, over an input displacement range of 1 – 10
mm and input velocities of 100 and 1000 mm.s−1, was performed in air in order to
determine the capabilities of the apparatus for the aim of developing a contusion and
distraction model in vitro. The system was then verified with the addition of hydrogels,
to determine whether their presence affected output displacement and velocity
measurements. It was hypothesised that the BOSE would be a suitable apparatus for
generating accurate and reproducible compressive and tensile loads in air and with
collagen hydrogels.
In vitro models present a potentially useful pre-animal model to further investigate
and better inform in vivo studies, where outcomes can be highly variable, complex, and
control of certain parameters is more difficult. In vitro systems are less complex and less
variable than the native CNS, but the user can more precisely control the environment
depending on the research question. Two-dimensional (2D) cultures are increasingly
being rejected in favour of three-dimensional (3D) cultures due to their lack of
physiological relevance and inability to faithfully replicate the cytoarchitecture of native
tissue (Pampaloni et al., 2007; Pedersen and Swartz, 2005). Regarding the central
nervous system (CNS), a 2D environment has previously been shown to mimic a reactive
environment, resulting in upregulation of astrocyte reactivity markers typically observed
following a SCI (Du et al., 2010; East et al., 2009).
3D in vitro biomaterials have been used in neural tissue engineering due to their
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improved abilities to support native cellular behaviour, allowing cell-cell and cell-matrix
interactions to occur in all dimensions (Boni et al., 2018). Type I collagen possesses
many properties which make it suitable for use as a 3D biomaterial in this project:
cytocompatible, contains intrinsic cell attachment motifs, easily accessible from a variety
of sources, simple handling procedures, and fast preparation and gelation characteristics
(Dinescu et al., 2018). The modulus of collagen hydrogels ( 60 Pa, Smith (2016)) does
not completely match that of CNS tissue, which values reported vary due to differences
in specimen and testing method (Bartlett et al., 2016b) and this may have implications
for cellular responses in vitro. However, it was deemed a suitable choice of biomaterial
herein due to its previously utilisation in neural tissue engineering to model the nervous
system and associated pathologies (East et al., 2009; Georgiou et al., 2013; Kirk, 2018;
O’Rourke et al., 2017; Phillips, 2014b; Phillips et al., 2005; Smith, 2016). These studies
show that collagen is amenable to neural cell survival and mimics a non-reactive
environment, particularly for glial cells.
In a more simplified environment of a 3D in vitro model, mechanical loads can be
applied to different populations of neural cells in a highly controlled environment. The
glial scar that forms after SCI is considered a major physical and physiological
impediment to neuronal regeneration (Fawcett and Asher, 1999; Liu et al., 2006; Yiu and
He, 2006). It is composed largely of reactive, hypertrophic astrocytes, which up-regulate
intermediate filaments including glial fibrillary acidic (GFAP) and vimentin, and deposit
ECM molecules such as chondroitin sulfate proteoglycans (CSPGs). Since the lesion is
composed largely of the dense reactive-astrocyte populated glial scar, and studies show
mechanism-specific differences in lesion size, astrocytes were selected to be seeded into
the collagen hydrogels.
Primary cortical astrocytes were isolated from early postnatal (P2 – 3) rats using a
mixed glial preparation and mechanical shaking to enrich the astrocytes. The purity of the
culture was assessed using immunocytochemical staining for glial fibrillary acidic protein
(GFAP), a commonly used marker for astrocytes (Eng, 1985). Primary astrocytes were
seeded into collagen hydrogels at various initial seeding densities, with cell metabolism
and viability monitored to select an appropriate density for future experiments. It was
hypothesised that cells would be viable and proliferate for up to 14 days in culture. This
timeframe was chosen as this would be the end-point for subsequent experiments, and
the glial scar has been shown to take approximately 14 days to form and begin maturing
(Hackett and Lee, 2016). Further, due to lack of blood supply and other cells and molecules
present, which likely contribute to cell survival, a timepoint of longer than 14 days would
not have been relevant.
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3.2 Aim and Objectives
3.2.1 Aim
The aim of this chapter was to assess the suitability of using the BOSE Electroforce
BioDynamic 5110 apparatus to simulate clinically relevant contusion and distraction spinal
cord injury mechanisms.
3.2.2 Objectives
The specific objectives were as follows:
I. To characterise and verify the displacement and velocity parameters of the BOSE in
air, under compressive and tensile waveforms.
II. To determine the effects of collagen hydrogels on the output displacement and
velocity values of the BOSE.
III. To develop a protocol to enable accurate measurement of the initial dimensions of
collagen hydrogels (contusion) and thus define the displacement parameters.
IV. To define a set of velocity and displacement depth parameters to be simulated
experimentally, in order to represent a range of injury severities in vitro.
V. To select an appropriate primary astrocyte seeding density.
VI. To define the shape and dimensions of a hydrogel to enable tensile loads to be applied,
simulating distraction-type spinal cord injuries.
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3.3 Specific Materials and Methods
3.3.1 Assembly of the BOSE Electroforce BioDynamic 5110 Rig
For the general set up and assembly of the BOSE chamber components, refer to Chapter
2 (Section 2.5.8).
3.3.1.1 Experimental Setup of Contusion Injury Simulation
The chamber was assembled and affixed to the load frame, according to the manufacturer’s
instructions. Due to manual differences in assembling the apparatus, and differences in the
preparation of individual hydrogel samples, the height of each sample had to be calculated
individually after being loaded onto the platen (Figure 3.1).
Figure 3.1: Calculation of the thickness of individual hydrogel samples using
the BOSE. Movement of the lower motor platen was controlled using the WinTest
software. The motor platen was moved upwards to an absolute displacement value of -5
mm (A). The load platen was then manually lowered until contact was registered with the
motor platen, as indicated by a change in load of at least 0.1 N (B). This represents 100%
compression. The motor platen was then moved downwards, to an absolute displacement
value of +5 mm and the sample loaded onto the motor platen (C). The motor platen was
moved upwards in increments, from 100 to 1 µm, as the sample approached the load platen
(D). Contact with the top surface of the sample was registered when surface tension from
the liquid caused the entire surface of the sample to be drawn to the load platen. The
absolute displacement value at this point, y mm, was recorded (E). The height, h, of the
gel was calculated by calculating the difference between y and the displacement value at
which the two platens were in contact with each other i.e. -5 mm.
3.3.1.2 Experimental Setup of Distraction Injury Simulation
To facilitate the application of tensile strain on collagen type I hydrogels, the dimensions
of the gel were modified from disc-shaped to I-shaped. A mould, originally designed by
Phillips et al., (2005), was used to cast the gels into the desired dimensions. The design
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of the mould was modified to come as two separate components, held together with a
pair of screws and dowels. For detailed designs of the distraction mould, refer to
Appendix C (Figures 6.2 to 6.5) This enabled the gel to be loaded into the BOSE, with
the ends of the moulds serving as attachment points with the tensile grips of the BOSE.
Distraction moulds were disinfected and sterilised by soaking the individual components
(mould pieces, parafilm, mesh bars) in 1% Trigene (v/v), followed by 70% (v/v) ethanol.
The stainless steel dowels and screws were sterilised by dry heat (Chapter 2; Section
2.5.1.2). All components sterilised in solutions were allowed to air dry within a Class II
safety cabinet. Once dry, the moulds were assembled in 6-well plates using sterile gloves
and forceps. A volume of 150 µL neutralised gel solution was pipetted into each mould,
taking care to ensure the solution was sufficiently integrated around and through the
holes of the mesh. The gels were allowed to set by placing them in a humidified
incubator at 37 °C, 8% CO2:92% air. Once set, each gel was overlayed with 2 mL cell
culture medium. After 24 hours incubation, the gels were ready to be experimented on.
To transfer the moulds from the well-plate and secure them into the tensile grips of
the BOSE, a pair of sterile forceps was used to grasp onto a screw and transfer it to the
lower grip. The end of the tensile grip was aligned with the end point of the scribe on the
mould and secured by tightening the knurl screw. Under displacement control, the lower
grip was moved upwards towards the upper grip until the mould entered the upper grip
and the end point of the scribe aligned with the end of the upper tensile grip. The upper
grip was then closed and tightened around the mould by tightening the knurl screw. The
screws were then removed, followed by the dowels. Tensile loading forces were now able
to be applied.
3.3.2 Waveform Setup and Data Acquisition
The waveform defined by the user was programmed into the Waveform Setup tab of the
workspace (Figure 3.2).
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Figure 3.2: Building a waveform using the WinTest software.A view of the
software interface where the user can input their desired waveform as a series of individual
blocks (A). A visual representation of the input displacement profile of the waveform
defined in A (B).
The waveform regime, defined to represent a contusion injury, was defined in the
following steps:
1. Dwell: 10 ms
2. Ramp:
(a) Velocity: 100, 1000, 3000 mm.s−1.
(b) Relative displacement: -1, -2, -4, -6, -8, -10 mm (characterisation in air);
percentage of the total gel height (characterisation with collagen hydrogels).
Note, displacement is negative as the lower motor platen moves upwards,
towards the load platen.
3. Dwell: 100 ms
4. Ramp:
(a) Velocity: 100, 1000, 3000 mm.s−1.
(b) Relative displacement: Return to starting displacement (air); 0% of gel height
(hydrogels).
Data acquisition settings were defined in the Standard Timed Data tab of the
workspace. The user is able to select which channels to acquire data on, and define the
scan rate in the ’Scan Info’ section. In this project, the scan information defined for each
velocity used was the same:
• Scan time = 0.4096 s.
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• Number of scan points = 2048.
• Number of scans = 1.
3.3.3 Proportional Integral Derivative Tuning
A proportional-integral-derivative (PID) controller is a control loop mechanism which
continuously monitors the response of the specimen to a desired input, and then adjusts
the system until the desired input is met (Åström and Hägglund, 1995). The PID
system comprises three terms, which can be adjusted individually to achieve an optimal
response. The proportional term (P term) calculates the difference between the input
and output value and places a multiplier on the error. The integral term (I term) is a
multiplier on the integral of the error, with respect to time. Integral tuning attempts to
overcome the limitation of the P term by combining the error result from the
proportional action and increasing the correction factor (although this can lead to an
overshoot of the desired value). The derivative term (D term) is a multiplier on the
differential of the error signal, with respect to time. Derivative tuning attempts to
minimise overshoot by slowing the correction applied as the desired value approaches.
The desired waveform was programmed and simulated, and the input (command) and
output displacement and/or velocity profiles were visualised on the scope within the
software. The PID parameters were then adjusted, according to the instructions in the
manufacturer’s reference manual (BOSE, 2015). These profiles were compared against
the corresponding non-PID tuned simulations (waveforms simulated using the default
proprietary TuneIQ®tuning system; TA Instruments, Newcastle, UK).
3.3.4 Verification of Output Measurements against the Input
Verification of both displacement and velocity was undertaken by comparing the output
(recorded) peak displacement and velocity values against the input value. A percentage
error was calculated using the following equation:
Error (%) = experimental − theoretical
theoretical
x 100 (3.1)
3.3.5 Preparation of Collagen Hydrogel Samples
For this study, a commercially available rat tail type-I collagen product was used (>2
mg.ml−1 in 0.6% (v/v) acetic acid). For details on the preparation of the collagen hydrogel
solution, refer to Chapter 2 (Section 2.5.5). Samples for modelling contusion injury were
prepared by pipetting 300 µL of the neutralised collagen solution into 48-well plates, which
had a well diameter of 11 mm. Samples for modelling distraction injury were prepared
by pipetting 150 µL of the neutralised collagen solution into the cavity of the distraction
moulds set up as in Section . The gels were then incubated for 10 minutes, at 37 °C, 8%
CO2:92% air to enable gelation to complete. The gels were then overlayed with complete
cell culture medium (300 µL per sample for contusion; 2 mL per sample for distraction).
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3.4 Results
3.4.1 The BOSE Electroforce BioDynamic 5110 as an Apparatus for
Inducing Contusion Injury
The BOSE has not been verified for use as an apparatus for generating high velocity
compressive forces, on cell-seeded collagen hydrogels. As previously described, the limited
studies utilising the BOSE system for simulating contusive spinal cord injuries in vitro did
not compare input and output displacement and velocity parameters. This knowledge is
essential in attempting to define how input mechanics may influence cell behaviour and
whether thresholds exist. The work carried out in this section aimed to characterise and
verify the feasibility of using the BOSE to simulate reproducible contusion injuries. This
was achieved by, firstly, simulating defined contusion waveforms in air. The input and
output velocity and displacement values were recorded and compared to their respective
output values. The system was then tested with collagen hydrogels loaded onto the rig,
using the same protocol.
3.4.1.1 Incorporation of a Dwell Step to Optimise the Displacement
Parameter
The results in this section describe the outcomes of characterising the displacement
parameter of the BOSE, in air, under a compression waveform to model the transient
compressive forces imparted onto the spinal cord during contusion injury. The first
waveform tested comprised a ramp to a displacement depth between 1 and 10 mm,
immediately followed by a ramp back to the starting displacement (Section 3.3.2). This
waveform was simulated at three velocities: 100, 1000, and 3000 mm.s−1. The raw input
(command) and output (experimental) displacement values were plotted against time
and the resultant profiles compared (Figure 3.3).
The desired displacement was not achieved at any displacement depth. The error
between the input and output displacement profiles increased as the input velocity was
increased, at a given input displacement value (Appendix B Table 6.4). For instance, at
an input displacement value of 1.000 mm the mean output peak displacement values were
0.642, 0.128, and 0.064 mm, at input velocities of 100, 1000, and 3000 mm.s−1, respectively.
Further, the error between the input and output displacement profiles decreased with
increasing displacement, at a given input velocity. At 100 mm.s−1 the mean percentage
error of the output peak displacement value decreased from 35.85% to 5.40%, as input
displacement was increased from 1.000 mm to 10.000 mm. Similarly, the mean percentage
error decreased from 87.20% to 22.37% and 93.65% to 61.11%, at input velocities of 1000
mm.s−1 and 3000 mm.s−1, respectively.
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Figure 3.3: Comparison of input and output displacement profiles of a
simulated contusion regime without the presence of a dwell period. Dashed
lines represent the output profiles; solid lines represent the input command. The simulated
waveform was programmed as follows: dwell (10 ms), ramp at 100 (A), 1000 (B), or 3000
mm.s−1 (C) to the defined displacement depth relative to 0 mm in compression, then ramp
at 100, 1000, or 3000 mm.s−1 back to 0 mm. N = 4.
Each output displacement profile exhibited a lag period after displacement was defined
to be initiated (at 10 ms), which was not observed in the input profiles. The mean time at
which the first ramp initiated was 11.63 ± 0.05 ms, thus the mean lag time was calculated
to be 1.63 ± 0.05 ms. The time at which peak displacement was achieved thus also shifted,
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compared to the theoretical time at peak displacement (Table 3.1). For instance, at an
input displacement and velocity of 1.000 mm and 100 mm.s−1, respectively, the theoretical
time at peak displacement was 20 ms. However, the mean experimental output time at
peak displacement was 26.25 ± 0.05 ms, with a mean lag time of 6.25 ± 0.05 ms. The
grouped mean lag time was 6.45 ± 0.05 ms at 100 mm.s−1, 6.29 ± 0.1 ms at 1000 mm.s−1,
and 5.68 ± 0.04 ms at 3000 mm.s−1.
Table 3.1: Mean lag time at peak displacement compared to the input
command. Output displacement values were recorded, under waveforms of various
combinations of input displacement and velocity parameters, with the time at which
peak output displacement was achieved being selected and compared to the input time.
Data is presented as the mean ± SEM. N=4.
Input Displacement (mm) Mean Lag Time (ms)
100 (mm.s−1) 1000 (mm.s−1) 3000 (mm.s−1)
1.000 6.25 ± 0.05 5.50 ± 0.06 5.50 ± 0.10
2.000 6.40 ± 0.08 5.65 ± 0.05 5.40 ± 0.00
4.000 6.80 ± 0.08 6.00 ± 0.00 5.60 ± 0.00
6.000 6.60 ± 0.00 6.60 ± 0.00 5.80 ± 0.00
8.000 6.55 ± 0.05 7.00 ± 0.00 5.80 ± 0.00
10.000 6.10 ± 0.06 7.00 ± 0.00 6.00 ± 0.00
To this end, the initial waveform was modified to include an additional dwell period
between the two ramp steps. A dwell time of 100 ms was selected as this was determined
to be the shortest length of time possible to allow the desired displacement depth to be
achieved, and without contributing potential confounding effects of prolonged
compression of the sample. Further, this was to distinguish between compression models
of injury, which comprises an initial contusion injury (milliseconds) followed by
sustained compression over a period ranging from seconds to minutes (Cheriyan et al.,
2014). Again, the modified waveform was simulated, in air, and the input and output
displacement profiles plotted and compared (Figure 3.4 and Appendix B Figure 6.1).
At each input displacement depth, there was a significant increase in peak displacement
achieved with the incorporation of the dwell step, and this was observed at all input
velocities. The dwell step also increased the accuracy of the peak displacement achieved
as the percentage errors at each input displacement depth was reduced from approximately
95% to less than 1.00% (Appendix B Table 6.4). The greatest reduction in percentage error
was observed with an input displacement of 1 mm and velocity of 3000 mm.s−1: 93.65%
to 0.10% (93.55% decrease). The improved capability of achieving the input displacement
value was also observed visually, where the input and output displacement profiles aligned
more closely.
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Figure 3.4: Comparison of input and output displacement profiles of a
simulated contusion regime with the addition of a 100 ms dwell step at 100
mm.s−1. Dashed lines represent the output profiles; solid lines represent the input
command. The simulated waveform was programmed as follows: dwell (10 ms), ramp
(1000 mm.s−1 to the defined displacement depth) in compression, dwell (100 ms), and
ramp (1000 mm.s−1) to 0.000 mm. Displacement profiles for all velocities can be seen in
Appendix B (Figure 6.1).
Another observation of the displacement profiles showed a recoil event, which was not
observed in the input command displacement profiles (Figure 3.4), nor the displacement
profiles under the condition without the dwell step (Figure 3.3). This observation was
more pronounced at velocities of 1000 and 3000 mm.s−1. During the first ramp step to
the desired input displacement value, displacement increased as expected. However, the
system stopped short of the desired displacement value and decreased slightly, before
increasing again to reach the input displacement value. The time at which the peak
displacement was achieved was therefore shifted, compared to the input command profile,
as described above.
Whilst the addition of the 100 ms dwell step to the waveform increased the accuracy
of the desired output displacement values, the percentage errors calculated for peak
velocity remained high compared to displacement error (Appendix B Table 6.5). At 100
mm.s−1, there was no significant difference in peak velocity between conditions with and
without the dwell step, at each input displacement depth. The mean percentage error of
peak velocity ranged from 8.75 – 20.00% and 10.00 – 17.50%, without and with the dwell
step, respectively. At both 1000 and 3000 mm.s−1, there was a significant increase in the
peak velocity achieved with the dwell step, at each displacement depth. The mean
percentage errors were subsequently reduced; however, the condition which resulted in a
peak velocity closest to the target value was with an input of 1000 mm.s−1 and 10.000
mm. This condition resulted in a mean peak velocity of 927.50 ± 1 mm.s−1. This
corresponds to an error of 7.25% which was much greater than the range of error values
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calculated for peak displacement. Although the dwell step reduced the error in peak
velocity achieved at 3000 mm.s−1, the lowest error was still 60.69% (mean peak velocity
of 1176.25 ± 1 mm.s−1; 10.000 mm).
An exact output velocity of 100 mm.s−1 was not achieved: velocity was slightly
undershooting at a mean of 80.00 and 91.25 ± 1 mm.s−1, at input displacement values of
1.000 and 2.000 mm, respectively. Conversely, velocity was slightly overshooting the
desired value between a mean of 110.00 and 113.75 ± 3 mm.s−1, between input
displacement values of 4.000 and 10.000 mm. An exact output velocity of 1000 mm.s−1
was not achieved, with the mean peak velocities of 918.75 ± 1 and 927.50 ± 1 without
and with the dwell step, respectively, being the closest to the target (10.000 mm input
displacement). An exact output velocity of 3000 mm.s−1 was not achieved: the mean
peak velocities of 897.50 ± 1 and 1176.25 ± 3 mm.s−1 without and with the dwell step,
respectively, were closest to the target velocity (10.000 mm input displacement). At
input velocities of 1000 and 3000 mm.s−1 the mean output peak velocity increased with
increasing input displacement.
The results here demonstrate that an output velocity of 3000 mm.s−1 could not be
feasibly achieved. With an input velocity of 3000 mm.s−1, increasing the working
displacement distance to 10 mm, and incorporating a 100 ms dwell step to the waveform
only resulted in a mean peak output velocity of 1176.25 ± 3 mm.s−1 (mean percentage
error of 60.79%). Therefore, this velocity was omitted from the subsequent experiments.
Further characterisation and optimisation of the BOSE parameters was undertaken with
input velocities of 100 and 1000 mm.s−1, and with the addition of the 100 ms dwell step.
3.4.1.2 Manual Proportional Integrative Derivative Tuning
By incorporating the 100 ms dwell step into the contusion waveform, an output velocity
of 100 mm.s−1 was achieved with a minimum percentage error of 10% (input
displacement of 2.00 and 4.00 mm). Similarly, an output velocity of 1000 mm.s−1 was
achieved with a minimum percentage error of 7.25 ± 0.1% (input displacement of 10.00
mm). Proportional Integrative Derivative (PID) tuning was undertaken to evaluate
whether the accuracy of the BOSE system could be further optimised. The default
tuning system developed by the manufacturer is called TuneIQ®, with all the data
presented thus far using this method of control optimisation. The following data
compared output peak velocity values between TuneIQ®and manual PID tuning. For
details of the individual PID values for each input displacement and velocity
combination, refer to Appendix B (Table 6.6).
The addition of PID tuning imparted minor differences to the output displacement
profiles (Figure 3.5). By plotting the displacement profiles of the non-tuned and PID
tuned experiments onto a graph, it was observed that output displacement profiles of the
tuned experiments aligned closer to the corresponding command profiles. At both input
velocities, PID tuning shifted the profiles to the left thus the time to reach the first peak
decreased (examples highlighted in Figure 3.5 A – C). However, at 1000 mm.s−1 and
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10.000 mm, an overshoot in displacement was observed with PID tuning at the first peak
in the displacement profile, at 29.8 ms (mean 10.236 mm). This corresponded to the peak
output displacement depth. This contrasts to the other input displacement depths, where
the first peak was less than the actual peak displacement and the actual peak displacement
was achieved at approximately 108 ms.
Figure 3.5: Comparison of input and output displacement profiles of a
simulated contusion regime at 100 and 1000 mm.s−1 with and without PID
tuning. Coloured dashed lines represent non-PID tuned profiles (TuneIQ); corresponding
coloured solid lines represent PID tuned profiles; dashed black lines represent the input
command profiles. Higher magnification images of profiles at 10.000 (A), 8.000 (B), and
6.000 mm (C) displacement. N = 4.
At 100 mm.s−1, there was a significant difference in the mean peak displacement
between the non-tuned and PID tuned conditions at 1, 4, and 10.000 mm (Figure 3.6).
At 1000 mm.s−1, there was a significant difference in the mean peak displacement
between the non-tuned and PID tuned conditions at all displacement depths. PID
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tuning generally reduced the percentage error of peak displacement, but actually
increased the error under the following conditions: 100 mm.s−1 at 1 and 4.000 mm, and
1000 mm.s−1 at 1, 2, and 10.000 mm.
At an input velocity of 100 mm.s−1, PID tuning resulted in a significant increase in
the mean peak velocity achieved, between 1 – 4.000 mm, compared to the non-tuned
values. At 1.000 mm, PID tuning resulted in a change from an undershoot (82.50
mm.s−1) to an overshoot (117.00 mm.s−1) in peak velocity achieved, although the mean
percentage errors remained similar (mean 17.50% vs. 17.00% for non-tuned vs. tuned,
respectively). PID tuning reduced the extent of undershoot in velocity at 2.000 mm
which was closer to 100 mm.s−1, and the error was reduced from 10 to 6.00%. However,
tuning further increased the extent of overshoot at 4.000 mm and thus increased the
mean error from 10 to 18.00%.
Conversely, PID tuning decreased the mean peak velocity achieved between 6 – 10.000
mm, although this was only significant at 8.000 mm. At this displacement range, PID
tuning reduced the extent of the overshoot that was observed without tuning, thus the
errors also decreased as the values were closer to 1000 mm.s−1. At an input velocity
of 1000 mm.s−1, PID tuning resulted in a significant increase in the mean peak velocity
achieved compared to the non-tuned values, at each displacement depth. This resulted in
peak velocity values which were closer to the desired 1000 mm.s−1. PID tuning resulted in
a peak velocity closest to 1000 mm.s−1, using an input displacement of 10.000 mm (mean
1031.00 mm.s−1; 3.10% error).
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Figure 3.6: Summary of the effects of a 100 ms dwell step and PID tuning
on output peak displacement and velocity measurements of the BOSE. Black
dashed line represents the target velocity. Data presented as the mean ± SEM. Two-way
ANOVA with Tukey’s post-hoc test performed for each displacement group. Statistical
significance levels * p<0.05 (– dwell – PID vs. + dwell – PID); # p<0.05 (+ dwell – PID
vs. + dwell + PID); ‡ p<0.05 (– dwell – PID vs. + dwell + PID). N = 4. Note: PID
tuning experiments were not undertaken at an input velocity of 3000 mm.s−1 as results
from the preceding experiments showed this velocity could not be feasibly achieved.
Overall, the input displacement value which resulted in the most accurate output
measurements at both 100 and 1000 mm.s−1 was 8.000 mm since this was a large enough
distance for the system to accelerate to the desired velocity (Table 3.2). This was in
addition to modifications to the contusion protocol, including incorporating the 100 ms
dwell step and performing PID tuning. Therefore, for subsequent characterisation
experiments utilising hydrogel specimens, the initial distance between the sample and
the upper load platen was set to 8.000 mm (working displacement).
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Table 3.2: Summary of the output peak displacement and velocity
measurements representing the most accurate contusion protocol. Input
displacement 8.000 mm. Data is presented as the mean (% error). N=4.
100 mm.s−1 1000 mm.s−1
Peak displacement (%) 8.003 (0.04%) 7.997 (0.04%)
Peak velocity (mm.s−1) 107.50 (7.50%) 943.00 (5.70%)
3.4.1.3 Characterisation of the BOSE under Compression with Collagen
Hydrogels
Further characterisation of the displacement and velocity parameters of the BOSE was
undertaken with the presence of acellular rat tail type-I collagen hydrogels. The
objective was to determine whether the presence of the gels significantly affected the
ability of the system to achieve the input displacement and velocity defined and whether
this differed from tests in air (control). Gels were prepared to a volume of 300 µL in 48
well-plates (11 mm diameter discs), according to the methods described in Section3.3.5.
The gels were transferred to the BOSE apparatus and the height of each individual gel
was calculated, according to the methods described in Section 3.3.1.1. The working
distance- the distance between the surface of the gel and the upper load platen- was set
to 8.000 mm based on the preceding results suggesting this as the displacement for
achieving optimum desired output displacement and velocity (Section 3.4.1). Given the
height of the gel, the desired displacement depth was calculated as a percentage of the
total height (25, 50, 75%). After experimental contusion was performed on each gel, the
same waveform was simulated in air to serve as the control.
Comparison of the recorded peak displacement and velocity values showed that there
was no significant difference between the gel and air, thus the PID settings were suitable
for use with the hydrogels (p> 0.05; Figure 3.7). All input displacement depths were
achieved with high precision and accuracy, as demonstrated by the low percentage errors
and small error bars (Appendix B Table 6.7). A mean peak velocity of 115 mm.s−1 was
achieved under all input displacement and velocity conditions. This resulted in a higher
percentage error (15%) than previously reported in air. Greater variation was observed
with the output velocity data, compared to displacement. At an input velocity of 1000
mm.s−1 resulted in a mean peak velocity ranging from 900.00 – 967.50 mm.s−1. Output
peak velocity appeared to increase with increasing displacement, although this was not
statistically significant (p>0.05).
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Figure 3.7: Output peak displacement and velocity parameters of the BOSE
with and without collagen hydrogels. Rat tail type-I collagen (2 mg.mL−1) was
used to prepare 300 µL, 11 mm disc-shaped hydrogels in 48-well plates. Contusion
waveforms were simulated, using velocities of 100 and 1000 mm.s−1, and displacement
depths calculated as 25, 50, and 75% of the total gel height. The peak displacement and
velocity values were recorded. Under control conditions, the same waveform was performed
as above, but without the gel. Dashed black lines represent the target velocities. Data
presented as the mean ± SEM. One-way ANOVA with Tukey’s post-hoc test performed.
N = 3.
Comparison of the output displacement and velocity profiles also demonstrates that
there was little disparity between the presence of the gel, and air (Figure 3.8). At an input
velocity of 100 mm.s−1 the target displacement was achieved and was maintained for the
duration of the 100 ms dwell step. A recoil event was observed in the displacement profiles
with an input velocity of 1000 mm.s−1, which was not observed at 100 mm.s−1. The recoil
was observed in profiles for both experimental and control experiments but shows that the
target displacement was achieved. Recoil was also observed in the velocity profiles at an
input velocity of 100 mm.s−1, but not 1000 mm.s−1. Some noise was recorded as the target
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velocity was achieved, illustrated by the oscillations in velocity during the dwell step and
there was an overshoot in velocity. However, this velocity was generally maintained in a
stable manner and was observed both with gels and in air.
Figure 3.8: Output displacement and velocity profiles with and without
collagen hydrogels. Contusion waveforms were simulated, using various combinations
of input displacements (% gel height) and velocities, with displacement and velocity
data recorded. Solid coloured lines represent experiments with the presence of a gel.
Corresponding dashed coloured lines represent experiments in air (control). Black dashed
lines represent the input command profiles. N = 3.
To summarise, a reproducible contusion protocol was developed, although certain
modifications to the waveform and sample set up were required. Increasing the initial
distance between the two platens (working displacement), and the addition of the 100 ms
dwell step enabled the system to reach the target velocity and displacement depth and
reduced the error. Manual PID tuning reduced the error in the peak velocity and
enabled the displacement profiles to better match their command profiles. Applying this
waveform to the hydrogels showed that there were no significant differences in the
recorded displacement and velocity parameters between air and in the presence of the
hydrogel. Thus, no further modifications to the protocol were required.
3.4.2 Modelling Contusion Injury Using the BOSE – Compression
Platen Fixture Design
The original compression platen fixtures supplied by the manufacturer consisted of a flat
surface on which the sample could sit, but with an angled raised circumference (Figure
3.9A). This was screwed onto a ported shaft, which was then attached to the motor shaft
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(i.e. movement of this platen was controlled by being connected to the motor).The diameter
of the cavity was measured to be 12 mm; thus the diameter of the hydrogels selected for
experiments was 11 mm (48-well plate). A volume of gel of 300 µL was selected as it was
the smallest volume of gel which enabled its transferral to and from the plate and the
BOSE rig without damaging it. The diameter of the upper load platen fixture (connected
to the load cell) was 10 mm, and was selected as this resulted in the majority of the gel
being in contact with the load platen during compression (global compression as opposed
to a focal one). With the edges of the gel being cultured in a hard plastic well-plate and
manipulated by the spatula during transferral to and from the well-plate and the BOSE,
these areas would be excluded from subsequent cell behaviour analysis.
Figure 3.9: Diagram of the different platen fixtures tested for compressing
collagen hydrogels. The original compression platen fixture supplied by the
manufacturer exhibited a circular central cavity with a slanted circumference (A). First
design iteration of the compression platen, modified to exhibit a flat surface on which the
sample could sit (B). Second design iteration and working prototype of the compression
platen, modified with a larger cavity and vertical sides (C).
The highly hydrated nature of hydrogels meant the structure collapsed slightly when
removed from the well plate. Consequently, the gels would have been compressed to a
greater extent towards the edges compared to the inner region. A new platen was
manufactured which featured an entirely flat surface ( 18 mm) on which the hydrogel
could sit (Figure 3.9B). This enabled the gel to be compressed in an unconfined system,
removing confinement as a potential confounding factor in how cells react to the
application of compressive forces in subsequent experiments. Unfortunately, during a
simulated contusion the gels did not remain on the platen and became displaced (Figure
3.10). As such, it was difficult to determine whether complete compression of the gel
took place. Recovery of the sample was also difficult as it was often ejected outside the
chamber, thus compromising sample integrity and sterility.
A design modification was thus made to the original manufacturer’s compression
platen design, by increasing the diameter of the internal cavity from 12 mm to 13 mm
(Figure 3.9C). The enlarged cavity was designed to allow better handling of the hydrogel
sample (11 mm) to and from the platen minimising damage to the edges with a spatula.
Additionally, the additional space enables uniform compression across the gel surface
and. Testing an acellular hydrogel under a contusion waveform using this modified
compression platen resulted in the gel successfully remaining within the cavity of the















Figure 3.10: Gels did not remain on the platen with a flat surface following compression. The original platen design comprised a completely
flat surface. The gels were placed on the lower motor platen, which travels towards the upper load platen, once the waveform is initiated (A). As the
surface of the gel makes contact with the load platen (B) and is compressed, it was observed that the gel would slip off the platen (C).
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3.4.3 Evaluation of the BOSE Electroforce BioDynamic 5110 with
Collagen Hydrogels – Measurement of Gel Height
In order to control and accurately apply contusion injury to the hydrogels a quick, accurate
and non-destructive method to measure the gel height was required which also minimised
the total volume of starting reagents. Acellular collagen hydrogels were prepared according
to the protocol in Chapter 2 (Section 2.5.5) and cast in a 48 well-plate as these produced
uniform sized hydrogels of a diameter suitable for loading into the BOSE. Preliminary
experiments indicated that a minimum gel volume of 300 µL resulted in hydrogels which
were easy to handle. The height of the gels were measured in the BOSE according to
the method described in Section 3.3.1.1. To assess the reproducibility of this method
and of the preparation of gels at 300 µL, this was performed across multiple independent
experiments (Figure 3.11).
Figure 3.11: Height of collagen hydrogels measured across independent
experiments. Rat tail type-I collagen hydrogels were seeded with primary rat cortical
astrocytes at a density of 5 x 105 cells.mL−1 gel (300 µL) and their heights measured using
the BOSE. Box represents the interquartile range (IQR). Line across the box represents the
median. Whiskers represent the non-outlier minimum and peak values. Mean is denoted
as ’+’. Individual data values plotted show those which are less than the lower quartile -
1.5 IQR, or greater than the upper quartile + 1.5 IQR (circles). N ranged from 12 – 72
for each experiment.
Between experiments, the mean height of the gels ranged from 1.276 ± 0.1 mm in
Experiment 10, to 1.619 ± 0.1 mm in Experiment 2. The mean height of gels in
Experiments 9 and 10 were significantly lower than Experiments 1 – 7 (p<0.05, one-way
ANOVA with post-hoc Tukey test), but all experiments displayed a similar spread, with
a mean range of 0.603 mm. The mean interquartile range across all experiments was
0.213 mm. Although the absolute displacement imparted onto the gels may influence
subsequent cellular behaviour, the gel preparation and height measurement protocols
resulted in heights with a similar spread, thus was deemed a reproducible method. In the
context of this contusion model, a threshold for the range of thickness values considered
acceptable was not considered, since the displacement parameters were calculated based
on the individual samples themselves.
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3.4.4 Development of an In Vitro Model of Distraction Injury
Distraction is another mechanism of TSCI, which remains infrequently modelled in vivo
compared to contusion SCI. Tensile grips were provided with the BOSE, which enables
the user to perform tensile tests. The grips are of a clamp design with a knurled screw
for securing the sample between a serrated grip surface (Figure 3.12). Development of
a protocol to model distraction injury using collagen hydrogels required characterisation
and verification of the BOSE system under tensile loads. As with characterisation and
verification of the BOSE under contusion loads, various combinations of input distraction
lengths and velocities were tested and the respective output values compared. Additionally,
gel shape and dimensions were investigated to determine the optimum method of gel
preparation and handling with the BOSE apparatus.
Figure 3.12: Tensile Grips of the BOSE. Photo of the tensile grips provided by the
manufacturer for the BOSE Electroforce BioDynamic 5110 (left) and configuration of the
grips on the BOSE apparatus (right). Scale bar represents 10 mm.
3.4.4.1 The BOSE Electroforce BioDynamic 5110 as an Apparatus for
Inducing Distraction Injury
Characterisation of the BOSE was performed under a distraction waveform to determine
whether accurate and reproducible tensile loads could be modelled in air and with the
presence of the distraction mould, using the BOSE. The waveform was similar to that
of contusion, except this time the displacement ramps were distracted as opposed to
moving towards each other. Input velocities of 100 and 1000 mm.s−1 were tested, at
input distraction lengths of 2, 4 and 6.000 mm. Characterisation results for contusion
suggested the use of PID tuning could increase the accuracy of the output parameters
achieved (Section 3.4.1.2). Therefore, comparison of distraction waveforms was performed
with and without PID tuning. The use of PID tuning generated displacement profiles
which better aligned with the command profiles, compared to the non-PID tuned profiles
(Figure 3.13). This was more evident at 6 mm distraction, where a larger disparity was
observed between the non-tuned and PID tuned profiles during the first ramp step.
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Figure 3.13: Comparison of input and output displacement profiles of a
simulated distraction regime with and without PID tuning in air. Distraction
waveforms were simulated, using various combinations of input displacements and
velocities, with displacement data recorded. Coloured dashed lines represent non-PID
tuned profiles (TuneIQ); corresponding coloured solid lines represent PID tuned profiles;
dashed black lines represent the input command profiles. N=3.
At an input velocity of 1000 mm.s−1, PID tuning reduced the extent of displacement
overshoot which was observed during the first ramp step in the non-tuned displacement
profiles (Figure 3.13B). At all input distraction lengths, displacement at this first peak
(at approximately 25 ms) also corresponded to the actual peak displacement under both
non-tuned and PID tuned conditions. Conversely, at an input velocity of 100 mm.s−1 the
first peak did not correspond to the actual peak displacement, which was not achieved
until towards the latter stages of the dwell step (at approximately 143 ms). At an input
velocity of 100 mm.s−1, both non-tuned and PID tuning conditions resulted in the
desired input displacements being achieved accurately and precisely, with no significant
difference in the mean peak displacement achieved (Figure 3.14). The percentage error
in peak displacement was slightly higher with an input velocity of 1000 mm.s−1 due to
the overshoot in displacement in the non-tuned conditions. PID tuning significantly
reduced the mean peak displacement achieved at all depths, resulting in values closer to
the target displacement and thus reducing the error (Appendix B Table 6.8).
A velocity of 100 mm.s −1 was achieved at all distraction lengths, although slightly
overshooting, with a mean peak velocity of 111.11 mm.s−1 across all lengths (Figure 3.14A).
PID tuning did not have a significant effect on the mean peak velocity achieved, compared
to the non-tuned values (p>0.05). At an input velocity of 1000 mm.s−1, increasing the
distraction length also resulted in an increase in the peak velocity. PID tuning resulted
in a significant increase in the peak velocity achieved at each distraction length. However,
the target velocity could not be achieved at any distraction length under both non-tuned
and PID tuned conditions. The maximum velocity achievable was 856.67 mm.s−1, using a
6 mm input distraction length and PID tuning, which resulted in a mean error of 14.33%
(Appendix B Table 6.8).
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Figure 3.14: Peak output displacement and velocity of a simulated distraction
regime with and without PID tuning in air. Distraction waveforms were simulated,
using various combinations of input displacements and velocities, with peak displacement
and velocity values calculated. Dashed black lines represent the target input velocity. Data
presented as the mean ± SEM. Two-way ANOVA with Tukey’s post-hoc test performed.
Statistical significance * p<0.05 untuned vs. PID tuned at each distraction length. N=3.
Due to the setup of the BOSE, the tensile grips would be in a fixed starting
displacement length, securing the samples and maintaining them at 0% distraction.
Therefore, working displacement could not be modified to allow the system a greater
distance to accelerate to the higher velocity as was performed in the contusion
experiments. This meant that with an input velocity of 1000 mm.s−1, the maximum
velocity achievable was 333.33 and 628.33 mm.s−1, at 2 and 4.000 mm, respectively. The
significant differences in the peak velocity achievable at different distraction lengths
meant that this input velocity could not be used.
3.4.4.2 Design of a Mould for Modelling Distraction Injury
The BOSE instrument is designed for the evaluation of biologically oriented samples,
including biomaterials and soft tissue constructs. In typical tensile testing experiments, a
specimen is loaded between two grips, which secures the specimen and allows tensile
forces to be applied to it. However, the low elastic modulus and hydrated properties of
the collagen hydrogels used in this study presented challenges regarding loading and
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securing them to the tensile grips. Therefore, an alternative method was sought which
would not require the sample to be in direct contact with the tensile grips. Engineered
anisotropic tissue constructs with aligned cell and ECM structures has resulted in 3D
hydrogel models which better mimic the spatial organisation of cells in the native spinal
cord (Silva et al., 2014). A mould, developed by Phillips et al., (2005), was originally
developed to generate self-aligned hydrogels, using Schwann cells and fibroblasts, without
the application of an external stimulus (Figure 3.15). Cell-seeded collagen hydrogels
prepared in these moulds have previously been used to model contusion injury, along
with the Infinite Horizons Impactor to apply the mechanical load (Smith, 2016).
Figure 3.15: Tethered hydrogel mould. CAD drawing of a hydrogel mould originally
designed to prepare matrix and cell-aligned gels (A). Photo of the mould manufactured
out of polyether ether ketone (PEEK), with the placement of plastic mesh bars at each
end (B). Two mesh bars were required at each end and a volume of 1 mL of gel solution
was required to fill each mould. Measurements are in millimetres (mm).
As the moulds have already been used to model one mechanism of TSCI, it was
hypothesised that it could be adapted for use as a distraction model as well. Because the
ends of the gel were cast around plastic mesh bars, it was hypothesised that these could
be used to secure the gel within the tensile grips of the BOSE instead of the gel itself.
Acellular gels were prepared in this mould to investigate this hypothesis. The size of the
original mould required 1 mL of hydrogel solution to fill the I-shaped cavity.
Additionally, the size of the mould meant it could not fit in standard sized well-plates
and had to be cultured in individual petri dishes, which required greater volumes of cell
culture medium. The mould was therefore initially scaled down by half to reduce the
starting material and cell culture reagents required (Figure 3.16). The smaller moulds
required a volume of 150 µL hydrogel solution and could be housed in wells of a 6
well-plate, overlayed with 2 mL of cell culture medium.
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Figure 3.16: 0.5X scaled tethered hydrogel mould. CAD drawing of the 0.5 X
scaled mould (A). Measurements are in millimetres (mm). Photo of a mould with an
acellular rat tail type-I collagen hydrogel cast within it (B). One mesh bar was required
at each end of the mould. Scale bar represents 5 mm.
To remove the gels from the mould, a 23 G needle was used to separate the gel from
the edges of the mould. A pair of tweezers was then used to grip onto the tethered mesh
bars at the ends of the gels to remove the construct. However, it was difficult to maintain
the dimensions of the gel once it was removed from the mould, and often became stretched
during transfer from the mould to the tensile grips of the BOSE. Additionally, the small
contact surface area between the mesh bars and the tensile grips meant securing the sample
without it slipping was unsuccessful. Therefore, instead of the need to remove the gel from
the mould and securing it directly into the tensile grips, a design modification was made
which would remove this requirement and a method to secure the mould to the tensile
grips was explored. A mould with two separate pieces, which could then be connected
and secured as one piece was designed (Figure 3.17). For detailed CAD drawings with full
measurement specifications refer to Appendix C.
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Figure 3.17: CAD drawing of the components of the tethered mould. CAD
drawings of four main components of the distraction mould: top piece (A), bottom piece
(B), dowel (C), and screw (D). Scale bar represents 2 mm.
The mould components were manufactured out of PEEK, with the two pieces held
together with pairs of 316 stainless steel dowels and screws. The moulds were tested in
the BOSE system and set up according to the methods in Section 3.3.5. Handling of the
mould was easy and sterility was maintained as demonstrated by the absence of visual
contamination when the acellular gels were tested on and then cultured for a period of
14 days. Testing was less high-throughput compared to the gels used to model contusion
injury due to the addition of several more time-consuming components: assembly and
set up of the mould, removal of the parafilm used to cast the gel to allow separation of
the mould pieces once in the BOSE, alignment and securing of the mould into the tensile
grips, removal and installment of the screws and dowels before and after testing.
However, successful distraction of the mould pieces was achieved, so the system was
then tested with gels. With a gauge length of 8.25 mm, distraction lengths of 25, 50, and
75% of the total length was tested. It was hypothesised that these values would represent a
range of injury severities and represented the same range used in the contusion experiments.
However, results showed that at distraction lengths of 50 and 75%, failure of the gels was
observed. Failure always occurred at the ends of the gel, where the gel interfaced with the
plastic mesh bars, and at the bottom end of the gel, which was connected to the moving
motor shaft (Figure 3.18B). This could potentially be due to increased stress concentration
in this region, where there is a change in geometry, or incomplete integration of the gel
and the mesh bars.
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Figure 3.18: Application of tensile load to gels prepared in the distraction
mould. Video stills from the simulation of a distraction type injury on gels prepared in
the distraction mould. At 0% displacement (A) and 50% distraction (B), where failure of
the gel was observed. Scale bar represents 5 mm.
Failure was determined to not be due to insufficient integration of the gel with the
tethered bars, as the gel could be successfully removed from the mould with the gel and
tethered bars still intact. The original design purpose for the tethered bars was to create
anchor points for cells to generate tension and contract the gel and self-align at a certain
seeding density. As this was not necessary for this study, the tethered bars were removed.
However, failure of the gels was still observed under tensile loads above 50% displacement,
and at the same end regions of the gel as with the presence of the tethered bars. Therefore,
an experiment was performed to determine the maximum displacement achievable without
gel failure. The maximum displacement achieved without resulting in failure of the gel was
35%, which corresponds to a distraction length of 2.888 mm. For subsequent experiments
using cell-seeded gels in this system, distraction lengths of 10, 20, and 30% would be used.
3.4.4.3 The effects of the distraction mould on output parameters of the
BOSE
Verification of the input and output displacement and velocity parameters of the BOSE
was undertaken with the presence of collagen hydrogels prepared in the distraction
moulds. The objective was to determine whether the presence of the mould and/or gel
significantly affected the ability of the system to achieve the input displacement and
velocity defined. Previous results showed that 35% was the maximum achievable
distraction length without causing failure of the gel. Additionally, a velocity of 1000
mm.s−1 could not be achieved at any distraction length. Therefore, testing of the BOSE
system with the distraction mould was performed using an input velocity of 100 mm.s−1
and three different distraction lengths: 10, 20, and 30% of the gel gauge length (8.25
mm). This corresponds to absolute distraction lengths of 0.825, 1.650, and 2.475 mm,
respectively.
There was a good concordance between the displacement profiles of the gels
subjected to tensile forces (experimental) and control (air) simulations, indicating that
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the presence of the gel did not adversely affect the ability of the system to achieve the
desired displacements. Similarly both of these profiles aligned well with the command
profiles (Figure 3.19). Recoil was observed at all distraction lengths during the first
ramp step towards the desired length. However, the target distraction lengths were
achieved during the dwell step and remained stable.
Figure 3.19: Output displacement profiles after applying distraction loads to
gels matched those in air. Solid coloured lines represent the experimental profiles (with
gel); corresponding coloured dashed lines represent the control profiles (air); black dashed
lines represent the input command profiles. N = 3.
Statistical analysis showed that there was no significant difference in the peak
displacement achieved, between air (control) and the gels at each distraction length
(Figure 3.20A). The target lengths were achieved with precision as demonstrated by the
small error bars (Appendix B Table 6.9). Slightly more variation was observed in the
peak velocity data. The peak velocity achieved in air was significantly higher than with
the gel, at 10% distraction, which was undershooting at 90.00 mm.s−1 (Figure 3.20B).
There was no significant difference between air and the gel at 20 and 30% distraction.
The input velocity of 100 mm.s−1 was achieved, although there was an overshoot in
velocity in all conditions at 115.00 mm.s−1.
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Figure 3.20: Peak output displacement and velocity values are applying
distraction loads to gels prepared in the distraction mould. Black dashed line
represents the target velocity. Two-way ANOVA with Tukey’s post-hoc test performed.
Significance levels * p< 0.05 control (air) vs. gel. N = 3.
3.4.5 A Biologically Relevant In Vitro Model of the Spinal Cord
With a protocol developed for applying mechanical forces in a reproducible and accurate
manner, the aim of this study was to develop a three-dimensional biological model of the
spinal cord which would be capable of being subjected to mechanical forces, using the
BOSE.
3.4.5.1 Analysis of Purification of Astrocytes from a Mixed Glial Culture
Primary rat astrocytes were selected in this project to evaluate the effects of varying
severities of contusion and distraction loads on cellular outcomes, such as viability and
reactivity. The method used to isolate these cells involved generating a culture of mixed
glial cells in the first instance. After a period of 7 – 10 days, astrocytes were enriched by
mechanically separating them from the rest of the cell types (Section 2.5.4.2). To
characterise potential contamination of other neural cells which may exert confounding
influences on astrocyte behaviour and viability, the purity of the enriched astrocytes was
analysed. Immunocytochemical staining for glial fibrillary acidic protein (GFAP) was
performed (Figure 3.21). The population of cells was predominantly GFAP-positive,
demonstrated by nuclei associated with GFAP staining (green). In comparison, there
were few GFAP-negative cells which were demonstrated by nuclei which were not also
GFAP-positive. Quantification of the percentage purity of enriched astrocytes was
performed across three independent preparations and the mean astrocyte purity was
calculated to be more than 90% (data not shown).
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Figure 3.21: Immunocytochemical staining of enriched astrocytes using GFAP.
Astrocytes were seeded onto PDL-coated glass coverslips at 5 x 104 cells and cultured for
24 hours before fixing and immunostaining for astrocytes (A). Primary antibody control
(B). Astrocytes (GFAP; green), nuclei (DAPI; blue). Scale bar represents 50 µm.
3.4.5.2 Selection of an optimal primary astrocyte initial seeding density
The selection of three different input displacement depths and two different input
velocities (one velocity for distraction) to apply to 3D seeded astrocytes (300 µL gels)
and evaluate responses over a 14 day time period presented the issue of selecting a
seeding density that would result in the preparation of enough samples for a single
experiment. Further, subsequent studies using cell-seeded hydrogels would be cultured
for up to 14 days. Therefore, an initial seeding density which, by Day 14, would result in
a density which was still easy to perform image analysis was ideal. To obtain an
appropriate number of cells and account for variation across different animals, primary
astrocytes were isolated and pooled from six pre-weaner female Wistar rats. All gels for
one experiment were prepared at the same time to minimise cross-experiment
confounding factors, such as differences in the preparation of the cells and hydrogels.
A preliminary experiment was set up with 100 µL hydrogels seeded at a range of
different densities, from 5 x 104 to 4 x 106 primary astrocytes per mL of hydrogel. The
hydrogels were cultured in an equal volume of cell culture media, with media changes
undertaken 24 hours after plating, and every two to three days thereafter. On Days 1, 7,
and 14 the metabolic activity of the cells was measured, using the ATPlite™Luminescence
Assay System (Figure 3.22). With an initial seeding density of 5 x 105 and 1 x 106
cells.mL−1 gel, there was no significant change in metabolic activity across the 14-day
time period. Both conditions resulted in a slight decrease in metabolic activity at Day 7,
but this was not significant and had recovered by Day 14. At an initial seeding density of
2 x 106 cells.mL−1 gel, a significant decrease in metabolic activity was observed between
Days 1 and 7 and Days 7 and 14, suggesting a suboptimal environment leading to decreased
viability. There was no significant difference in metabolic activity between Days 1 and
14. At an initial seeding density of 4 x 106 cells.mL−1 gel, metabolic activity significantly
decreased between Days 1 and 7, before significantly increasing again by Day 14. However,
metabolic activity remained significantly lower compared to Day 1. Live/dead cytotoxicity
staining was also performed to compare with the ATPlite data and supported the selection
of an initial seeding density of 5 x 105 primary astrocytes per millilitre of gel, with no
significant difference in percentage viability over the 14 day culture period (mean 86.4%
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viability).
Figure 3.22: Metabolic activity of primary astrocytes seeded into hydrogels at
various initial densities. Rat tail type-I collagen hydrogels were seeded with primary
rat cortical astrocytes at various initial seeding densities, ranging from 5 x 104 to 4 x
106 cells p.ml−1 gel. At Days 1, 7, and 14 metabolic activity of the cells was evaluated
using the ATPlite assay. The positive control represents 70% methanol treatment for one
hour. Error bars represent the mean ± SEM. Two-way ANOVA with post-hoc Tukey test.
Significance levels * p<0.05 (Day 1 vs. Day 7); # p<0.05 (Day 7 vs. Day 14); ‡ p<0.05
(Day 1 vs. Day 14). N = 3.
Immunohistochemical staining of primary astrocytes for GFAP was also performed to
evaluate the distribution of cells at a seeding density of 5 x 10−5 over a period of 14 days.
However, there were few GFAP-positive cells, thus using GFAP as a marker to evaluate the
morphology of non-reactive astrocytes in 3D could not be achieved. Those cells which were
GFAP-positive were small and round in morphology. This contrasts to primary astrocytes
seeded at an initial density of 4 x 10−1 cells.mL−1, where after 24 hours in culture there
were more GFAP-positive cells and they exhibited a reactive morphology with ramification
of processes and hypertrophy (Figure 3.23). Overall, an initial seeding density of 5x105
cells.mL−1 demonstrated stable metabolic activity and viability over a period of 14 days
whilst maintaining a non-reactive morphology. This also meant that enough samples and
replicates could be prepared for one experiment in a suitable timeframe. Therefore, this
seeding density would be used in subsequent experiments in the proceeding chapters.
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Figure 3.23: Higher seeding densities resulted in a more reactive astrocyte
morphology in 3D. Astrocytes were seeded into collagen hydrogels at 5 x 105 (A) and
4 x 106 (B) cells.mL−1 gel and cultured for 24 hours before fixing and immunostaining for
astrocytes. Astrocytes (GFAP; green), nuclei (DAPI; blue). Confocal maximum intensity
projection, 36 µm z-stack. Scale bar represents 50 µm.
3.5 Discussion
The aim of this chapter was to verify the capabilities of the BOSE Electroforce
BioDynamic 5110 apparatus and determine whether clinically relevant TSCI mechanisms
(contusion and distraction) could be simulated in a controlled and reproducible manner
in vitro, using cell-seeded collagen hydrogels as a 3D model of the environment of the
spinal cord. The study successfully enabled precise and accurate compressive and tensile
loads to be applied to hydrogels. Protocols were defined with a range of input
displacement and velocity parameters to represent contusion and distraction injury with
ranging severities in subsequent chapters. Additionally, an appropriate method was
defined for the preparation and seeding of collagen hydrogels with primary astrocytes,
including the optimal gel volume and dimensions, and initial cell seeding density.
3.5.1 Contusion
Modification of the initial compression waveform tested in this study, by increasing the
initial working distance between the platens and incorporating a dwell step, reduced the
error between the input and output peak displacement value to less than 0.5%. Kirk
(2018) also reported work on modelling contusion injury in vitro using the same BOSE
apparatus. However, characterisation and verification of the parameters was not
undertaken in air. In that study, the distance between the two platens was set to 4.000
mm, representing 100% displacement in the presence of the hydrogel. The height of the
gels was not reported so the actual working distance is unknown. Verification of
displacement in this study, using an input of 4.000 mm and 3000 mm.s−1 (the
parameters of Kirk (2018)), resulted in peak displacement values of 0.699 ± 9 x 10−4 and
4.007 ± 5 x 10−4 without and with a 100 ms dwell step, respectively. A dwell step of 10
ms was used by Kirk (2018) and the actual input and output displacement values were
not reported so it is difficult to verify how accurate the displacement parameter was in
that study. However, by comparing the input and output displacement profiles using the
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same input displacement and velocity parameters as in that study, it is suggested that
the desired input displacement depths were unlikely to have been achieved.
It was clear that a velocity of 3000 mm.s−1 could not be achieved in this study,
despite this being the maximum value that was allowed to be inputted into the
waveform. The velocity of 3000 mm.s−1 stated by Kirk (2018) was therefore not
achieved. As mentioned previously, the distance between the two platens was set up to
be 4 mm in that study. Characterisation of the BOSE in air in this study showed that at
an input velocity of 3000 mm.s−1, displacement of 4 mm, and 100 ms dwell step (without
PID tuning) the resultant mean peak output velocity was only 458.75 ± 1 mm.s−1.
The results in this study showed the presence of recoil in the system, which
occasionally led to an overshoot in velocity and displacement. This was observed both in
air and with hydrogels, suggesting this is instability within the BOSE itself. Kirk (2018)
also observed recoil with the BOSE and hypothesised that this was due to the elastic
properties of the hydrogels, but did not perform the same experiment in air to compare.
The contusion protocol in that study was modified to account for the recoil by setting
the first ramp step to move at 3000 mm.s−1 to a displacement depth that was 0.1 mm
less than the desired displacement depth. An additional ramp step was then
incorporated to move the motor platen the remaining 0.1 mm, but at a lower velocity of
3 mm.s−1.
However, the displacement profiles presented in that study showed a recoil of up to
0.5 mm remained present. The peak displacement values were not reported, but visually
comparing this point of the displacement profile to the command profile suggests the
peak displacement remained below that of the desired displacement. The shape of this
recoil was similar to that observed in this study, but given the longer dwell step of 100
ms, the target displacement was then achieved here. Impact velocity and the velocity at
peak displacement was not likely to have been 3000 mm.s−1 due to the input velocity
being reduced to 3 mm.s−1. This makes it difficult to know what the precise output
velocity measurements were to discuss and compare the relationship between velocity
and cellular response in this subsequent work. However, the original aim of that study
was to evaluate the effects of only displacement on cellular response.
An overshoot in displacement was also reported in vivo by Kim et al., (2009), using
the UBC multimechanism electromagnetic device to inflict contusion SCI on mouse
spinal cord. An overshoot in displacement of ∼0.02 mm was reported, both in air and
with mouse spinal cord. This was deemed insignificant compared to the desired input
displacement values. Once optimisation steps were undertaken in this study (increasing
working distance; 100 ms dwell step; PID tuning) an overshoot in displacement of less
than 0.089 and 0.236 mm was observed at 100 and 1000 mm.s−1, respectively. Where an
undershoot in displacement was observed this was calculated to be 0.007 and less than
0.039 mm with an input velocity of 100 and 1000 mm.s−1, respectively. These values are
within a similar range to that observed by Kim et al., (2009).
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Overshoot was also observed by Brody et al., (2007), who designed a custom
electromagnetic device to model controlled cortical impact (CCI). The apparatus
generated overshoots in displacement of 0.28 – 0.31 mm. These values are an order of
magnitude greater than those measured by Kim et al., (2009) and in this study,
although higher velocities were used in that study (3.6 and 5.2 m.s−1). The overshoot
was found to be caused by deformation of the apparatus support structures during the
impact stroke and not the dynamic response of the tissues. Compared to a commercially
available pneumatic device, these electromagnetic devices are more accurate, with Brody
et al., (2007) measuring an overshoot in displacement of up to 0.61 mm with the
pneumatic device under the same conditions. These studies demonstrate that overshoot
is a common effect observed with multiple apparatus designed to model high velocity
contusion-type injuries; however, as the scale of overshoot is relatively small compared to
the desired displacement, correction was not undertaken. Similarly, correction for
overshoot or undershoot was not performed in subsequent experiments.
PID tuning did not significantly improve the accuracy of the displacement parameter,
and actually decreased its accuracy under some conditions. This could potentially be
attributed to the nature of PID tuning itself as higher values may result in a more
aggressive response to reach the desired values, increasing instability. As it was also
performed manually, sub-optimal modifications to the tuning parameters by the user
could have increased instability in the system. There are numerous other methods of
PID tuning available, including heuristic and automated methods, which may provide a
more accurate and methodical approach to tuning which should be considered in future
(Bucz and Kozáková, 2018; Ziegler and Nichols, 1942).
However, the PID tuning undertaken in this study did improve the accuracy of the
peak velocity measured, with errors reduced to less than 10% at 8.000 and 10.000 mm
displacement at both velocities tested. The errors were still greater for velocity
compared to those for displacement, which was observed in other contusion studies too
(Chen et al., 2016; Choo et al., 2007; Lam et al., 2014). For instance, percentage errors
of 1 – 3% and 3 – 10% were calculated for displacement and velocity, respectively, given
the mean values reported by Lam et al., (2014). Tuning was either not applied to other
TSCI apparatus or was not reported, thus the characterisation and verification processes
of other in vivo studies using mechanical injury apparatus is not known.
The most common method for registering the surface of the spinal cord in vivo is to
gradually lower the impacting tip towards the cord until a change in load is registered.
An additional ’pre-load’ is commonly applied to maintain standardisation across subjects.
However, this method could not be employed in this study due to the lack of sensitivity.
The low elastic modulus of the hydrogel meant that a change in load was not registered,
even when the upper load platen was clearly in contact with the surface of the gel.
Busby et al., (2013) was able to use a change in load (0.01 N) to register the surface of
rat-tail type I collagen hydrogels (0.2, 0.3, 0.4% w/v) used in their study using the
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BOSE (3200 model). However, this was not possible in this study as the apparatus was
housed in a Class II cabinet to maintain sample sterility. The fan used in the cabinet
caused oscillations in load which made it difficult to distinguish between baseline noise,
and contact with the sample surface. The environment surrounding the BOSE apparatus
in the Busby et al., (2013) was not reported.
Therefore, the height of the gel was measured by moving the motor platen containing
the sample towards the load platen until contact was achieved with the surface of the gel.
Despite a limitation being that determining when the surface of the gel was in contact
with the load platen was manual, being able to control displacement to a resolution
down to 0.001 mm increased the reliability of this method. This protocol was used by
Koivisto et al., (2017) to set the starting point of the compression experiment as opposed
to specifically measuring its height. Instead, calipers were used to measure the
dimensions of their gels, which were considerably thicker at approximately 6.5 mm. It
was not clear whether the caliper measurements were performed before or after loading
the sample into the BOSE (5100 model), and which method was used to calculate the
subsequent displacement value to be used for compression testing.
Most studies reporting use of the BOSE Electroforce BioDynamic system performed
mechanical testing experiments and, as such, output biomechanics were generally not
characterised or reported (Bartlett et al., 2016a; Busby et al., 2013; Koivisto et al., 2017;
Sparrey and Keaveny, 2011). The strain rates used here were greater than those used for
mechanical testing, but characterisation data showed the BOSE was capable of
modelling different mechanisms of TSCI in vitro. The input displacement and velocity
range of the BOSE is comparable to other apparatus used to model SCI in vivo.
Although it was hypothesised that a velocity of 3000 mm.s−1 could be achieved based on
indications by the software and work by Kirk (2018), the results herein show that this
was not the case. However, input velocities of 100 and 1000 mm.s−1 could be achieved.
These are within the range of previous contusion studies in vivo (Chapter 1; Table 1.5).
The output displacement measurements were precise and had minimal percentage errors
within a similar range to the UBC multimechanism device, as described above.
The BOSE possesses more controllable parameters compared to some other contusion
apparatus used in vivo and offers high quality real-time data acquisition capabilities.
The IH impactor, for instance, offers only force control. Displacement was controlled to
an extent by Smith (2016) via manually adjusting the starting height of the impactor tip,
but this is not a standardised or validated method. The TestBench™system, also
manufactured by TA Instruments, was adapted for modelling contusion injury in
non-human primates (NHP) in vivo (Salegio et al., 2016). The system offers the same
controllable parameters as the BOSE Electroforce BioDynamic series and the study
reported various impact mechanical data, including input and output displacement and
velocity, time to maximum displacement, force at peak displacement, and peak force.
The output velocity ranged from 270 – 580 mm.s−1 which was lower than the input
velocity of 1000 mm.s−1. Output displacement ranged from 1.71 – 1.91 mm, 2.66 – 2.78
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mm, and 3.46 – 3.72 mm for inputs of 2.0, 3.0. and 4.3 mm, respectively showing an
undershoot of at least 0.09 mm which is greater than that in this study.
This demonstrates that the BOSE used in this study is more accurate compared to
the TestBench™system. Standard deviation was not reported so repeatability cannot be
discussed. The UBC multimechanism device is the only apparatus which is designed to
model contusion, distraction and dislocation mechanisms of SCI in rats in vivo (Chen et
al., 2016; Choo et al., 2008, 2007, 2009; Lam et al., 2014). Again, input displacement
and velocity can be defined by the user and output injury mechanics include impact
depth, impact velocity, force, and energy applied Lam et al., (2014). Similar to the
BOSE, variability was greater for velocity compared to displacement. Optimisation of
the apparatus and reduction in variability has been achieved through improvements in
vertebral clamp design to prevent slippage, for instance.
3.5.2 Distraction
Verification of the BOSE with the gels revealed higher errors in the peak displacement
achieved, compared to in air. The PID values used were based on input distraction
lengths of 2, 4, and 6.000 mm, thus the PID values may not have been entirely
appropriate for the gels since the distraction lengths used for the gels ranged from 0.857
(10%) – 2.480 (30%). These values were selected based on results showing 35% being the
maximum distraction length without causing gel failure. Consequently, a limitation of
this study is that the low mechanical strength of collagen hydrogels precluded longer
distraction lengths being used. However, there was no significant difference in the peak
displacement achieved between control and gel. Additionally, each distraction length was
significantly different from one another so the error is unlikely to affect subsequent
cellular outcomes. The distraction lengths used in this study are slightly lower than the
range of values used in vivo in rodents, where distraction lengths ranged from 2.5 – 7
mm (Chapter 1 Table 1.5).
An input velocity of 100 mm.s−1 was achieved in air and with the gels, with a similar
magnitude of error (mean 109.17 mm.s−1 across all conditions). However, a significant
difference in the peak velocity was calculated between control and gel at 10% distraction
length (Figure 3.20). It is not clear why the presence of the gels resulted in a
significantly lower peak velocity at 10% distraction, whilst there were no significant
differences between air and the gel at 20 and 30% distraction. A peak velocity of 90
mm.s−1 was achieved for all three replicates at 10%, so it was unlikely due to differences
in the gel itself. The command data showed the correct velocity and displacement values
were inputted into the system. For future studies, the peak velocity would be evaluated
after the test and repeated and/or re-tuned if necessary.
An input velocity of 1000 mm.s−1 could not be achieved accurately in air over the
distraction range (Figure 3.14). For contusion injury, increasing the working distance was
hypothesised to enable a greater peak velocity to be achieved, which was shown to be true.
However, the setup of the BOSE for tensile studies meant that the mould was secured
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into the grips in a fixed position of 0% distraction. As there was a positive correlation
between the distraction length and peak velocity, an inaccurate peak velocity was achieved
regardless of the input velocity. Therefore, 1000 mm.s−1 was excluded from subsequent
experiments modelling distraction injury. The in vivo distraction studies which utilised the
UBC multimechanism device used an input velocity of 1000 mm.s−1; Dabney et al., (2004)
used input velocities of 1, 5, and 10 mm.s−1, whilst the remaining studies used manual
distraction methods where velocity was not controlled (Table 1.5). An input velocity of
100 mm.s−1 is thus within the range of velocities used in vivo. However, it would be
difficult to discuss future results in the context of these studies as the input distraction
length and velocity varies.
3.5.3 3D Model of the Spinal Cord Environment
Primary astrocyte-seeded collagen hydrogels were selected to model contusion and
distraction type SCI in vitro. In order to develop a model which was suitable for use
with the BOSE, a protocol was needed which specified the gel volume, dimension, initial
seeding density and an accurate method for measuring gel dimensions. Mechanical
enrichment of primary astrocytes has been used successfully in other studies, where
populations of 95% (East et al., 2009) and 85 – 90% (Kerstetter and Miller, 2012)
astrocytes were considered acceptable for subsequent experimentation. The mean
astrocyte purity achieved in this study was 92.87%, which is within the range of that
reported by other studies.
The hydrogels prepared in this study were cast in 48-well plates, using a volume of
300 µL gel solution per sample. This resulted in gels with a diameter of 11 mm (as
defined by the diameter of the well). Smaller diameter gels were considered but for ease
and time reasons, standard well-plates were used. A gel volume of 300 µL was the
smallest volume which enabled ease of handling in and out of the BOSE, without
damaging the gel or causing folding. For contusion model development, measurement of
the gel heights using the BOSE was selected over methods such as taking a photo or
calipers which required additional tools and increased the time spent outside the cell
culture medium. Using the platens of the BOSE in displacement control reduced the
amount of handling required as the gel was then already in position to be experimented
on.
The mean height of gels across 10 independent experiments was 1.276 ± 0.1 mm.
McMurtrey (2016) calculated a viable tissue thickness range of 0.4 – 2 mm, given the
oxygen consumption and diffusion coefficient values of human neurons. This thickness
limit for cell viability was similarly observed in hydrogels seeded with 4 x 105
differentiated SH-SY5Y neurons (McMurtrey, 2014). The limit of diffusion can also
dependent on many factors, such as cell type, seeding density, cellular activity, and
matrix concentration (Cheema et al., 2012; Griffith et al., 2005). Although the hydrogels
used in this study lack a complex microvascular system to facilitate mass transfer, the
height of gels used should support adequate oxygen and nutrient diffusion throughout
the gel.
91
Chapter 3. In Vitro Model Development Section 3.5
The initial seeding density was evaluated in order to determine the density which
would enable a high number of samples and replicates to be prepared in a single session.
The ATPlite™Luminescence Assay was used to monitor metabolic activity over a period
of 14 days. Results showed that both densities of 5 x 105 and 1 x 106 cells.mL−1
exhibited stable metabolic activity over 14 days. The decrease in astrocyte metabolic
activity at 2 and 4 x 106 cells.mL−1 gel could have been due to insufficient nutrients
available from the volume of cell culture medium used. Figueiredo et al., (2018) observed
a significant reduction in glucose and oxygen concentration after 6 hours, with an almost
complete depletion of oxygen concentration at 72 hours, using human adipose derived
stem cell-seeded hydrogels at 4 x 106 cells.mL−1 (cellulose-derived hydrogel; 1 cm thick
24 well-plate). Due to the number of samples which were calculated to be required in
this project, an initial density of 5 x 105 cells.mL−1 was selected.
Immunostaining for glial fibrillary acidic protein (GFAP) was performed to analyse
the morphology of the astrocytes at 5 x 105 cells.mL−1 gel and to determine whether
there was an appropriate distribution of astrocytes. However, the lack of GFAP positive
cells meant that this could not be achieved. This effect has previously been reported by
East et al., (2007) and Smith (2016) in vitro, whereby cells seeded in 3D hydrogels
expressed low levels of GFAP, and were small and rounded in morphology. East et al.,
(2007) also demonstrated that astrocytes cultured in 3D had lower levels of mRNA for
GFAP, compared to 2D cultured astrocytes. This was attributed to the less reactive
phenotype of the astrocytes. The presence of a predominantly astrocyte population was
confirmed when cells from the same suspension were seeded into gels and onto
PDL-coated coverslips at the same time, with the majority of cells on coverslips being
GFAP-positive. As the live/dead cytotoxicity staining and metabolic activity (ATPlite)
results suggested that the majority of the cells were viable, so the lack of GFAP-positive
astrocytes did not suggest they were non-viable.
When developing the distraction model, one difficulty encountered was what the gel
shape and dimensions should be. Application of tensile loads for mechanical testing of
hydrogels, for instance, is generally performed on rectangular strips or rings of sample
(Ahearne et al., 2008). Due to the low stiffness of the collagen hydrogels used in this
study, a literature search was performed to investigate whether there were existing
protocols on how to prepare similar hydrogels for modelling tensile loads, or for
mechanical tensile testing. Many in vitro models of CNS injury utilise tissue (such as
organotypic brain slices) or cells attached to a substrate which strain can then be applied
to, as reviewed by LaPlaca et al., (2007). Although distraction injuries likely involve
shear deformation, this does not fully represent the tensile loads also being applied to
the tissue. Additionally, studies where cells were cultured directly onto deformable
membranes are 2D in nature so the 3D microenvironment is lacking.
Although not necessarily evaluating cellular responses to mechanical loads,
mechanical testing of hydrogel biomaterials and constructs have been performed. Studies
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which involved mechanical testing of collagen hydrogels using tensile methods were
looked at to determine the sample setup, their dimensions, and how samples were
secured to tensile clamps. Brown et al., (2005) used uniaxial tensile testing to determine
the Young’s modulus of plastically compressed spiral constructs made of rat tail type-I
collagen (2 mg.mL−1). These spiral constructs- 13 mm long and 1.75 mm in diameter-
were clamped into the tensile testing grips of a DMA-7e rig using strips of
cyanoacrylate-reinforced steel mesh. Hadjipanayi et al., (2009) performed dynamic
mechanical analysis (DMA) of rat tail type-I collagen (2.2 mg.mL−1) in tension, using
plastically compressed strips of collagen (1 mm wide; 0.1 mm thick) although no details
of how the sample was affixed to the rig were reported. These studies used a similar
starting collagen material as used in this study (2 mg.mL−1 in 0.6% v/v acetic acid;
First Link, UK Ltd.). However, due to the materials’ low stiffness, plastic compression
was used in both studies to generate denser, mechanically stronger hydrogels which were
amenable to manipulation such as tensile testing and forming layered constructs.
Plastic compression (PC) utilises the application of a weight to remove interstitial
fluid, thus stabilising the specimen and increasing protein density but also irreversibly
modifying its structure. PC has been widely used to modulate the mechanical properties
of various collagen hydrogel constructs for tissue engineering applications (Bitar et al.,
2007; Brown et al., 2005; Neel et al., 2006), including in the nervous system (Georgiou et
al., 2013; Kayal et al., 2020; Phillips, 2014a). One issue with PC is whether this has an
effect on cell viability or behaviour. Bitar et al., (2007) found no differences in cell
viability and responses between non-compressed and compressed matrices, seeded with a
human osteosarcoma cell line. Brown et al., (2005) and Hadjipanayi et al., (2009) used
adult human dermal fibroblasts and found PC supported cell viability and proliferation
for up to 5 weeks in culture. These cell types are generally associated with tissues (bone
and skin) which are stiffer than neural tissue (Barnes et al., 2017). Therefore, PC of
these gels likely does not increase the stiffness of the matrix enough to significantly affect
cell behaviour.
Astrocytes have been shown to be responsive to stiffness (Georges et al., 2006). For
example, East et al., (2009) observed increased reactivity of astrocytes at the edges of the
3D cultures, which were in closer proximity to the tissue culture plastic. Smith (2016)
reported that astrocytes cultured in plastically compressed collagen hydrogels were more
hypertrophied and ramified in morphology, compared to the smaller rounded astrocytes
in the fully hydrated gels. Further, they expressed significantly more GFAP compared
to astrocytes in fully hydrated gels. In order to evaluate the effects of injury mechanics
on astrocyte responses, the astrocytes need to have a low baseline reactivity phenotype.
Therefore, PC was not used in this study. Instead, a mould previously designed to generate
neural cell-aligned constructs (engineered neural tissue, EngNT) was used to prepare gels
with an I-shape suitable for applying tensile loads (Section 3.4.4.2). As the mechanical
properties of the hydrogels were not modified, the mould was adapted to consist of two
pieces held together with screws and dowels, with the gel cast in the I-shaped cavity in
the centre (Figure 3.18A). These were secured into the tensile grips instead of having to
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remove the gel and secure it directly into the grips, which could not be achieved without
stretching or damaging the gel.
3.6 Conclusions
The displacement and velocity parameters of the BOSE 5110 Electroforce BioDynamic
were verified against the input values and determined to be accurate and precise, with
protocols for modelling both contusion and distraction injury being developed using
collagen hydrogels as the substrate. This apparatus was easy to use and set up,
providing an extra tool for researchers to investigate traumatic spinal cord injury
biomechanics in vitro which is comparable to those used in vivo. This chapter addressed
the main objectives of the project, which were to assess the suitability of utilising the
BOSE as a rig capable of simulating controlled, repeatable loads representative of
contusion and distraction injury scenarios, and to develop a protocol for the simulation
of contusion and distraction injuries using three-dimensionally encapsulated astrocytes in
collagen hydrogels (Chapter 1).
The specific objectives set out in this chapter were met with the following observations:
I. Characterise, verify and optimise the displacement and velocity parameters of the
BOSE in air, under compressive and tensile waveforms:
• Addition of a 100 ms dwell step, increasing working distance between the
sample and load platen (contusion) and PID tuning increased the accuracy of
the output peak displacement and velocities achieved.
• The most accurate peak velocity achieved was 943.00 mm.s−1 under the
following conditions: compression; input displacement 8.000 mm; input
velocity 1000 mm.s−1; + 100 ms dwell step; + PID tuning.
II. Determine the effects of collagen hydrogels on the output displacement and velocity
values of the BOSE:
• Modelling of contusion and distraction waveforms with hydrogels did not
significantly affect the displacement and velocity profiles, nor their peak
values compared to air.
III. Develop a protocol to enable accurate measurement of the initial dimensions of
collagen hydrogels (contusion) and thus define the displacement parameters:
• Measurement of the height of gels for contusion studies was successfully achieved
using the BOSE, by determining the distance between the surface of the gel and
the upper load platen.
IV. Define a set of velocity and displacement parameters to be simulated experimentally,
in order to represent a range of injury severities in vitro:
• A range of velocity and displacement depth/distraction length parameters
have been defined, which will represent a range of injury severities in vitro in
subsequent studies (Table 3.3).
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V. Select an appropriate primary astrocyte seeding density:
• An initial astrocyte seeding density of 5 x 105 cells.mL−1 gel was determined
as the optimal density for preparing a large number of samples, with stable
metabolic activity and low reactive phenotype across 14 days.
VI. To define the shape and dimensions of a hydrogel to enable tensile loads to be applied,
simulating distraction-type spinal cord injuries:
• A mould was adapted to prepare I-shaped collagen hydrogel samples (150 µL),
from which the mould could be affixed into the tensile grips of the BOSE and
distracted.
The input biomechanical parameters for contusion and distraction injury to be used
in Chapters 4 and 5 are described in Table 3.3.
Table 3.3: Input biomechanical parameters for modelling of contusion and
distraction injury. The working displacement is applicable for contusion injuries and
defines the distance between the surface of the gel and the upper load platen. Since in
distraction injury the distraction mould is fixed into both tensile grips, the working
displacement cannot be modified so is not applicable.
Contusion Distraction
Input displacement (%) 25, 50, 75% gel height 10, 20, 30% gel length
Input velocity (mm.s−1) 100, 1000 100
Working Displacement (mm) 8.000 NA











NA = Not Applicable.
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Chapter 4
The Effects of Varying Displacement Depth and
Velocity on Astrocyte Responses in an In Vitro
Model of Contusion Spinal Cord Injury
4.1 Introduction
Contusion spinal cord injury (SCI) most commonly arises as the result of failure of the
vertebral column, caused by a burst fracture. It is one of the most prevalent mechanisms
of TSCI in humans (Sekhon and Fehlings, 2001). The contusion mechanism also remains
the most widely modelled injury mechanism in vivo (Sharif-Alhoseini et al., 2017).
Increasing attention is being paid towards evaluating the relative importance of
mechanical parameters in determining injury severity, although this idea has been
investigated as early as the 1980s by Kearney et al., (1988), who described the spinal
cord as rate sensitive: displacement acted as the dominant determinant of injury severity
at low impact velocities; however, with increasing velocities (up to 6 m.s−1) injury
severity becomes a function of the viscous response.
Mechanical thresholds for astrocyte damage, including viability and reactivity, are
not fully defined. Establishing such tolerances may be beneficial in understanding the
pathophysiology of trauma as a function of biomechanical parameters, and may lead to
more directed therapeutic targets as well as improved preventative measures. In this
study, combinations of velocity and displacement were modelled on primary rat
astrocyte-seeded collagen hydrogels. There is a lack of consensus on which biomechanical
parameter(s) is/are dominant in determining the severity of contusion injury in vivo.
Velocity has been shown to primarily influence injury severity at a fixed displacement (1
mm) in a rat model (Sparrey et al., 2008); Kim et al., (2009) demonstrated that velocity
did not influence injury severity at a fixed displacement (0.8 mm) in a mouse model.
Ghasemlou et al., (2005) concluded that displacement and force were important in
determining injury severity, although displacement and velocity will have been inherently
coupled with the IH impactor used. Other studies have shown that both velocity and
displacement can be used to predict injury severity and an interaction between the two
exists due to the viscoelastic properties of the spinal cord (Kearney et al., 1988; Lam et
al., 2014). Differences in animal model, injury model (including whether displacement
and velocity were decoupled), biomechanical parameters, and outcome measures used
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have contributed to the difficulties in comparing studies and defining thresholds.
Input contusion displacement depth values reported in in vivo studies are often
reported as an absolute value. Additionally, injury is commonly categorised as either
mild, moderate, or severe based on a range of outcome functional and histological
measures. For instance, Anderson et al., (2009) classed injuries which resulted in
forelimb motor deficits as mild, and injuries which resulted in complete loss of forelimb
motor function as moderate. Therefore, the severity of the outcome has typically been
used to inform the input mechanical parameters. The anteroposterior diameter of a rat
spinal cord has been reported to be approximately 2.4 mm (Watson et al., 2009). Given
the values of input displacement reported in rat contusion studies, this represents an
approximate percentage cord displacement range between 33% (Pearse et al., 2005) and
83% (Bresnahan et al., 1987). Studies by Wilcox et al., (2003, 2002) used an ex vivo
bovine model to dynamically investigate canal occlusion at velocities of 3.7 – 5.2 m.s−1.
Maximum canal occlusion was found to be upwards of 80%, although the spinal cord
does not occupy the entire canal volume. Due to variations in the injury location, impact
tip dimensions, and animal model between studies the displacement values selected in
this project were calculated as a percentage of the sample thickness. A range of
displacement (25, 50, 75% gel height) and velocity (100 and 1000 mm.s−1) values were
selected to investigate primary astrocyte responses over a range of injury severities.
TSCI can be broadly described by the initial injury, which encompasses the
mechanical injury and events that occur immediately after. This is followed by the
secondary injury, a cascade of biological and biochemical reactions which attempt to
remediate further damage and repair the injury (Sekhon and Fehlings, 2001). This phase
can last from weeks to years in humans. A key feature is the formation of a cystic cavity
and glial scar around the injury site. The glial scar is composed mainly of reactive cells,
including astrocytes, microglia, fibroblasts and oligodendrocyte precursor cells (OPCs),
and extracellular matrix components (Silver and Miller, 2004). Reactive astrocytes form
a dense physical and chemical barrier which inhibits axonal outgrowth. Markers of
astrogliosis are varied and numerous: upregulation of GFAP expression, proliferation,
migration to the lesion core, alterations to astrocyte morphology including hypertrophy
and ramification, and expression of neuroinhibitory molecules, such as inflammatory
cytokines and CSPGs (Sofroniew, 2009; Sofroniew and Vinters, 2010). Aside from its
neuroinhibitory effects, astrogliosis has been shown to be beneficial by limiting further
extension of the lesion and facilitating regenerative activities, such as the secretion of
neurotrophic factors. Further, genetic ablation of astrocytes or prevention of glial scar
formation has been shown to impede regeneration and lead to worsened functional
outcomes in vivo (Rolls et al., 2009).
To summarise, although research is beginning to appreciate and consider injury
mechanisms and biomechanics in their models, it is still unclear precisely how
parameters, such as displacement, velocity and force determine injury outcomes. With
the complexity of in vivo systems presenting varying results, it may be beneficial to
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utilise a more simplified in vitro model to investigate how the biomechanics of injury
affects individual cell populations, without confounding influences from other cell types.
As a key cellular component of the lesion, primary rat cortical astrocytes were utilised in
an isolated in vitro culture. This may provide information on the precise contributions of
astrocytes to the primary and secondary pathophysiology of TSCI. As a positive
astrogliosis control, transforming growth factor β-1 (TGF-β1) was selected. TGF-β1
plays a role in regulating the induction of glial scar formation (Silver and Miller, 2004;
Wang et al., 2018), and has been shown to induce astrogliosis in vivo (Logan et al., 1994)
and in vitro (Cullen et al., 2007; East et al., 2009; Kirk, 2018; Smith, 2016).
4.2 Aim and Objectives
The aim of this chapter was to evaluate the responses of primary astrocytes to contusion
injury, using a range of displacement and velocity parameters representing different
injury severities.
The specific objectives were as follows:
I. Verify the accuracy and precision of the BOSE 5110 Electroforce BioDynamic
(BOSE) at simulating contusion injury at velocities of 100 and 1000 mm.s−1 and
displacement depths of 25, 50, and 75% using primary astrocyte-seeded hydrogels.
II. Calculate the kinetic outputs following simulated injury using the BOSE apparatus,
including the impact velocity, peak displacement, peak load, and energy applied.
III. Measure the responses of primary astrocytes to contusion injury through GFAP
immunostaining, CSPG expression, metabolic activity and viability analyses.
IV. Compare the biological responses of primary astrocytes to contusion injury against
a known chemical inducer of astrogliosis, TGF-β1.
V. Evaluate the effects of contusion injury mechanics on astrocyte responses.
The null hypotheses postulated for the study were as follows:
I. There is no statistical difference between the reactivity of astrocytes in response to
contusion injury compared to no injury (control).
II. There is no statistically significant relationship between injury velocity and astrocyte
reactivity.
III. There is no statistically significant relationship between injury displacement depth
and astrocyte reactivity.
IV. There is no statistically significant relationship between astrocyte reactivity and
time.
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4.3 Specific Materials and Methods
4.3.1 BOSE Waveform Setup and Data Acquisition
For details on the assembly and set up of the BOSE apparatus, refer to Chapter 2 (Section
2.5.8). The parameters for contusion injury, including the input displacements, velocities,
and PID values were developed in Chapter 3, and defined in Table 3.3. The waveform
regime, defined to represent a contusion injury, was set up using the parameters in the
following steps:
1. Dwell: 10 ms
2. Ramp:
(a) Velocity: 100 or 1000 mm.s−1.
(b) Displacement: 25, 50, or 75% of gel height.
3. Dwell: 100 ms
4. Ramp:
(a) Velocity: 100 or 1000 mm.s−1.
(b) Displacement: Return to 0% of gel height.
Following this, the following data was exported into Excel: time (s), experimental
displacement (mm), axial command (input displacement, mm), load (N).
The data acquisition settings were as follows:
• Scan time = 0.4096 s.
• Number of scan points = 2048.
• Number of scans = 1.
4.3.2 Calculation of Energy Applied
The energy applied, or work done, is a measure of energy transfer: when an external force
moves an object through a distance, energy is transferred from one store to another. For
work done by a constant force, this is defined as:
Work done (J) = F x d (4.1)
where F = force (N) and d = distance (m).
In this study, a variable force was observed during the contusion event. Therefore,
the energy applied was calculated by performing a trapezoidal integration of the area
underneath the load-displacement curve for each sample, using the following equation:




(xi+1 − xi)(yi+1 + yi) (4.2)
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where x = displacement and y = load. The experimental displacement and load values
plugged into the equation were derived from the moment of impact (tI), until the end of
the dwell step (ti).
4.3.3 Preparation of astrocyte-seeded hydrogels
Hydrogels seeded with 5 x 105 primary rat astrocytes per mL of gel were prepared, as
described in Chapter 2 (Section 2.5.5). Gels were incubated at 37 °C, 8% CO2:92% air for
24 hours prior to experimentation. TGF-β1 treatment was used as a positive astrogliosis
control. For these gels, complete cell culture medium supplemented with TGF-β1 (10
ng.mL−1) and pipetted on top of the gels, refreshing every two days.
4.3.4 Immunohistochemical Staining
Astrocyte-seeded hydrogels were processed for immunofluorescent staining using the
methods described in Chapter 2 (Section 2.5.7). Primary antibodies specific for glial
fibrillary acidic protein (GFAP) and chondroitin sulfate proteoglycan (CS-56) were used
to label astrocytes and CSPGs, respectively, and DAPI was used as a nuclear
counterstain. Details of the antibodies used, including their dilutions are described in
Table 2.1 (Chapter 2 Section 2.4). Hydrogels were incubated with isotype control
antibodies, and omission of the primary antibodies was routinely used as the negative
control.
4.3.5 Confocal Image Acquisition
Confocal z-stack images were acquired using a Zeiss LSM880 Axio Imager.Z2 upright
microscope (Chapter 2 Section 2.5.9.3). A total of five fields of view were acquired for
each gel (Figure 4.1).
Figure 4.1: Image acquisition locations of a hydrogel following experimental
contusion injury. Five fields of view were imaged per gel, with images acquired from
the same five positions, as denoted by the green dots. d1 = diameter of the gel, 11 mm;
d2 = diameter of the impact area, 10 mm; d3 = outer edge of the imaging region, with
diameter 7 mm. At each imaging position, a 36 µm z-stack was acquired, composed of 10
z-slices at 4 µm intervals. Confocal images presented in this report are maximum intensity
projections.
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The surface of the gel was located, as defined by the z-position in which the cells
first became visible. Each z-stack was 36 µm in depth, with 10 slices acquired at 4 µm
intervals. To ensure consistency in image acquisition, the laser settings were configured for
the sample with the greatest GFAP expression. Confocal images of cell-seeded hydrogels
presented in this study are maximum intensity projections generated from their respective
stacks.
4.3.6 Image Analysis
4.3.6.1 Volume of GFAP Expressed Per Cell
For three-dimensional analysis of astrocyte GFAP volume the .czi files were loaded into the
Volocity 3D Image Analysis Software (Volocity). The objects (cells) were located in the
GFAP channel and an automatic threshold was used. A minimum object size limit was set
to 100 µm3, which excluded objects below this volume threshold. The objects were pseudo-
coloured as a rainbow to visualise the individual objects. The volume measurement was
selected to calculate the total volume of GFAP expressed per cell, from which the mean
volume of GFAP per cell was calculated.
4.3.6.2 Shape Factor – Sphericity of Astrocytes
The shape factor of the astrocytes with and without injury were measured using
Volocity, following the same protocol as in 4.3.6.1 to locate the objects. The shape factor
measurement was selected to be measured. Shape factor is a dimensionless numerical
indication of the shape of an object and, in this study, describes how similar a 3D object
is to a sphere (sphericity). A value of 1 describes a perfect sphere, with decreasing values
indicating more irregular shapes. Sphericity is defined as the ratio of the surface area of
a sphere- with the same volume as the given object- to the surface area of the object,
first described by Wadell (1935):







where A0 = object area and V0 = object volume.
4.3.6.3 Chondroitin Sulfate Proteoglycan Expression
The total area of CSPG expression was measured using the Fiji Is Just ImageJ (FIJI) image
analysis software, together with a macro to run automatic analysis. Each fluorescent multi-
channel confocal image file (.czi) was exported as TIFFs into their separate fluorophore
channels: GFAP (green channel), CS-56 (red channel), and DAPI (blue channel). The
CSPG image files were then imported into FIJI and converted into 8-bit images. The
Phansalkar Auto Local Threshold method was used to binarise the images and distinguish
cells from the background. The total area of CSPG expression was then measured.
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4.3.7 Analysis of Astrocyte Viability
Viability of the astrocytes following simulated contusion injury was assessed using the
LIVE/DEAD™Viability/Cytotoxicity Assay Kit. The live/dead solution was prepared
according to Chapter 2 (Section 2.5.3.6) and handled under dark working conditions. The
positive cell death control consisted of cell-seeded gels treated with 70% (v/v) methanol
for one hour. After aspirating the cell culture medium, the gels were washed twice with
600 µL PBS to remove residual esterase activity from the complete cell culture medium
(methanol from positive control samples). A volume of live/dead solution twice that of
the gel (i.e. 600 µL) was pipetted on top of each gel. The plate was then covered with foil
and incubated for 1 hour on an orbital shaker (90 rpm), at 37 °C, 8% CO2:92% air. The
live/dead solution was then discarded and 3x 5 minute PBS washes were performed at 37
°C, on an orbital shaker (90 rpm). The cells were imaged using confocal microscopy, and
percentage viability was calculated using the following formula:
Viability (%) = # viable cells
# viable cells+# dead cells × 100 (4.4)
4.3.8 Quantification of Astrocyte Metabolic Activity
Metabolic activity of astrocytes following simulated contusion injury was performed
using the ATPlite™Luminescence Assay System, with the methods described in Chapter
2 (Section 2.5.6). The cell culture medium was aspirated from each gel and replaced with
mammalian cell lysis solution at a volume twice that of the gel (600 µL). The gels were
incubated at room temperature for 30 minutes, with agitation at 700 rpm to lyse the
cells and release the ATP. Working under dark conditions, a volume of 50 µL from each
sample was transferred to an individual well of a 96-well Optiplate™. An equal volume
of substrate solution was then added to each well. The plate was sealed, covered with
foil, and incubated at room temperature for 15 minutes with agitation at 700 rpm. The
plate was then placed into the plate reader spectrophotometer and dark adapted for 10
minutes. Luminescence was measured at 570 nm, with the data being exported into
Excel for analysis. The positive cell death control consisted of cell-seeded gels treated
with 70% (v/v) methanol for one hour.
4.3.9 Collagenase Treatment of Astrocyte-Seeded Hydrogels
Astrocyte-seeded hydrogels were treated with collagenase in order to digest the collagen
and recover the cells for analysis of GFAP expression in 2D. A stock solution of collagenase,
at 0.2% (w/v), was prepared by reconstituting 20 mg collagenase powder into 10 mL
DMEM. The solution was filter sterilised and aliquoted into 2 mL volumes. The solution
was stored at -20 °C, for up to one year. The cell culture medium was aspirated and
replaced with 0.2% (w/v) collagenase solution, at a volume twice that of the gel (600 µL).
The gels were incubated for 15 minutes, at 37 °C 8% CO2:92% air. Following this, the
cell solution was gently triturated to evenly suspend the cells and plated onto PDL-coated
glass coverslips. The coverslips were incubated for 30 minutes, at 37 °C to enable cell
attachment, before overlaying with complete DMEM cell culture medium.
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4.3.10 Digestion of CSPGs with Chondroitinase ABC
Chondroitinase ABC (ChABC) is an enzyme derived from the bacterium Proteus
vulgaris, and has been shown to create a more permissive environment for
neuroregeneration by degrading CSPGs deposited by reactive astrocytes following SCI
(Bradbury et al., 2002). ChABC catalyses the degradation of chondroitin sulfate and
dermatan sulfate chains of proteoglycan molecules (chondroitin-4-sulfate,
chondroitin-6-sulfate, dermatan sulfate), with some hyaluronidase activity (Prabhakar et
al., 2005). A stock solution of ChABC (10 U.mL−1) was prepared by reconstituting 5 µg
ChABC powder in 500 µL PBS. Aliquots of 50 µL were prepared and stored at -20 °C,
for up to 3 years. A working concentration used in this study was 200 mU and was
prepared by diluting the required volume of stock ChABC solution in complete cell
culture medium (DMEM).
Astrocyte-seeded hydrogels (5 x 105 cells.mL−1) subjected to contusion injury at 100
mm.s−1 were incubated for 14 days. Following this, the cell culture medium was aspirated
and replaced with complete cell culture medium supplemented with ChABC, at a volume
twice that of the gel (600 µL). The gels were incubated for 4 hours at 37 °C, 8% CO2:92%
air. After 4 hours, the media was aspirated and 3x 5 minute PBS washes were performed
at 37 °C. Complete cell culture medium was pipetted on top of the gels and incubated for
a further 48 hours before fixing for immunohistochemical analysis using antibodies against
GFAP and CS-56 (Section 5.3.3).
4.3.11 Evaluation of Cytokine Expression using an Enzyme-Linked
Immunosorbent Assay
One of the objectives of the study was to evaluate the expression of several pro- and
anti-inflammatory cytokines known to be released by reactive astrocytes following SCI,
including IL-6, IL-10, TNF-α, and IL-1β. The first cytokine to be evaluated was IL-
6, using an enzyme-linked immunosorbent assay (ELISA). The reagents were prepared
according to the manufacturer’s instruction (Table 4.1).




Capture Ab 4.00 ug.mL−1 PBS
Detection Ab 100 ng.mL−1 Reagent Diluent with 2% (v/v) NGS
IL-6 Standard 125 - 8000 pg.ml−1 Reagent Diluent
Streptavidin-HRP 1:200 Reagent Diluent
Substrate Solution 1:1 Colour Reagent A: Colour Reagent B
Reagent diluent = 1% BSA in PBS; NGS = normal goat serum; Colour Reagent A = H2O2; Colour
Reagent B = tetramethylbenzidine
All incubation steps were performed at room temperature. A 96-well plate was coated
with 100 µL of the Capture Antibody, sealed, then incubated overnight. The solution was
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then aspirated and washed three times with 400 uL wash buffer (0.05% v/v Tween 20
in PBS) per well. The plate was blotted onto a paper towel to remove residual solution.
Blocking was performed by adding 300 uL of Reagent Diluent to each well and incubating
the plate for 1 hour. The solution was then aspirated and three wash steps performed as
before. A volume of 100 uL of sample or standard was then added to each well, the plate
sealed, then incubated for two hours. The aspiration/wash step was then performed. A
volume of 100 uL of Detection Antibody was added to each well, sealed, then incubated for
two hours. The aspiration/wash step was then performed and 100 uL of Streptavidin-HRP
added to each well. The plate was covered and incubated for 20 minutes, followed by the
aspiration/wash step. A volume of 100 uL of Substrate Solution was then added to each
well then incubated for 20 minutes. A volume of 50 uL of Stop Solution (2 N H2SO4) was
then added to each well and the plate gently tapped against a surface to ensure proper
mixing. The optical density of each well was determined at 450 nm using a plate reader.
4.4 Results
Contusion SCI was modelled in vitro using input velocities of 100 and 1000 mm.s−1, and
displacement depths of 25, 50, and 75% of the height of the gel. Time (s), experimental
displacement (mm), axial command (input displacement, mm), and load (N) data was
recorded by the BOSE and exported to Excel for data processing. At Days 1, 7, and 14
after injury, the gels were processed in order to investigate a number of astrocyte responses:
cell viability by live/dead staining, metabolic activity using the ATPlite assay, astrocyte
reactivity by immunostaining for GFAP, and expression of CSPGs by immunolabelling
with a CS-56 antibody. Attempts were made at quantifying the concentrations of known
pro- and anti-inflammatory cytokines in the cell culture medium: IL-6, IL-10, and IL-1β,
using an ELISA assay. However, the concentration of analyte was not sufficient to be
detectable by the assay at the timepoints used in this study.
4.4.1 Kinetic Outputs
Using the data recorded by the BOSE, additional kinetic outputs were calculated: the
peak experimental displacement (mm), impact velocity (mm.s−1), peak velocity
(mm.s−1), peak load (N), and energy applied (mJ) (Appendix D; Table 6.10). Impact
velocity was determined as the velocity at which the upper load platen first came into
contact with the surface of the gel, and the peak velocity was the greatest velocity value
that was recorded.
There was little variation in the peak experimental displacement achieved at all
displacement depths as demonstrated by the small errors (Figure 4.2). The error was
also similar at both input velocities. The peak displacement achieved was expected to be
the same at each input displacement depth, regardless of input velocity. There was slight
variation in the peak displacement achieved when comparing the same displacement
depth across both velocities. For instance, the mean peak displacement achieved at 50%
was 0.770 ± 0.01 and 0.737 ± 0.02 mm at 100 and 1000 mm.s−1, respectively. However,
statistical analysis showed there was no significant differences at all displacement depths
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(p>0.05). Thus, displacement depth was achieved consistently across both input
velocities.
Figure 4.2: Peak experimental displacement achieved at input velocities of
100 and 1000 mm.s−1. Astrocyte-seeded hydrogels were subjected to contusion injury
at varying input velocities and displacement depths (calculated as a percentage of the total
height of the gel), with the peak displacement calculated. Data presented as the mean ±
SEM and analysed by two-way ANOVA with Tukey’s post-hoc test. Significance levels *
p<0.05. N = 12 per condition.
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Greater variation was observed in the impact velocity measurements compared to peak
displacement, with larger errors. At both 100 and 1000 mm.s−1, there was an undershoot
in velocity at the point of impact (Figure 4.3). Further, the peak velocity was achieved
prior to the peak displacement being achieved. The extent of undershoot was greater at
an input velocity of 1000 mm.s−1, where a mean impact velocity of 669.31 mm.s−1 was
achieved across all displacement depths (Figure 4.4). The mean impact velocity achieved
across all displacement depths, with an input of 100 mm.s−1, was 97.64 mm.s−1.
Figure 4.3: The impact velocity is lower than the peak velocity in an example
of experimental contusion injury at 1000 mm.s−1 to 25% displacement. Example
profile of a contusion experiment with the impact velocity and corresponding displacement
(red circles) and peak velocity (blue circle) depicted.
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Figure 4.4: Impact vs. peak velocity following simulated contusion injury. 100
mm.s−1 (A) and 1000 mm.s−1 (B). Data presented as the mean ± SEM and analysed by
two-way ANOVA with Tukey post-hoc test. Significance levels * p<0.05 (impact vs peak
at each displacement depth); # p<0.05 (25 vs 75% impact velocity); ‡ p<0.05 (50 vs 75%
impact velocity); † p<0.05 (25 vs 75% peak velocity). N = 12 per condition.
At an input velocity of 100 mm.s−1, there was no significant difference in the impact
or peak velocity achieved across the displacement depths (Figure 4.4A). However, at an
input velocity of 1000 mm.s−1, there was a significant difference in impact velocity
between 25 and 75% and 50 and 75% displacement depths (Figure 4.4B). Further, the
peak velocity at 25% displacement was significantly lower than the peak velocity at 75%
displacement. Therefore, inconsistent impact and peak velocities were achieved at 1000
mm.s−1. The peak velocities achieved were significantly greater than the impact
velocities achieved, under all conditions. The mean peak velocity across all displacement
depths was 115.14 and 887.92 mm.s−1 at input velocities of 100 and 1000 mm.s−1,
respectively.
107
Chapter 4. Astrocyte Responses to Contusion SCI In Vitro Section 4.4
An increase in displacement resulted in an increase in the peak load measured, and
increasing the input velocity to 1000 mm.s−1 resulted in a further increase in the peak
loads measured across all displacement depths (Appendix D; Table 6.10). As such, the
calculated energy applied followed the same trend (Figure 4.5).
Figure 4.5: Mean energy applied scales with velocity and displacement depth.
Rat tail type-I collagen hydrogels (2 mg.mL−1; 300 µL; 11 mm) were seeded with primary
rat cortical astrocytes at 5 x 105 cells.ml−1 gel and subjected to contusion injury. Energy
applied was calculated by performing a trapezoidal integration of the area under the curve
of the load-displacement curves. Data presented as the mean ± SEM and analysed by
two-way ANOVA with Tukey’s post-hoc test. Significance levels * p< 0.05. N = 12 per
condition.
At each input velocity group, there was a significant increase in the mean energy applied
with increasing displacement depth. The mean energy applied increased from 0.150 ±
0.008 to 0.945 ± 0.08 mJ at 100 mm.s−1, and from 0.954 ± 0.05 to 3.709 ± 0.1 mJ at 1000
mm.s−1. At each displacement depth, the mean energy applied was significantly greater
at an input velocity of 1000 mm.s−1, compared to 100 mm.s−1. Comparison of the energy
applied across both input velocities and displacement depths showed that there was no
significant difference between the following conditions: 100 mm.s−1 – 75% displacement,
and 1000 mm.s−1 – 25% displacement (p>0.05), with mean energy applied values of 0.945
± 0.08 and 0.954 ± 0.05 mJ, respectively.
4.4.2 Primary Astrocyte Behaviour Following a Contusion Injury
Astrocytes respond to mechanical trauma through a vast number of morphological,
biochemical, transcriptional, physiological, and functional changes across a spectrum of
severity and time, in a process called astrogliosis. Hypertrophy and ramification of
processes are common morphological features of reactive astrocytes, which was evaluated
by immunostaining for glial fibrillary acidic protein (GFAP), a cytoskeletal protein also
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known to be upregulated following injury.
4.4.2.1 GFAP Expression and Gross Morphology
Figure 4.6 illustrates representative images of GFAP stained astrocytes in hydrogels
following simulated contusion at 100 mm.s−1, over a 14 day time period. Quantification
of the mean volume of GFAP expressed per cell was also performed (Figure 4.7). For
details of the individual values, refer to Appendix D (Table 6.11). Under control
conditions (no injury), few astrocytes were GFAP-positive, as shown by the majority of
nuclei not being co-stained with GFAP. Morphologically, the GFAP-positive cells were
small and rounded with fewer processes. Astrocytes in the control group represented the
group with the lowest mean volume of of GFAP expressed per cell, across the 14 day
time period: 427.67 ± 40 µm3 (Day 1), 873.93 ± 30 µm3 (Day 7), and 867.08 ± 50 µm3
(Day 14). However, GFAP volume did significantly increase between Day 1 and 7, but
not between Day 7 and 14.
Upon application of mechanical contusion injury, a progressive change in morphology
was observed, which also resulted in differences in the mean GFAP volume per cell. At
25% displacement, the mean volume of GFAP expressed per cell was significantly greater
than the control on Day 1 post-injury (mean 758.73 ± 40 µm3), but not on Days 7 and
14. Over 14 days, GFAP volume at 25% was only significantly different between Days 1
and 14, with the greatest GFAP volume expressed on Day 14 (1064.99 ± 80 µm3). The
morphology of the GFAP-positive astrocytes at 25% displacement were similar to those
in the control group, with some astrocytes beginning to possess processes.
At 50% displacement, the mean volume of GFAP expressed per cell was significantly
greater than the control at all timepoints. GFAP volume significantly increased between
Days 1 and 7, but not between Days 7 and 14, with the greatest GFAP volume expressed
on Day 7 (1452.23 ± 80 µm3). Morphologically, the GFAP-positive astrocytes appeared
less rounded in shape compared to the control astrocytes, and ramification was observed
on Day 1 and increasing with time. On Day 14 post-injury, interdigitation of the
processes was observed.
At 75% displacement, the mean volume of GFAP expressed per cell was significantly
greater than the control at all timepoints. There was a significant increase in GFAP
volume per cell between Days 1 and 7, and Days 7 and 14 post-injury, with the greatest
GFAP volume expressed on Day 14 (1834.90 ± 100 µm3). Morphologically, evidence of
reactive gliosis was observed from Day 1 post-injury, with the cells appearing larger,
with many processes developing at Day 7 and 14. An increase in the density of the
overlapping domains was observed (Figure 4.6; inset at Day 7 – 75% displacement).
TGF-β1 treatment did result in an astrogliosis response, as expected. The mean GFAP
volume of cells in these gels were significantly greater than the respective control groups at
each time point. On Day 1 post-injury, TGF-β1 treatment was not significantly different
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from the experimental contusion injury groups. On Day 7 post-injury, TGF-β1 treatment
resulted in a significantly higher mean GFAP volume compared to 25% but not 50 and 75%.
On Day 14 post-injury, TGF-β1 treatment resulted in significantly higher GFAP volume
than 25 and 50%, but not 75% contusion displacement. Within the TGF-β1 treatment
group, there was a significant step-wise increase in GFAP volume as time progressed.
Figure 4.6: Mechanical contusion injury at 100 mm.s−1 induces astrogliosis
which progresses over 14 days. Representative immunofluorescent maximum intensity
projection images of primary rat cortical astrocyte-seeded hydrogels (5 x 105 cells.mL−1)
and subjected to contusion injury. Cells were labelled with a polyclonal antibody against
GFAP (astrocytes, green) and counterstained with DAPI (nuclei, blue). 36 µm depth.
Scale bar represents 50 µm. Scale bar of inset images represents 10 µm.
Only on Day 14 post-injury was there a step-wise significant increase in GFAP volume
per cell with a corresponding increase in displacement depth. On Day 1 post-injury, there
was no significant difference in GFAP volume per cell between any of the displacement
depths. On Day 7, there was a significant increase in GFAP volume per cell from 25 and
50% and 25 and 75%, with no significant difference between 50 and 75%. A contusion
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displacement depth of 75% resulted in the greatest volume of GFAP being expressed per
cell at each timepoint. Overall, the condition which resulted in the greatest GFAP volume
expression per cell was 75% on Day 14 post-injury, with a mean of 1834.90 ± 100 µm3.
Figure 4.7: Volume of GFAP measured over 14 days following simulated
contusion at 100 mm.s−1. Rat tail type-I collagen hydrogels (2 mg.mL−1; 300 µL;
11 mm) were seeded with primary rat cortical astrocytes at 5 x 105 cells.ml−1 gel and
subjected to contusion injury. The 3D volume of GFAP expression per cell was measured
using Volocity. Data presented as the mean ± SEM and analysed by two-way ANOVA.
Significance levels * p<0.05 (vs. control, Dunnett’s post-hoc); # p<0.05 (25% vs. 50%,
Tukey’s post-hoc); † p<0.05 (50% vs. 75%, Tukey’s post-hoc); ‡ p<0.05 (25% vs. 75%,
Tukey’s post-hoc); ∆ p<0.05 (vs. TGF-β1, Tukey’s post-hoc). N=3.
Contusion injury was also modelled at an input velocity of 1000 mm.s−1. Figure 4.8
illustrates representative images of GFAP stained astrocytes in hydrogels following
simulated contusion at 1000 mm.s−1, over a 14 day time period. Quantification of the
mean volume of GFAP expressed per cell was also performed (Figure 4.9). For details of
the individual values, refer to Appendix D (Table 6.11). In agreement with the
immunohistochemical analysis of astrocytes following contusion injury at 100 mm.s−1,
mechanical injury at 1000 mm.s−1 also induced an astrogliosis response, compared to the
control. However, a more prominent response was observed at an earlier time point, and
at a lower displacement depth.
The morphology of astrocytes in the control group remained similar over the 14 day
period: most of the GFAP-positive astrocytes were small and rounded in shape, with
little observation of ramification. This contrasts with the morphology of astrocytes from
the experimental groups. Hypertrophy and ramification was observed in all conditions,
and from as early as Day 1 post-injury. A contrasting morphological observation was
made between the two injury velocities at 25% displacement on Day 1 post-injury. At
100 mm.s−1, the GFAP-positive astrocytes were hypertrophied but did not exhibit many
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processes, with a mean GFAP volume per cell of 758.73 ± 40 µm3. At 1000 mm.s−1, both


















Figure 4.8: Mechanical contusion injury at 1000 mm.s−1 induces an astrogliosis response from as early as Day 1 post-injury.
Representative immunofluorescent maximum intensity projection images of primary rat cortical astrocyte-seeded hydrogels (5 x 105 cells.mL−1) and
subjected to contusion injury. TGF-β1 (10 ng.mL−1) was used as a positive astrogliosis control. Cells were labelled with a polyclonal antibody against
GFAP (astrocytes, green) and counterstained with DAPI (nuclei, blue). 36 µm depth. Scale bar represents 50 µm.
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Figure 4.9: Astrocytes appear to respond in a binary manner to contusion
injury at 1000 mm.s−1. Rat tail type-I collagen hydrogels (2 mg.mL−1; 300 µL; 11 mm)
were seeded with primary rat cortical astrocytes at 5 x 105 cells.ml−1 gel and subjected
to contusion injury. The 3D volume of GFAP expression per cell was measured using
Volocity. Data presented as the mean ± SEM and analysed by two-way ANOVA. All
experimental contusion groups were significantly greater than the TGF-β1 group (Tukey’s
post-hoc, p<0.05). Significance levels * p<0.05 (vs. control, Dunnett’s post hoc). N=3.
Astrocytes in the experimental groups expressed significantly greater volumes of
GFAP per cell than those in the control group, at all displacement depths and across all
timepoints. The mean GFAP volume expressed per cell for the control group was 930.13
µm3, across the 14 day time period. At a fixed time point, there was no significant
difference in the volume of GFAP expressed per cell between the three displacement
depths (p>0.05), with means of 2591.21 ± 100, 2919.12 ± 100, and 2857.40 ± 100 µm3
at Days 1, 7, and 14 post-injury, respectively. Further, at a fixed displacement depth,
there was no significant difference in the mean GFAP volume expressed per cell across
the 14 day time period. TGF-β1 treatment was significantly greater than the control
group on Day 14, but was significantly lower than the experimental contusion injury
groups, at all timepoints.
Comparison of the volume of GFAP expression per cell for both input velocities
showed that increasing the input velocity to 1000 mm.s−1 resulted in a more severe
reactive astrogliosis response, as measured morphologically. The mean volume of GFAP
expressed per cell was significantly higher at 1000 mm.s −1 compared to 100 mm.s−1, at
all displacement depths and timepoints. At each timepoint, there was no significant
difference between the control groups at both input velocities. On Day 1 post-injury,
there was an approximate 2.8-fold increase in the mean GFAP volume across all
displacement depths, as input velocity was increased from 100 to 1000 mm.s−1.
Similarly, an increase in velocity to 1000 mm.s−1 resulted in a 2.2-fold and 2.0-fold
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increase at Day 7 and 14, respectively.
4.4.2.2 Sphericity
Sphericity was another morphological feature which was analysed in astrocytes, since the
progression of non-injured astrocytes to activated astrocytes is characterised by an
increase in ramification of processes. An increase in ramification is associated with a
decrease in sphericity, thus this measure was used as another indication of astrogliosis.
Figure 4.10 illustrates the sphericity of astrocytes, following simulated contusion at 100
and 1000 mm.s−1, over a 14 day time period.
At 100 mm.s, there was no significant difference in mean sphericity between the
experimental and control groups on Day 1 post-injury (Figure 4.10A). On Day 7, the
mean sphericity of the 50 and 75% displacement and TGF-β1 groups was significantly
lower than the control, with means of 0.27 ± 0.01 AU, 0.30 ± 0.01 AU and 0.25 ± 0.01
AU, respectively. Similarly, the mean sphericity of these same three groups was
significantly lower than the control on Day 14 post-injury, with means of 0.27 ± 0.01 AU
and 0.27 ± 0.01 AU and 0.28 ± 0.01 AU, respectively. Evaluating the change in
sphericity at a fixed displacement depth over time, there was a significant decrease in
sphericity between Days 1 and 14 in the control group suggesting a potential increase in
the reactivity of astrocytes in this group. In all test groups, there was a significant
decrease in sphericity between Days 1 and 7, and Days 1 and 14 post-injury.
At 1000 mm.s−1, the mean sphericity of all displacement groups was significantly
lower than the control, at each timepoint (Figure 4.10B). On Day 1 post-injury, increasing
displacement depth did not significantly affect the sphericity of astrocytes. The mean
sphericity across the displacement depths was 0.26 ± 0.01 AU, compared to a mean of
0.39 ± 0.02 AU in the control group. Similarly, increasing displacement depth did not
significantly affect the sphericity of astrocytes on Day 7 and 14, with means of 0.23 ±
0.008 AU and 0.21 ± 0.007 AU (grouped displacement). Over time, the sphericity of
astrocytes in the control group significantly decreased between Days 1 and 14 (from a
mean of 0.39 to 0.32 AU), although remained significantly higher than the experimental
groups. There was no significant change in sphericity over time, at 25% displacement. At
50%, there was a significant reduction in sphericity between Days 1 and 7, followed by no
further significant change between Days 7 and 14. At 75%, there was a trend of decreasing
sphericity over time, but was only significant between Days 1 and 14.
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Figure 4.10: Sphericity of astrocytes following simulated contusion at 100 and
1000 mm.s−1. Primary astrocyte-seeded hydrogels (5 x 105 cells.mL−1) were subjected
to contusion injury at 100 mm.s−1 (A) and 1000 mm.s−1 (B). Sphericity was measured
using Volocity. Data presented as the mean ± SEM and analysed by two-way ANOVA.
Significance levels * p<0.05 (vs. control, Dunnett’s post-hoc) † p<0.05 (25% vs 50%,
Tukey’s post-hoc). # p<0.05 (25% vs 75%, Tukey’s post-hoc); ∆ p<0.05 (vs. TGF-β,
Tukey’s post-hoc). N=3.
4.4.3 Astrocyte Viability Following Contusion Injury
Together with morphological changes following injury, astrocyte viability was evaluated
over 14 days using the LIVE/DEAD™Viability/Cytotoxicity Assay in order to
determine whether mechanical insult is particularly cytotoxic to astrocytes. Viability
was calculated as the percentage of live cells out of the total number of live and dead
cells counted (Figure 4.11). TGF-β1 treatment had no effect on astrocyte viability over
the 14 day time period.
At 100 mm.s−1, the viability of astrocytes in the control group remained stable over
the 14 day time period, with a mean viability of 79.86 ± 4% (Figure 4.11A). On Day 1
post-injury, there was a trend of decreasing viability with increasing displacement depth.
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However, viability was only significantly lower than the control at 50 and 75%
displacement. Viability was reduced to its lowest at 75% displacement, with a mean
viability of 56.87 ± 2%. Further, viability at 75% was significantly lower than viability
at 25% displacement. On Days 7 and 14, there was similar trend of decreasing viability
with increasing displacement depth, similar to that observed on Day 1. However,
viability on Day 7 was only significantly reduced at 75% displacement (mean 71.01 ±
2%), compared to the control group. There was no significant difference between
viability in the experimental and control groups at Day 14.
At 1000 mm.s−1, viability in the control group remained stable over the 14 day time
period, with a mean viability of 86.45 ± 1% (Figure 4.11B). On Day 1 post-injury, a
widespread decrease in viability was observed at all displacement depths, which was
significantly lower than the viability of the control group. There was no significant
difference in the mean viability between the experimental groups, with a mean viability
of 58.19 ± 1%, over all three displacement depths. On Days 7 and 14, there was no
significant difference in viability between the experimental and control groups.
Figure 4.11: Astrocyte viability following simulated contusion at 100 and 1000
mm.s−1. Astrocyte-seeded hydrogels were subjected to contusion injury at 100 mm.s−1
(A) and 1000 mm.s−1 (B), with cell viability measured over 14 days, using the live/dead
assay and Equation 4.4. Data presented as the mean ± SEM and analysed by two-way
ANOVA. Significance levels * p<0.05 (vs. control, Dunnett’s post-hoc), # p<0.05 (25%
vs 75%, Tukey’s post-hoc). N=3.
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To investigate the relative contributions of the number of viable and dead cells to the
total population- particularly from Day 7 onwards where percentage viability was not
significantly different than the control the number of live and dead cells were evaluated,
with data presented at 100 mm.s−1 (Figure 4.12). A similar observation of trends in the
viable and dead cell populations was made at 1000 mm.s−1 (data not shown). There was
no significant difference in the mean number of live cells between the experimental and
control groups, on Day 1 suggesting there was no injury-induced proliferation. Between
Days 1 and 7, there was a decrease in the number of live cells, although this was not
significant (p>0.05).
There was an increase in number of live cells between Days 7 and 14, which was only
significant at 50 and 75% displacement. Overall, there was no significant change in the
mean number of live cells between Days 1 and 14. It is difficult to determine whether the
increase in the number of live cells between Days 7 and 14 was due to proliferation as a
result of mechanical trauma, or the general process of cell growth and division. However,
the percentage increase was greater in the experimental groups, compared to the control.
The mean percentage increase in the number of live cells was 15.2% for the control
group. The mean percentage increase was 24.0, 45.3, and 30.9% at 25, 50, and 75%
displacement, respectively.
Analysis of the mean number of dead cells showed that cell death was greatest on
Day 1, with cell death at 50 and 75% displacement significantly higher than the control.
Given there was no difference in the number of live cells on Day 1, this increase in cell
death contributed to the reduction in percentage viability (Figure 4.11A). A significant
reduction in the number of dead cells was then observed in all groups, on Day 7 (Figure
4.12B). There was no significant reduction in the number of live cells between Days 1
and 7, thus percentage viability was no different compared to the control, except at 25%
displacement. There was then no further significant change in the number of dead cells
observed between Days 7 and 14, suggesting cell death primarily occurred as an acute
response to mechanical injury.
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Figure 4.12: Quantification of the number of live and dead cells following
contusion injury at 100 mm.s−1. Astrocyte-seeded hydrogels were subjected to
contusion injury at 100 mm.s−1 and a live/dead assay performed to quantify the number
of live (A) and dead cells (B) per field of view, over 14 days. Data presented as the mean
± SEM and analysed by two-way ANOVA with Tukey’s post-hoc test. Significance levels
* p<0.05 (Day 7 vs Day 14), # p<0.05 (Day 1 vs Day 7). N=3.
4.4.4 Astrocyte Metabolic Activity Following Contusion Injury
The adenosine triphosphate (ATP) content of astrocytes per sample was measured
following contusion injury using the ATPlite™Luminescence Assay System, as described
in Section 4.3.8. Metabolic activity of astrocytes in the control groups (no injury)
remained stable across the 14 day time period, with no significant differences in
metabolic activity between the timepoints at both 100 and 1000 mm.s−1 (Figure 4.13).
Treatment of the cells with 70% (v/v) methanol (positive cell death control) successfully
resulted in a significant reduction in ATP content compared to the control. Acellular
gels were included as a control to show that the gels did not contribute significant
artefacts which may have affected the measurements.
Contusion injury inflicted at 100 mm.s−1 did induce changes in astrocyte metabolic
activity (Figure 4.13A). On Day 1, contusion injury resulted in increased metabolic
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activity, which was significantly greater than the control at 50 and 75% displacement.
However, there was no significant difference in metabolic activity between any of the
displacement depth groups. Chemical treatment with TGF-β1 did not significantly affect
astrocyte metabolic activity. On Day 7, metabolic activity of the experimental injury
groups was greater than the control, but this was only significant at 25% displacement.
TGF-β1 treatment did not significantly affect astrocyte metabolic activity. Contusion
injury to 25 and 75% displacement depth resulted in a significantly higher metabolic
activity compared to the TGF-β1 group. On Day 14, all test groups showed significantly
increased metabolic activity compared to the control. Contusion injury to 75%
displacement depth resulted in the greatest metabolic activity (mean 7.01 x 105 ± 1 x
105 CPS). Metabolic activity at 75% was also significantly greater than that at 25 and
50% displacement, and the TGF-β1 group. Evaluating each test group over time
revealed that between Days 1 and 7, there was no significant change in metabolic
activity of any of the groups. However, a significant increase in metabolic activity was
observed in all test groups between Days 7 and 14 (and thus Days 1 and 14).
Contusion injury inflicted at 1000 mm.s−1 did not result in any significant changes to
the metabolic activity of the astrocytes on Day 1, nor were there any differences between
the test groups (Figure 4.13B). On Day 7, only contusion to 75% displacement depth
results in a significant increase in metabolic activity compared to the control group.
However, this was not significantly different from any of the other test groups. On Day
14, all test groups showed significantly increased metabolic activity compared to the
control. Contusion injury to 75% displacement depth resulted in the greatest metabolic
activity (mean 8.50 x 105 ± 1 x 105 CPS), which was also significantly higher than all
other test groups. At 75% displacement, metabolic activity significantly increased with
time. However, similar to 100 mm.s−1, metabolic activity for the other test groups did
not significantly change until Day 14.
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Figure 4.13: Astrocyte metabolic activity following simulated contusion at 100
and 1000 mm.s−1. Astrocyte-seeded hydrogels (5 x 105 cells.mL−1) were subjected to
contusion injury at 100 mm.s−1 (A) and 1000 mm.s−1 (B) and ATP content was measured
over 14 days. Data presented as the mean counts per second (CPS) ± SEM. Data analysed
by two-way ANOVA. Significance levels * p<0.05 (vs. ctrl, Dunnett’s post-hoc); † p<0.05
(25% vs. 75%, Tukey’s post-hoc); ‡ p<0.05 (50% vs. 75%, Tukey’s post-hoc); ∆ p<0.05
(vs. TGF-β1, Tukey’s post-hoc). TGF-β1 (positive astrogliosis control) and +ve (positive
cell death control; 1 hour 70% v/v methanol treatment). N=4.
4.4.5 Chondroitin Sulfate Proteoglycan Expression
Astrocytes are known to secrete several molecules which are inhibitory to
neuroregeneration. A group of such molecules, chondroitin sulfate proteoglycans
(CSPGs), are expressed by astrocytes following injury. The monoclonal antibody, CS-56,
was used to label the glycosaminoglycan portion of CSPGs following contusion injury.
Figure 4.14 shows representative images of CS-56 labelling in astrocyte-seeded hydrogels
14 days following contusion injury, at 100 mm.s−1. Differences were observed in the area
of CSPG expressed, particularly in the control group where little CSPG expression was
observed. Contusion injury and TGF-β1 treatment appeared to induce astrocytes to
express and release more CSPG into the surrounding microenvironment. Quantification
was undertaken by calculating the total area of CSPG expression using FIJI (Figure
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4.15).
Figure 4.14: Immunofluorescent labelling of CS-56 in astrocyte-seeded
hydrogels 14 days post-contusion injury at 100 mm.s−1. Representative maximum
intensity projection images (36 µm depth) of astrocyte-seeded gels subjected to no injury
(A), isotype control (B), contusion to 25% (C), 50% (D), and 75% (E) displacement, and
TGF-β1 treatment (F) and incubated for 14 days before labelling with a monoclonal
antibody against CS-56 (CSPG, red). Nuclei were counterstained with DAPI in B (blue).
Scale bar represents 50 µm.
Contusion injury at 100 mm.s−1 to varying displacement depths did have an effect on
CSPG expression (Figure 4.15A). On Day 1, increasing displacement depth resulted in
a trend for increased CSPG expression; however, this was only significantly higher than
the control at 75% displacement. On Day 7, significantly greater CSPG expression was
observed at 50 and 75% displacement. TGF-β1 treatment also resulted in significantly
higher CSPG expression compared to the control. On Day 14, all test groups showed
greater CSPG expression compared to the control. Astrocytes in the 75% displacement
group expressed more significantly more CSPG compared to those in the 25% and TGF-
β1 group. Within each test group, there was no significant increase in the mean CSPG
area between Days 1 and 7, except for the TGF-β1 group. However, significant increases
were observed between Day 7 and 14 in all test groups. In the control group, CSPG area
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significantly increased between Days 7 and 14.
Figure 4.15: Expression of CSPGs following simulated contusion at 100 and
1000 mm.s−1. 100 mm.s−1 (A) and 1000 mm.s−1 (B). Data presented as the mean
± SEM. Data analysed by two-way ANOVA. Significance levels * p<0.05 (vs. control,
Dunnett’s post-hoc); † p<0.05 (25% vs. 75%, Tukey’s post-hoc); # p<0.05 (50% vs. 75%,
Tukey’s post-hoc); ∆ p<0.05 (vs. TGF-β1, Tukey’s post-hoc). N=4.
Contusion injury at 1000 mm.s−1 to varying displacement depths also had an effect
on CSPG expression (Figure 4.15B). At Day 1 post-injury, astrocytes in the 75%
displacement group expressed significantly more CSPG than all other groups, although
there was no difference between 25 and 50%. On Day 7 post-injury, all test groups
expressed significantly more CSPG compared to the control. As displacement increased,
the mean CSPG area also increased, although this was not statistically significant
(p>0.05). Astrocytes in the 75% displacement group expressed significantly more CSPG
than those in the 25% and TGF-β1 groups. On Day 14, all test groups expressed
significantly more CSPG compared to the control group. There were no differences in
the mean CSPG area between any of the test groups. Over time, astrocytes in the 25%
displacement group saw a step-wise significant increase in CSPG area. At 50 and 75%
displacement, the mean CSPG area significantly increased between Days 1 and 7, but
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not between Days 7 and 14.
4.4.5.1 Summary of Primary Astrocyte Outcomes Following Contusion Injury
Overall, mechanical trauma simulating contusion injury induced changes in astrocyte
behaviour which differed to that of non-injured astrocytes. Astrocyte morphology
progressively changed from small and rounded, to larger and more ramified with many
interdigitating processes. Significant changes in GFAP volume were observed from Day 1
at 100 mm.s−1, although without a corresponding decrease in sphericity suggesting
hypertrophy of astrocytes initiated earlier (Figure 4.10). At 1000 mm.s−1, a similar
reduction in sphericity was observed across all displacement depths and timepoints,
which corresponded to the increase in GFAP volume, suggesting hypertrophy and
ramification was induced at the same time.
The viability and metabolic activity data did not fully corroborate each other, with
maximum cell death occurring at Day 1 post-injury but with no difference in ATP
content compared to control. Further, a significant increase in metabolic activity was
observed between Days 7 and 14, but there was no significant change in GFAP volume
per cell or sphericity. It was suggested that cell death was offset by increased
proliferation; however, the number of live cells was not significantly greater than the
control group. However, the rate of increase in the number of live cells between Days 7
and 14 was greater in the experimental groups compared to the control, suggesting more
proliferation as a result of injury and thus increased metabolic activity. Temporal
differences in CSPG expression were also observed following injury, with velocity having
little effect on the level of expression. There was more variation in quantification of
CSPG area as demonstrated by the large error bars so although displacement appeared
to influence the level of CSPG expressed, this was largely not significant.
There was evidence of astrocytes in the control group beginning to deviate from the
baseline non-reactive state by the end of the 14 day time period. Increased GFAP volume
and CSPG expression, and decreasing sphericity of astrocytes in the control group suggests
that although they were not as adversely affected as the injured groups, some stresses may
have been experienced by the cells. TGF-β1 treatment did induce astrogliotic changes;
however, the response was not as immediate as with mechanical trauma and less severe.
4.4.6 Effect of Enzymatic Digestion of CSPGs on Astrocyte Reactivity
Enzymatic digestion of CSPGs by chondroitinase ABC (ChABC) has previously been
utilised in vivo to digest and remove the neuroinhibitory molecules and create a
permissive microenvironment for axon outgrowth (Bradbury et al., 2002). In this study,
the effects of CSPG digestion on astrocyte reactivity was briefly explored.
Astrocyte-seeded hydrogels subjected to contusion injury at 100 mm.s−1 to displacement
depths of 25, 50, and 75% were cultured for 14 days. The gels were then treated with cell
culture medium supplemented with 200 mU ChABC, for 4 hours, before removing the
treatment and incubating the gels for a further 48 hours. Immunostaining for CS-56 and
GFAP was then performed to evaluate astrocyte morphology (Figure 4.16).
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Figure 4.16: Astrocyte morphology following chondroitinase ABC digestion
of CSPGs at 14 days post-injury. Primary rat cortical astrocyte-seeded hydrogels
(5 x 105 cells.mL−1) were subjected to contusion injury at 100 mm.s−1 and incubated
for 14 days before treating with ChABC (200 mU; 4 hours). After 48 hours, the cells
were fixed and immunostained for CS-56 (CSPG, red) and GFAP (astrocytes, green), and
counterstained with DAPI (nuclei, blue). Representative maximum intensity projection
images of astrocytes following ChABC treatment. 36 µm depth. Scale bar represents 50
µm.
Four hours treatment with ChABC resulted in successful digestion of CSPGs as
shown by the lack of CS-56 staining, and successful digestion was achieved across all
displacement depths. GFAP staining of astrocytes showed that 48 hours post-treatment,
the astrocytes maintained their reactive morphology, with ramification and
interdigitation of their processes with neighbouring astrocytes. This could suggest that
the injury was severe enough to induce a permanent non-reversible astrogliosis state, in
which removal of CSPGs does not reverse this, or that CSPG expression and release does
not feed back into the astrogliosis pathway. However, a longer incubation period
post-CSPG digestion is required to further investigate the possibility of astrogliosis being
reversible and/or able to be attenuated under these conditions.
4.4.7 An Enriched Population of Astrocytes Persists Following Removal
of Cells from Gels
Immunohistochemical staining of astrocytes using an anti-GFAP antibody revealed that,
although mechanical injury resulted in the induction of an astrogliotic response, a large
proportion of the astrocytes remained GFAP-negative. This was despite the confirmation
of an enriched population of astrocytes, which was achieved by staining cells for GFAP
seeded onto glass coverslips, prior to seeding hydrogels for subsequent experimentation.
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Therefore, an experiment was performed whereby astrocyte-seeded hydrogels subjected
to contusion injury were digested with collagenase, with the cells reseeded onto glass
coverslips and immunostained with GFAP (Figure 4.17).
Figure 4.17: GFAP immunoreactivity of primary astrocytes isolated from
experimental hydrogels. Representative immunofluorescent images of primary
astrocyte-seeded hydrogels subjected to simulated contusion injury, at 1000 mm.s−1 to
75% displacement, and incubated for 14 days. The cells were isolated using collagenase
treatment (0.125% w/v) for 15 minutes and seeded onto PDL-coated glass coverslips for
subsequent immunolabelling with a polyclonal antibody against GFAP (astrocytes, green)
and counterstained with DAPI (nuclei, blue). Control astrocytes were cultured in tissue
culture flasks and seeded onto PDL-coated coverslips. Scale bar represents 100 µm (10 X)
and 50 µm (20 X).
Figure 4.17 shows representative images of cells recovered from collagenase-digested
hydrogels, which had been subjected to contusion injury at 1000 mm.s−1 to 75%
displacement. Astrocytes in the control panels contained astrocytes which had
undergone culture and enrichment in tissue culture flasks before seeding straight onto
PDL-coated coverslips. The majority of the cells derived from the digested hydrogels
stained positive for GFAP, with very few GFAP-negative nuclei. The cells in the control
group were also primarily GFAP-positive, similar GFAP expression and morphology to
cells derived from the hydrogels. This confirms that the population of cells were indeed
astrocytes, despite the lack of GFAP staining.
4.5 Discussion
The aims of this chapter were to apply the contusion injury protocol developed in Chapter
3 to primary astrocyte-seeded hydrogels and evaluate responses of the astrocytes to a range
of input velocity and displacement values in vitro. Over 14 days, astrocyte responses were
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evaluated through a range of assays to evaluate astrocyte morphology, viability, metabolic
activity, and secretion of chondroitin sulfate proteoglycans (CSPG).
4.5.1 Biomechanics of Contusion Injury In Vitro
The contusion protocol used in this chapter was developed based on characterisation of
the BOSE 5110 Electroforce BioDynamic (Chapter 3), which showed that a maximum
input velocity of 1000 mm.s−1 was achievable, with up to 10% error. This velocity is
within the range of velocities used in in vivo studies, particularly in smaller animals such
as rodents (Chapter 1 Table 1.5). As it is impossible to measure the precise velocity of a
clinical injury, cadaveric models have been useful tools for measuring deformation rates.
Impact velocities between 0.08 – 10 m.s−1 have been measured in human and bovine
cadaveric burst fracture models (Panjabi et al., 1994; Saari et al., 2011; Wilcox et al.,
2004), thus the velocities reported in this study could be considered relevant too.
The input displacement was consistently achieved with the gels, as shown by the
small error bars and there was no significant difference between the peak displacement
achieved between both input velocities. There was more variation in the velocities
achieved, which is consistent with the verification work performed in Chapter 3 and with
studies in vivo (Chen et al., 2016; Choo et al., 2007; Lam et al., 2014). Here, an
unexpected increase in mean velocity with an increase in displacement was observed.
This was not observed with gels in Chapter 3 (Figure 3.7) so the reason for this change is
unknown and will likely affect the interpretation of the results as velocity was not
consistent and thus the energy applied will be affected. The in vivo contusion models
summarised in Chapter 1 (Table 1.5) mostly report either the impact or peak velocity, so
it is difficult to determine whether those values were significantly different to their peak
velocities.
Lam et al., (2014) reported detailed kinetic information following contusion SCI in a
rat model, using the University of British Columbia (UBC) multimechanism device. A
range of input displacement and velocity values were used: 0.9 and 1.5 mm displacement,
and 8, 80, and 800 mm.s−1. From low displacement and low velocity to high
displacement and high velocity, incremental increases in force and energy applied were
measured (0.250 – 1.775 mJ). The displacement depths and velocities used in this study
are of similar magnitude, and the mean energy applied ranged from 0.150 – 3.709 mJ,
which is similar to the values observed by Lam et al., (2014). The differences may be
attributed to the differing mechanical properties between collagen hydrogels and rat
spinal cord tissue and the presence of supporting tissue structures, including dura and
ligaments in the in vivo model.
In this study, the impact velocity was determined as the velocity at which the platen
first came into contact with the surface of the gel. A limitation of this method is that it
was potentially not an accurate way to verify whether the initial calculation of the height
of the gel remained the same at the point of impact. Additionally, it was difficult to assess
by eye the precise point at which the load platen first came into contact with the gel and
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compare this with the theoretical impact position. Other studies which report impact
velocity, such as Lam et al., (2014) and Choo et al., (2007) do not detail how impact
velocity was determined but it is assumed that the value is derived from the displacement
position where the initial surface of the cord was registered (force value of 0.03 N). In
future, further preliminary experiments could be undertaken to verify the precise impact
position, such as measuring the gel height multiple times over a given period of time to
determine whether this changes. Alternatively, a high speed video camera could be set
up to film the injury process, such as one used by Wilcox et al., (2002) to measure the
dynamics of canal occlusion in an ex vivo model of thoracolumbar burst fracture. Analysis
of the still frames could be used to determine the impact position and the time at which
this occurs. The time at impact could be used with the output biomechanical data to then
determine the actual impact velocity.
4.5.2 Effects of Contusion Impact Depth and Velocity on Astrocyte
Responses
The advantage of using the BOSE to model mechanical injury is that velocity and
displacement can be decoupled. An additional input velocity of 100 mm.s−1 was selected,
alongside three displacement depths (25, 50, 75% gel height) in order to generate a range
of injury conditions. The aim was to evaluate the relative importance of each
biomechanical parameter in determining astrocyte responses and its severity. In this
study, it was hypothesised that an increase in velocity and displacement would result in
an increase in the severity of the astrogliosis response, due to the increased energy
applied to the cells.
However, an input contusion velocity of 1000 mm.s−1 resulted in an increase in
astrogliosis severity, whereby displacement depth had little effect on astrocyte volume
and sphericity across 14 days, and little effect on viability and metabolic activity at the
earlier timepoints. This suggests the potential for a threshold for astrogliosis which may
have been surpassed at 1000 mm.s−1. Tissue-level strain thresholds have been reported
for axonal injury through measuring morphological and functional changes following
tensile stretching of optic nerve axons (Bain and Meaney, 2000), but less is known about
astrocyte tolerances to mechanical injury. Cullen et al., (2007) found that astrocytes
were less susceptible to cell death compared to neurons, 48 hours following shear
deformation.
Lam et al., (2014) reported no significant differences in the energy applied between
velocities at a fixed displacement depth except between 80 and 800 mm.s−1, at 1.5 mm
displacement. However, differences were observed in behavioural deficit measurements
at 0.9 mm – 800 mm.s−1 and 1.5 mm – 8 mm.s−1, for instance, despite no significant
difference in their energy applied (0.506 and 0.711 mJ, respectively). This was thought to
be due to the increased strain experienced by the nerve fibres at 1.5 mm, which resulted in
demyelination and thus affecting cell behaviour. In this study, a similar energy applied was
calculated for the following conditions: 100 mm.s−1–75% and 1000 mm.s−1–25% (0.945
and 0.954 mJ, respectively). Comparison of the outcome measures for these two injury
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groups was performed (Table 4.2).
Table 4.2: Comparison of outcome measures for injury groups with similar
energy applied. The following injury groups had energy applied values which were not
significantly different from one another: 100 mm.s−1–75% and 1000 mm.s−1–25%.
Comparison of the outcome measures for these two groups were made by two-way
ANOVA with a Tukey’s post-hoc test. Significance levels * p<0.05. n.s = not significant.
Day 1 Day 7 Day 14
Volume GFAP.cell−1 µm3) * * *
Sphericity (AU) * n.s n.s
Viability (%) n.s * n.s
Metabolic activity (CPS) n.s n.s *
CSPG expression area (µm2) n.s n.s *
Despite energy applied being similar for those two conditions, there were some
differences in astrocyte responses over time, although there was no clear pattern. For
example, there were differences in astrocyte morphology between the two injury groups,
but not for viability, metabolic activity, or CSPG expression one day post-injury. The
volume of GFAP per cell was the only outcome measure which significantly differed
between the two groups at all timepoints, whereby the values at 1000 mm.s−1–25% were
significantly greater than those at 100 mm.s−1–75%. This could be due to the
viscoelastic behaviour of cells: the elastic component dominates at the higher strain rate
causing the cells to behave in a more rigid manner. Conversely, at the lower strain rate,
the viscous component dominates and the cells may be able to accommodate
deformation better. It may be expected then that all the outcome measures would
exhibit differences. However, the activation mechanisms and pathways of these activities
may be differentially affected by mechanical trauma.
Several in vivo studies have reported on the existence of dominant biomechanical
parameters in determining injury severity: Kim et al., (2009) observed no significant
decrease in functional outcomes of mice at a fixed displacement depth (0.8 mm), with
increasing impact velocity (100, 200, and 400 mm.s−1). Pearse et al., (2005) observed an
increase in axon demyelination and decrease in motor function with increasing impact
depth (0.80, 0.95, and 1.1 mm), at a fixed velocity ( 100 mm.s−1). Sparrey et al., (2008)
reported that contusion velocity affected the magnitude of white matter and neuronal
damage in the rat spinal cord at a displacement depth of 1 mm. Basso et al., (1996)
reported a reduction in locomotor outcomes following increasing drop height (6.25, 12.5,
25, and 50 mm), thus impact velocity and depth using the NYU impactor. However, it is
difficult to compare these studies with one another as each used different experimental
procedures, including the injury apparatus, animal model, and input biomechanical
parameters (where some studies varied both displacement and velocity; others only one).
Further, impact velocity and depth are inherently coupled in the Basso et al., (1996)
study, thus an increase in one parameter results in an increase in the other. This makes
it difficult to evaluate the relative importance, if any, of each parameter in determining
injury severity.
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4.5.2.1 Experimental Model and Setup
The diameter of the impactor tip used in this study was 10 mm with a flat surface,
which generated a global injury on the gels which were 11 mm in diameter. This
contrasts to the smaller impactor tips used in in vivo studies, which range from 0.6 – 2.0
mm in rodents (Chapter 1, Table 1.5), and are typically rounded in geometry. Larger
animal model studies, such as porcine and non-human primates (NHP) employed larger
impactor tips up to 15 mm, due to the increase in size of the spinal cord compared to
rodents. A similar in vitro contusion study using the BOSE apparatus used a 3.34 mm
diameter impactor tip to inflict a focal injury to cell-seeded hydrogels (Kirk, 2018).
These studies contrast to this study as a focal injury was modelled, which resulted in the
generation of a defined lesion. The aim of this study was to evaluate the effects of
varying contusive impacts on astrocyte responses as an overall population, thus a focal
injury was not modelled. However, this prevented the formation of a lesion which would
have facilitated more in depth analysis of the lesion epicentre, lesion border, and the
uninjured local and distal microenvironment. Also, employment of a smaller impaction
tip means force is distributed over a smaller area, thus the astrocytes may respond
differently.
There are some similarities between this study and other in vitro studies, including
those by Smith (2016) and Kirk (2018). Smith (2016) used the same cell type and
collagen hydrogels to model contusion SCI using the Infinite Horizons impactor. The
hydrogels used by Kirk (2018) were reported to be a volume of 100 µL prepared in 96
well-plates (1 x 106 cells.mL−1). The thickness of these gels were not reported and
contusion displacement depths used were 50, 80, and 100%. Therefore, it is difficult to
compare the absolute displacement values with those in this study; however, both studies
showed a response by the astrocytes to injury.
Separate gels were prepared for each assay: immunostaining, viability, metabolic
activity. Viability and metabolic activity both exploit characteristics of cells which are
distinct between viable and dead cells, thus have been used interchangeably to evaluate
viability. However, the characteristics of astrogliosis, including hypertrophy,
ramification, and proliferation may affect metabolic activity in such a way that makes
distinguishing the contribution of these activities against cell death difficult. This may
necessitate further validation with additional assays but proliferation specific markers
such as BrdU could be utilised, for instance.
Whilst the BOSE 5110 Electroforce BioDynamic apparatus was shown to be capable
of modelling precise and accurate displacement of gels, simulating contusion injury, a
number of practical limitations exist. Firstly, the system is low-throughput and
relatively time consuming. The platens only had a capacity for testing one gel at any one
time. Manufacturing or acquiring a platen with the capacity for more than one sample
would be beneficial and could increase the precision of the injury simulated across
samples. TA Instruments advertises a four chamber model (model 5270) but this may be
cost prohibiting due to the increased number of components and a load cell required for
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each chamber.
Another practical limitation of the apparatus in this study was that manual alignment
of platens was required during assembly of the chamber, and manual adjustment was
often required once the chamber was loaded to the apparatus frame and stabilising collars
were removed. This limitation did not impede the simulation of contusion injury with the
gels as the impacting tip could easily be centred over each specimen. However, proper
alignment of tensile grips for the distraction study (Chapter 5) may be more difficult as
the specimen is secured to both grips and erroneous load readings and/or distribution of
strain may occur with unaligned grips. Additionally, the requirement of sterility meant
the apparatus was housed in a Class II cabinet. These cabinets do not have solid surfaces
to enable appropriate circulation of laminar air flow. As such, some noise was present in
the load readings caused by vibrations from movement of the platens, and the air flow.
The effects of these were reduced by placing a rubber sheet underneath the apparatus with
the aim of absorbing some of the vibrations. Also, the safety cabinet screen was closed
and power of the laminar air flow was reduced for the short duration of the experiment
itself, which did not affect the sterility of the samples.
4.5.3 Astrocyte Responses to Contusion Injury In Vitro
Astrocytes respond to insult by undergoing numerous cellular, molecular, and functional
changes, all of which contribute to the overall process of astrogliosis. GFAP is widely
used as a marker for reactive astrocytes as its upregulation is associated with injury
(Sofroniew, 2009). In this study, mechanical trauma resulted in morphological alterations
consistent with astrogliosis, including hypertrophy, ramification, overlapping of
parenchymal domains, and an increase in the volume of GFAP expressed per cell
(Anderson et al., 2014; Pekny and Nilsson, 2005; Sofroniew, 2009).
Evidence of a gradated response to injury was observed at 100 mm.s−1, where an
increase in displacement depth was associated with an increase in astrocyte reactivity.
This is consistent with the general consensus that astrocyte responses vary with injury
severity, along a spectrum (Sofroniew and Vinters, 2010). However, at 1000 mm.s−1, the
astrocytes were observed to be morphologically reactive at all displacement depths, with
similar GFAP volume expression and ramification. This suggests some threshold for
robust morphological alterations exists, although there were still differences in CSPG
expression, metabolic activity. Overlapping of astrocyte processes was observed,
particularly at the higher displacement depths and at later timepoints. Non-reactive
astrocytes have been shown to occupy distinct anatomical domains from one another,
with minimal overlap of processes (Bushong et al., 2002). Process overlapping is
associated with scar-forming astrocytes and as a more robust response to moderate to
severe injury (Sofroniew, 2009). These reactive astrocytes contribute to the glial scar, a
physical and chemical barrier against neuroregeneration.
Astrocytes under control conditions contrasted morphologically to those under injury
conditions, whereby they were smaller and more rounded in shape with a lower level of
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GFAP volume expressed per cell. This observation is also consistent with studies which
have demonstrated the mechanosensitive nature of astrocytes: astrocytes are small and
round in soft hydrogels while highly spread in stiffer gels (Georges et al., 2006; Pogoda and
Janmey, 2018). Many of the nuclei stained notably did not also stain positive for GFAP.
Numerous reports have discussed the heterogeneity of astrocytes, including the differential
expression of GFAP in astrocytes from different tissue regions, and under physiological
and pathological states (Anderson et al., 2014), and is discussed in more detail in the
General Discussion (Chapter 6).
4.5.3.1 Astrocyte Viability and Metabolic Activity
Temporal changes in astrocyte cell death and metabolism has not been the primary focus
of many in vivo and in vitro studies of contusion SCI, although research has reported
sustained neuronal, oligodendrocyte and microglial cytotoxicity following SCI (Beattie et
al., 2002; Gaudet and Fonken, 2018; Shuman et al., 1997; Yong et al., 1998). This may
suggest that astrocyte cell death is not a dominant pathophysiological feature of SCI. In
this study, cell death was maximal 24 hours post-injury, and viability was mostly
insignificant compared to the control group from Day 7 post-injury.
In a similar in vitro model using the same BOSE apparatus, Kirk (2018) observed a
significant increase in ATP content 24 hours post-injury, at focal contusion displacement
depths of 80% and 100% gel height (input velocity of 3000 mm.s−1). The study used the
ATPlite assay as a measure of cell metabolic activity, viability and astrocyte reactivity,
and inferred that the increase in ATP content was due to the processes involved in
astrogliosis. If this is true, potential cell death could have been masked and metabolic
activity and live/dead data here suggests so. Viability was not assessed at later
timepoints. Smith (2016) generated a contusion model using primary astrocyte-seeded
collagen hydrogels and modelled the injury using the IH impactor. Contrastingly, cell
death was insignificant compared to the control group at Days 1 and 5 post-injury, and
significantly greater than the control on Day 10 post-injury, as measured using the
live/dead assay. Both Kirk (2018) and Smith (2016) modelled focal contusion injuries,
thus there are differences in methods used to calculate viability/cell death compared
with each other and this study. Kirk (2018) used the ATPlite assay which measures the
ATP content of the bulk sample and does not specifically quantify cell death; whereas
Smith (2016) measured cell death at eight different regions around the sample, including
around the impact area, and reported the mean value. Therefore, artefacts from imaging
location choice may have affected the calculation.
In other in vitro studies, Cullen et al., (2007) applied shear strain to
neuron-astrocyte hydrogels at different strain rates and observed significant cell death of
neurons at moderate (10 s−1) and high (30 s−1) strain rates two days post-injury.
Astrocyte viability was not significantly affected, suggesting neurons were more
susceptible to high rate shear strains. Total cell density was significantly increased at the
low (1 s−1) and moderate strain rates suggesting a proliferative response. In this study,
significant cell death observed one day post-injury was consistent with a significant
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reduction in the percentage of viable cells (Figure 4.11 and 4.12B). Cullen et al., (2007)
did not evaluate cell death at time points later than two days so comparisons cannot be
made regarding longer term cell death. Together with the analysis of astrogliotic changes
(morphology and CSPG expression), Cullen et al., (2007) showed that low strain rates (1
s1) resulted in astrogliotic changes but did not produce significant cell death. This
suggests that local cell death is not necessary for initiating an astrogliosis response. In
this study, viability was not significantly different from the control group from Day 7
onwards, whereas expression of GFAP volume was significantly increased at these
timepoints. This also suggests cell death may not be required to sustain astrogliosis.
The live/dead assay used here is an end point assay, meaning that a repeated
measure of viability from the same sample could not be performed. Continuous
monitoring of viability would have been preferred, thus cumulative viability could be
measured whilst also reducing the need to prepare independent samples for the same
injury conditions for the three timepoints. Results in this study showed that the number
of dead cells was maximal Day 1 post-injury, but subsequently decreased with time. This
suggests that the immediate impact of mechanical damage causes some cell death, but
with the onset of secondary injury minutes later astrogliosis is initiated in injured but
viable astrocytes (Beattie et al., 2002; Sofroniew and Vinters, 2010). Additional
extracellular signals, such as damage and release of cytokines from other cell types, and
hypoxia are not as faithfully modelled in this system which may influence the viability
and behaviour of astrocytes long term.
Astrocyte proliferation is a known characteristic of astrogliosis and has been shown
to be prominent around the lesion area, enabling the formation of a compact scar
(Sofroniew, 2009). The lack of a focal lesion in this model could have meant there was no
signal for defined migration and proliferation of astrocytes around a lesion. Some aspects
of astrogliosis, such as proliferation, may not have been faithfully modelled in this study
due to the presence of astrocytes cultured in isolation. Neuronal injury has been shown
to induce astrogliosis so significant proliferation in an isolated astrocyte culture may not
have been detectable without additional extracellular signals (Zhang et al., 2010a).
Cullen et al., (2007) observed an increase in total cell density, suggesting a proliferative
response to shear deformation in their neuron-astrocyte co-culture model. Clear evidence
for astrocyte proliferation was not observed in this study, and the live/dead cytotoxicity
assay does not specifically probe for newly synthesised DNA of replicating cells. Instead,
the number of viable cells was quantified, which revealed that the number of live cells
significantly increased between Days 7 and 14 post-injury, at 50 and 75% displacement,
and at a greater rate than the control group. Therefore, assays specifically probing cell
proliferation, such as BrdU incorporation, would provide a clearer picture of whether
astrocytes proliferate following mechanical injury in this particular model.
The ATPlite assay is also said to evaluate cell viability, through measuring the ATP
content of the sample, but can also indicate proliferation and potentially astrocyte
reactivity too. Activities associated with astrogliosis- hypertrophy, increased synthesis
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and expression of GFAP and CSPGs, proliferation- are ATP dependent activities, thus
these activities increase the cells’ metabolic demands. Increases in GFAP volume
expression were observed as early as Day 1 post-injury and the magnitude of expression
was greater at 1000 mm.s−1. However, this was not reflected in the metabolic assay
results, particularly on Day 1 at 1000 mm.s−1. More significant changes in ATP content
were observed at Day 7 and Day 14 at both velocities. Further, significant cell death was
observed Day 1 post-injury but this was not reflected in terms of ATP content. With
astrogliosis encompassing a wide array of cellular and molecular changes, this assay may
not be sensitive enough to describe astrocyte behaviour.
4.5.3.2 CSPG Expression
Many neural cells express different members of the CSPG family in an organised
spatiotemporal pattern, as reviewed by Siebert et al., (2014), and increased CSPG
expression has been associated with SCI (Lemons et al., 1999; Moon et al., 2002). In this
study, CSPGs released from astrocytes following injury were visualised and quantified
through immunolabeling with a CS-56 antibody. Results showed that mechanical injury
resulted in increased CSPG expression in the microenvironment, compared to the control
group. Expression was maximal at 14 days post-injury, and was significantly greater
than at Day 7 at 100 mm.s−1.
CSPG expression has been shown to peak mostly two weeks after injury, in a
transection SCI model (Jones et al., 2003). It would be interesting to monitor CSPG
expression beyond 14 days to determine whether 14 days also corresponded to peak
expression in this study. Reactive astrocytes have been shown to synthesise brevican,
neurocan, and phosphacan (Jones et al., 2003; McKeon et al., 1999; Siebert et al., 2014;
Wanner et al., 2008) in response to injury and this study supports the notion that
reactive astrocytes are a source of CSPGs in vitro. However, the antibody used in this
study, CS-56, does not distinguish between specific core proteins thus it was not possible
to determine the precise identities of the CSPGs synthesised.
Increased CSPG expression is known to be inhibitory to neuronal regeneration,
generating a potent physical and chemical barrier against axon regeneration (Ohtake and
Li, 2015). Thus, modulation of the inhibitory microenvironment is an attractive target.
In particular, enzymatic degradation of CSPGs has been investigated in vivo with some
successes, including improved axonal sprouting and growth, and recovery of motor
function (Bradbury et al., 2002; Silver and Miller, 2004). Subsequently,
ChABC-mediated removal of these CSPGs was briefly explored in this in vitro study.
Results showed that successful removal of CSPGs was achieved with 4 hours treatment
with ChABC.
Due to time constraints, only the short term effects of CSPG removal on astrocyte
reactivity could be studied. Preliminary results showed that astrocyte reactivity was not
affected by CSPG removal, after 48 hours. This could be due to the fact that the injuries
modelled were severe thus the astrogliosis response was irreversible. Further, removal of
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CSPGs alone may not be enough to reverse or attenuate the process. However, a longer
timepoint would need to be explored. One limitation with a long-term study using
ChABC is that the enzyme is thermally unstable, with activity shown to be reduced by
50% after 1 hour of incubation, at 37 °C (Tester et al., 2007). This would therefore
require repeated treatment with fresh enzyme, which may be cost-inhibiting in the
current setup. Due to its neuroinhibitory effects, removal of CSPGs in a more complex
astrocyte-neuron co-culture model could also be utilised to evaluate neuronal behaviour
following mechanical injury in vitro.
Little is known about the effects of CSPG removal on reactive astrocyte behaviour
and whether the glial scar can be modulated in this way, since more focus has been
placed on the enhancement of axonal regeneration. A study by Milbreta et al., (2014)
utilised a rat hemitransection SCI model, with ChABC-mediated digestion of CSPGs
immediately following injury. Peak CSPG immunoreactivity and a well-established glial
scar was observed at 14 days post-injury. However, digestion of CSPGs resulted in altered
astrocyte dynamics: reduced GFAP expression, reduced density of astrocytes surrounding
the lesion, reduced interdigitation of processes, and an increased propensity for astrocyte
processes to be oriented towards the lesion site. These observations were made from one
to ten weeks post-injury. As ChABC was administered before the glial scar matured, its
effects on astrocyte behaviour are still not known once the glial scar has already formed.
In this study ChABC was administered at 14 days-post injury, but a time point of 48
hours was insufficient to fully evaluate the responses of the astrocytes to CSPG removal.
Future research should be directed towards this and 3D models, such as the one used in
this study, may be particularly beneficial as more clinically relevant injury mechanisms
can be modelled. This may enable a better understanding of the relationship between
CSPGs and reactive astrocytes in glial scar dynamics.
4.5.3.3 Analyses of Cytokine and RNA Expression
Cytokines are signalling proteins which play an important role in regulating the immune
response to SCI. Astrocytes have been shown to release numerous pro- and
anti-inflammatory cytokines in response to injury (Mukhamedshina et al., 2017;
Stammers et al., 2012). An ELISA assay was attempted to measure the levels of IL-6,
IL-10 and IL-1β cytokines in the media surrounding the gels following injury. However,
the ELISA assay used here was not sensitive enough to detect the low concentration of
cytokines present in the samples. Lyophilisation of the media and reconstituting it into a
smaller volume in order to concentrate the cytokines was unsuccessful.
Kirk (2018) reported the successful use of the ELISA assay to quantify cytokine
expression following simulated contusion injury using the BOSE. The study used the
same ELISA assay kit as in this study (Rat IL-6 DuoSet ELISA, Bio-Techne) and
reported cytokine levels of IL-6 and TNF-α of greater than 300 and 200 pg.mL−1,
respectively. This was despite using smaller hydrogels with a lower density of astrocytes:
5 x 104 cells in 100 µL gels. The input velocity used was 3000 mm.s−1, although results
in this project showed that the maximum velocity achieved was only 1176.25 ± 3 mm.s−1
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(Chapter 3). Further, displacement depths of 50, 80, and 100% gel height were used
which is within the upper range of those used in this study. The differences observed
could be due to the fact that Kirk (2018) modelled a focal contusion injury, with a
smaller impaction tip (3.34 mm rounded) meaning force was distributed over a smaller
area, thus the astrocytes may have responded differently.
Extraction of RNA for RT-PCR analysis was also attempted but could not be explored
in detail due to time constraints. The advantages of using this type of analysis is that
little starting material is required and multiple targets can be probed. Genomic analysis
of mouse astrocytes in response to ischaemic and lipopolysaccharide (LPS) endotoxin
treatment was performed by Zamanian et al., (2012), using Affymetrix GeneChip Arrays.
An interesting observation made was that at least 50% of the altered genes measured were
specific to a given injury mechanism. Therefore, it would be interesting to use the same
assay to compare gene expression of astrocytes in response to different mechanical injuries.
In future, using multiplex ELISA assays and gene profiling would provide a better profile
of astrocytes following injury, as more targets of interest can be targeted quantitatively.
4.6 Conclusions
Mechanical trauma simulating contusion injury in vitro, using the BOSE 5110
Electroforce BioDynamic apparatus, resulted in morphological changes in astrocytes
which were characteristic of astrogliosis observed elsewhere in vitro and in vivo. Multiple
aspects of astrogliosis were modelled in vitro, despite comprising an isolated population
of astrocytes. This model provides researchers with a simple but effective tool for
probing TSCI and cellular pathologies, with the capability of performing a wide range of
assays beyond those used in this study. This chapter addressed the main objectives of
the project, which were to evaluate the biological responses of astrocytes to simulated
contusion and distraction injury, and to investigate the relationship between the primary
mechanical input and responses of primary astrocytes cultured in isolation (Chapter 1).
The specific objectives set out in this chapter were met with the following observations:
I. Verify the accuracy and precision of the BOSE 5110 Electroforce BioDynamic
(BOSE):
• The input displacement and velocity parameters were achieved with high
precision and accuracy and matched the data from Chapter 3.
II. Calculate the kinetic outputs following simulated:
• Energy applied was calculated using the load displacement graphs, which
showed a significant step-wise increase in energy applied with increasing
displacement depth and velocity, except between 100 mm.s−1–75% and 1000
mm.s−1–25%.
III. Measure the responses of primary astrocytes to contusion injury:
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• Astrocytes responded to mechanical injury in a variety of ways which were
characteristic of astrogliosis, and differed from the control. Morphologically,
astrocytes became hypertrophied, ramified, and overlapping of domains was
observed.
• Reactive astrocytes in experimental groups expressed CSPGs at a greater level
compared to the control group. Further, significant cell death was observed
at Day 1 post-injury and ATP content was significantly increased at Day 14
post-injury.
IV. Compare the biological responses of primary astrocytes to contusion injury against a
known chemical inducer of astrogliosis, TGF-β1:
• Astrocytes subjected to mechanical contusion injury were observed to be more
reactive than astrocytes treated with TGF-β1 (positive astrogliosis control).
V. Evaluate the effects of contusion injury mechanics on astrocyte responses:
• Both displacement and velocity were correlated with astrocyte reactivity, with
a stronger correlation between velocity and GFAP volume.
Several hypotheses were also postulated at the beginning of the study:
I. There is no statistical difference between the reactivity of astrocytes in response to
contusion injury compared to no injury (control).
• Mechanical simulation of contusion injury induced astrocyte changes which were
consistent with astrogliosis and which was not observed in the control groups.
II. There is no statistically significant relationship between injury velocity and astrocyte
reactivity.
• An increase in injury velocity resulted in an increase in astrogliosis severity, in
terms of GFAP volume, sphericity, and CSPG expression.
III. There is no statistically significant relationship between injury displacement depth
and astrocyte reactivity.
• An increase in displacement depth resulted in a corresponding increase in
astrocyte reactivity at 100 mm.s−1, but not at 1000 mm.s−1, specifically in
terms of morphology.
IV. There is no statistically significant relationship between astrocyte reactivity and time.
• The astrogliosis response progressed over time, in terms of metabolic activity




The Effects of Varying Displacement Depth and
Velocity on Astrocyte Responses in an In Vitro
Model of Distraction Spinal Cord Injury
5.1 Introduction
Traumatic distraction spinal cord injury is another common mechanism of TSCI, in
which the vertebrae and spinal cord are subjected to axial tensile forces, and can arise
from hyperextension or flexion-distraction events (Dumont et al., 2001). Whilst there are
a myriad of contusion models available, distraction injury remains less frequently
modelled in vivo and in vitro. The tools available to model distraction injury lag behind
in terms of reproducibility and validation, and the main limitation of distraction models
is the high variability observed in outcome measures, even within injury grades (Chen et
al., 2016; Cheriyan et al., 2014). Further, relatively low distraction velocities have been
modelled which are less clinically relevant (1 – 10 mm.s−1; Chapter 1 Table 1.5). The
development of the University of British Columbia (UBC) multimechanism device has
seen an improvement in this, with a distraction velocity of up to 1000 mm.s−1 modelled
in rats (Chen et al., 2016; Choo et al., 2008, 2007, 2009).
It has become increasingly apparent that mechanism-specific characteristics of injury
exist, and that these differences could be exploited to enhance treatment paradigms. A
number of in vivo studies have directly compared two or more TSCI mechanisms within
the same study and distraction injury has been shown to be morphologically distinct
from contusion in rodents (Bhatnagar et al., 2016; Chen et al., 2016; Choo et al., 2008,
2007; Guo et al., 2019). For instance, contusion is typically a focal injury that causes
localised membrane compromise and the lesion cavity is confined to the epicentre.
Contrastingly, distraction injuries are more diffuse and result in widespread membrane
compromise and an extended lesion cavity (Choo et al., 2007; Wang et al., 2019). These
morphological differences have also extended to temporal behavioural differences (Chen
et al., 2016; Guo et al., 2019). As such, it is of benefit to patients, healthcare providers,
and researchers to understand the effects of different injury mechanisms on physiological
and behavioural outcomes.
So called stretch injury models have been developed in vitro to investigate the effects
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of rapid mechanical stretch on glial and neuronal physiology (Ahmed et al., 2000; Cullen
and LaPlaca, 2006; Cullen et al., 2007; Ellis et al., 1995; Geddes-Klein et al., 2006;
Miller et al., 2009). Altered astrocyte cellular dynamics have been observed following
injury: increased GFAP expression (Miller et al., 2009), increased cell density (Cullen et
al., 2007), membrane damage and altered ATP content (Ahmed et al., 2000). However,
it should be noted that whilst these have been called ’stretch models’ shear deformation
was typically applied to cell-seeded flexible membranes, thus strain was transferred from
the substrate to the cells. Distraction injuries likely involve shear forces, but pure
uniaxial tensile force was modelled in this study in a 3D model.
In vivo distraction models using defined distraction lengths have demonstrated that
injury severity is proportional to displacement (Dabney et al., 2004; Seifert et al., 2011;
Wu et al., 2016). Dabney et al., (2004) modelled mild (3 mm), moderate (5 mm), and
severe (7 mm) distraction injury in a rat model and concluded that distraction length
was the primary determinant of injury, regardless of velocity (1, 5 or 10 mm.s−1). Like
the other studies, relatively low velocities were used, so it is difficult to determine
whether these observations are reflected at higher, more clinically relevant velocities.
Chen et al., (2016) and Choo et al., (2008, 2007) characterised the histopathological and
functional outcomes of high velocity (up to 1000 mm.s−1) spinal distraction injuries in
rats. However, velocity nor displacement was varied as the aim was to compare the
damage patterns of different injury mechanisms.
Displacement parameters varied between studies depending on specimen dimensions,
injury location, animal type, and the optional incorporation of flexion into the injury
model. Wu et al., (2016) used a custom-designed distractor to apply caudal distraction
to L1 – L3 segments of male rabbits. Displacement was calculated as a percentage of the
distance between the L1 and L3 vertebral segments: control (0%), 10%, 20%. and 30%.
Other studies selected discrete displacement values: 5.6 mm in adult male
Sprague-Dawley (SD) rats (Chen et al., 2016), 5.1 – 6.1 mm in adult male SD-rats
(Choo et al., 2009), 4.1 mm in adult male SD-rats (Choo et al., 2008, 2007), and 3 mm
(mild), 5 mm (moderate), and 7 mm (severe) in adult female Long-Evans rats (Dabney
et al., 2004). Yang et al., (2013) used transcranial electrical stimulation-motor evoked
potential (TES-MEP) signals to increase displacement in 1 mm increments until a SCI
was achieved in pigs (as defined by a reduction in >80% TES-MEP signal). Results from
Chapter 3 demonstrated that failure of the hydrogel was observed when distraction
displacement values of 40% gel length and above were used (Section 3.4.4.2). Therefore,
three distraction lengths were selected: 10, 20, and 30% of the gel gauge length.
In summary, there is growing evidence for mechanism-specific differences in rodent
pathophysiology and behaviour. This highlights the importance of modelling the variety
of injury mechanisms observed in humans in order to better capture the heterogeneity of
TSCI, and improve preventative and interventional treatment regimes. However, whilst
multiple TSCI mechanisms have been modelled in vivo to evaluate physiological and
behavioural outcomes, these strains have not been modelled and directly compared in
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vitro, particularly for single cell populations. Therefore, primary astrocyte-seeded
hydrogels were subjected to uniaxial tensile forces, modelling the biomechanics of a
distraction injury at a velocity of 100 mm.s−1.
5.2 Aim and Objectives
The aim of this chapter was to evaluate the responses of primary astrocytes to tensile
forces experienced during distraction spinal cord injury, using a range of displacement
and velocity parameters representing different injury severities.
The specific objectives were as follows:
I. Verify the accuracy and precision of the BOSE 5110 Electroforce BioDynamic
(BOSE) at simulating distraction injury at a velocity of 100 mm.s−1 and
distraction lengths of 10, 20, and 30%, using primary astrocyte-seeded collagen
hydrogels.
II. Calculate the kinetic outputs following distraction injury using the BOSE apparatus,
including the impact velocity, peak displacement, peak load, and energy applied.
III. Measure the responses of primary astrocytes to distraction injury through GFAP
immunostaining, CSPG expression, metabolic activity and viability analyses.
IV. Compare the biological responses of primary astrocytes to mechanical distraction to
a known chemical inducer of astrogliosis, TGF-β1.
V. Compare the behaviour of astrocytes in response to contusion and distraction
injury.
The null hypotheses postulated were as follows:
I. There is no statistical difference between the reactivity of astrocytes in response to
distraction injury compared to no injury (control).
II. There is no statistically significant relationship between distraction length and
astrocyte reactivity.
III. There is no statistically significant relationship between astrocyte reactivity and time
following distraction injury.
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5.3 Specific Materials and Methods
5.3.1 Preparation of astrocyte-seeded hydrogels
Distraction tethered moulds were disinfected and sterilised by soaking the individual
components (mould pieces, parafilm, mesh bars) in 1% Trigene (v/v), followed by 70%
(v/v) ethanol. The stainless steel dowels and screws were sterilised by dry heat (Chapter
2; Section 2.5.1.2). All components sterilised in solutions were allowed to air dry within a
Class II safety cabinet. Once dry, the moulds were assembled in 6-well plates using
sterile gloves and forceps.
Hydrogels seeded with 5 x 105 primary rat astrocytes per mL of gel were prepared,
as described in Chapter 2 (Section 2.5.5). A gel volume of 150 µL per mould was used.
The gels were allowed to set by placing them in a humidified incubator at 37 °C, 8%
CO2:92% air. Once set, each gel was overlayed with 2 mL cell culture medium. After
24 hours incubation, the parafilm was removed and discarded using sterile forceps. TGF-
β1 treatment was used as a positive astrogliosis control. For these gels, complete cell
culture medium supplemented with TGF-β1 (10 ng.mL−1) and pipetted on top of the
gels, refreshing every two days.
5.3.1.1 Sample Setup in the BOSE
To transfer the moulds from the well-plate and secure them into the tensile grips of the
BOSE, a pair of sterile forceps was used to grasp onto a screw and transfer it to the lower
grip. The end of the tensile grip was aligned with the end point of the scribe on the mould
and secured by tightening the knurl screw. Under displacement control, the lower grip was
moved upwards towards the upper grip until the mould entered the upper grip and the
end point of the scribe aligned with the end of the upper tensile grip. The upper grip was
then closed and tightened around the mould by tightening the knurl screw. The screws
were then removed, followed by the dowels. Tensile loading forces were now able to be
applied.
5.3.2 BOSE Waveform Setup and Data Acquisition
For general assembly and set up of the BOSE Electroforce BioDynamic 5110, refer to
Chapter 2 (Section 2.5.8). The parameters for distraction injury, including the input
displacements, velocities, and PID values were developed in Chapter 3, and defined in
Table 3.3. The waveform regime, defined to represent a distraction injury, was defined in
the following steps:
1. Dwell: 10 ms
2. Ramp:
(a) Velocity: 100 mm.s−1
(b) Relative displacement: 10, 20, and 30% of the gel gauge length (8.25 mm).
This represented displacement lengths of +0.825, +1.650, and +2.475 mm,
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respectively. Note, displacement is positive as the lower motor platen moves
downwards, away from the load platen.
3. Dwell: 100 ms
4. Ramp:
(a) Velocity: 100 mm.s−1
(b) Relative displacement: Return to 0% distraction
Following this, the following data was exported into Excel: time (s), experimental
displacement (mm), axial command (input displacement, mm), load (N).
The data acquisition settings were as follows:
• Scan time = 0.4096 s
• Number of scan points = 2048
• Number of scans = 1
From the acquired raw data the following was calculated: peak experimental
displacement, peak experimental velocity, and energy applied. Energy applied was
calculated by performing a trapezoidal integration of the area underneath the
load-displacement curve for each sample, using Equation 4.2.
5.3.3 Immunohistochemical Staining
Astrocyte-seeded hydrogels were processed for immunofluorescent staining using the
methods described in Chapter 2 (Section 2.5.7). A 23 G needle was used to detach the
gel from the mould. The gels were transferred to a 48-well plate to reduce the volume of
reagents required for IHC processing. Primary antibodies specific for glial fibrillary
acidic protein (GFAP) and chondroitin sulfate proteoglycan (CS-56) were used to label
astrocytes and CSPGs, respectively, and DAPI was used as a nuclear counterstain.
Details of the antibodies used, including their dilutions are described in Table 2.1
(Chapter 2 Section 2.4). Hydrogels were incubated with isotype control antibodies, and
omission of the primary antibodies was routinely used as the negative controls.
5.3.4 Confocal Image Acquisition
Confocal z-stack images were acquired using a Zeiss LSM880 Axio Imager.Z2 upright
microscope (Chapter 2 Section 2.5.9.3). A total of five fields of view were acquired for
each gel (Figure 5.1).
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Figure 5.1: Image acquisition positions of a hydrogel following experimental
distraction injury. Five fields of view were imaged per gel, with images acquired from
the same five positions, as denoted by the green dots. At each field of view, a 36 µm z-stack
was acquired, composed of 10 z-slices at 4 µm intervals. Confocal images presented in this
report are maximum intensity projections.
The surface of the gel was located, as defined by the z-position in which the cells
first became visible. Each z-stack was 36 µm in depth, with 10 slices acquired at 4 µm
intervals. To ensure consistency in image acquisition, the laser settings were configured for
the sample with the greatest GFAP expression. Confocal images of cell-seeded hydrogels
presented in this study are maximum intensity projections generated from their respective
stacks.
5.3.5 Image Analysis
Evaluation of astrocyte morphology and behaviour, including GFAP volume, sphericity
and CSPG expression was undertaken using the same image analysis protocols detailed in
Chapter 4 (Section 4.3.6).
5.3.6 Analysis of Astrocyte Viability
Viability of the astrocytes following simulated distraction injury was assessed using the
LIVE/DEAD™Viability/Cytotoxicity Assay Kit (Chapter 2; Section 2.5.3.6). The
hydrogels were detached and removed from the distraction mould using a 23 G needle,
then transferred to a 48-well plate to reduce the volume of live/dead reagents required
per sample. The positive cell death control consisted of cell-seeded gels treated with 70%
(v/v) methanol for one hour. After aspirating the cell culture medium, the gels were
washed twice with 500 µL PBS to remove residual esterase activity (methanol for
positive control samples). A volume of live/dead solution twice that of the gel (i.e. 300
µL) was pipetted on top of each gel. The plate was then covered with foil and incubated
for 1 hour on an orbital shaker (90 rpm), at 37 °C, 8% CO2:92% air. The live/dead
solution was then discarded and 3x 5 minute PBS washes were performed at 37 °C, on
an orbital shaker (90 rpm). The cells were imaged using confocal microscopy, and
percentage viability was calculated using Equation 4.4.
5.3.7 Quantification of Astrocyte Metabolic Activity
Metabolic activity of astrocytes following simulated distraction injury was performed using
the ATPlite™Luminescence Assay System (Chapter 2; Section 2.5.6). The hydrogels were
detached and removed from the distraction mould using a 23 G needle, then transferred to
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a 48-well plate to reduce the volume of assay reagents required per sample. The cell culture
medium was aspirated from each gel and replaced with mammalian cell lysis solution at a
volume twice that of the gel (300 µL). The gels were incubated at room temperature for 30
minutes, with agitation at 700 rpm to lyse the cells and release the ATP. Working under
dark conditions, a volume of 50 µL from each sample was transferred to an individual
well of a 96-well Optiplate™. An equal volume of substrate solution was then added to
each well. The plate was sealed, covered with foil, and incubated at room temperature for
15 minutes with agitation at 700 rpm. The plate was then placed into the plate reader
spectrophotometer and dark adapted for 10 minutes. Luminescence was measured at 570
nm, with the data being exported into Excel for analysis. The positive cell death control
consisted of cell-seeded gels treated with 70% (v/v) methanol for one hour.
5.4 Results
Distraction SCI was modelled in vitro using an input velocity of 100 mm.s−1, and
distraction lengths of 10, 20, and 30% of the gauge length of the gel. Time (s),
experimental displacement (mm), axial command (input displacement, mm), and load
(N) data was recorded by the BOSE and exported to Excel for processing. At Days 1, 7,
and 14 after injury, the gels were processed in order to evaluate a number of astrocyte
responses: cell viability by live/dead staining, metabolic activity using the ATPlite assay,
astrocyte reactivity by immunostaining for GFAP, and expression of CSPGs by
immunolabelling with a CS-56 antibody.
5.4.1 Kinetic Outputs
Following distraction injury, the following kinetic outputs were calculated: the peak
experimental displacement (mm), peak velocity (mm.s−1), peak load (N), and energy
applied (mJ) (Appendix E; Table 6.12). The peak displacement and velocity was
calculated in order to verify the characterisation results in Chapter 3 and ensure that the
correct output values were being achieved with the experimental samples. Because the
hydrogels were cast into pre-manufactured moulds the sample dimensions, including
gauge length, were identical (± 0.01 mm). Therefore, there was no requirement to
calculate the length of each sample before simulating the injury and the input
displacement lengths were the same for each distraction group (Section 5.3.2).
There was little variation in the peak experimental displacement achieved at all
distraction lengths, as demonstrated by the small standard errors (Figure 5.2). The
percentage error was calculated using the input and output displacement value as the
theoretical and experimental values, respectively. The mean percentage error at 10, 20,
and 30% distraction was 3.2, 0.40, and 0.30%, respectively.
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Figure 5.2: Peak experimental displacement achieved at various distraction
lengths. Astrocyte-seeded hydrogels were subjected to distraction injury at 100 mm.s−1
to displacement lengths of 10, 20, and 30%. Data presented as the mean ± SEM and
analysed by one-way ANOVA with Tukey’s post-hoc test. Significance levels * p<0.05.
N=9.
The error in distraction length was greater at 10%, whereas a similar error was
calculated at 20 and 30%. This was attributed to the larger overshoot which was
observed at 10% displacement during the distraction phase (Figure 5.3). However, each
distraction group was significantly different from each other.
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Figure 5.3: Displacement profiles after applying distraction loads at 100
mm.s−1 show a displacement overshoot at 10% distraction during the
distraction phase. Astrocyte-seeded hydrogels were subjected to distraction injury
at 100 mm.s−1 to displacement lengths of 10, 20, and 30%. In the first 50 ms of the
experiment where the distraction was applied to the sample, a displacement overshoot
was observed at 10% displacement and this represented the peak displacement. At 20
and 30% distraction, the peak displacement was not achieved until later during the dwell
phase. Solid coloured lines represent the experimental profiles; dashed lines represent the
input (command) profile. N=9.
As discussed in Chapter 3, a velocity of 1000 mm.s−1 could not be achieved under
tensile forces, thus a velocity of 100 mm.s−1 was used with three different distraction
lengths. Unlike contusion injury, where the impact and peak velocity was calculated, there
was no impact with the distraction injury and so only the peak velocity was calculated.
The input velocity of 100 mm.s−1 was achieved at all distraction lengths (Figure 5.4).
However, an overshoot in velocity was observed in all groups: 107.22 ± 2 mm.s−1 at 10%,
and 115.56 ± 1 mm.s−1 at both 20 and 30%. The error in velocity was 8.33% at 10%
distraction, and 15.56% at 20 and 30% distraction. This was within the range of errors
calculated in the characterisation study in Chapter 3 (Section 3.4.4.1).
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Figure 5.4: Peak experimental velocity achieved at various distraction lengths.
Astrocyte-seeded hydrogels were subjected to distraction injury at 100 mm.s−1 to
displacement lengths of 10, 20, and 30%. Data presented as the mean ± SEM and analysed
by one-way ANOVA with Tukey’s post-hoc test. Significance levels * p<0.05. N=9.
The output load and displacement data was also used to calculate the energy applied
following distraction injury (Figure 5.5). The mean energy applied increased as
distraction length also increased. Further, with each increase in distraction length, there
was a significant increase in energy applied. The mean energy applied increased from
0.057 ± 0.003 at 10% distraction to 0.143 ± 0.01 mJ at 30% distraction. Between 10 and
20% distraction there was a near doubling in energy applied, although the relationship
was not directly proportional.
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Figure 5.5: Mean energy applied scales with the distraction length. Astrocyte-
seeded hydrogels were subjected to distraction injury at 100 mm.s−1 to displacement
lengths of 10, 20, and 30%. Energy applied was calculated by performing a trapezoidal
integration of the area under the curve of the load-displacement curves. Data presented
as the mean ± SEM and analysed by one-way ANOVA with Tukey’s post-hoc test.
Significance levels * p<0.05. N=9.
5.4.2 Primary Astrocyte Behaviour Following a Distraction Injury
Changes in astrocyte morphology in response to mechanical trauma have previously been
shown, both in this project (Chapter 3) and other in vitro studies. However, there has
been no direct comparison of astrocyte behaviour between different injury mechanisms
in those studies. Therefore, a distraction injury was modelled in this study and primary
astrocyte behaviour was evaluated using the same outcome measures as for the contusion
study, including GFAP expression to evaluate morphology, viability, metabolic activity,
and chondroitin sulfate proteoglycan (CSPG) expression. Initial grouping of data by
imaging position was performed in order to determine whether there were any differences
in the outcome measures evaluated based on the location of the gel that was imaged.
However, there were no significant differences and so all the values were analysed together
regardless of location.
5.4.2.1 GFAP Expression and Gross Morphology
The morphology of primary astrocytes was evaluated following distraction injury, using
an input velocity of 100 mm.s−1, and distraction lengths of 10, 20, and 30% of the gel
gauge length. This was achieved through immunolabelling astrocytes with an anti-GFAP


















Figure 5.6: Progression of astrogliosis over 14 days following simulated distraction injury at 100 mm.s−1. Representative maximum
intensity projection images (36 µm depth) of astrocyte-seeded hydrogels subjected to distraction injury. Inset image at 10% Day 7 and 20% Day 1
demonstrates the presence of process beading and swollen cell bodies, respectively. Astrogliosis appeared more severe with increasing distraction length
and time, with astrocytes progressing from less ramified, with distinct domains, to hypertrophied and ramified with domain overlapping (inset Day 14
20%). Cells were labelled with a polyclonal antibody against GFAP (astrocytes, green) and counterstained with DAPI (nuclei, blue). Scale bar represents
50 µm and 10 µm (inset).
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Under control conditions the majority of the cells were GFAP-negative, with few cells
labelling positive with GFAP. These GFAP-positive cells were small and rounded in
morphology, which was maintained over the 14-day period suggesting little reactivity.
Chemical treatment of astrocytes with TGF-β1 resulted in an astrogliosis response as
expected. At Day 1, the majority of GFAP-positive cells remained rounded in
morphology, but were more hypertrophied compared to the astrocytes in the control
group. Evidence of ramification was also observed but not as frequently as astrocytes in
the experimental distraction injury groups on Day 1. With time, the astrocytes became
increasingly more reactive, as shown by the increased ramification of processes,
hypertrophy, and overlapping of domains. GFAP reactivity was calculated by calculating
the percentage of GFAP-positive cells out of the total number of nuclei. Astrocytes in
the experimental groups (injury and TGF-β1) were significantly more GFAP reactive
compared to the control (mean 8 ± 1% GFAP-positive), with a maximum of 21%
GFAP-positive astrocytes (data not shown). There was no significant difference in GFAP
reactivity between the experimental groups.
Upon application of mechanical distraction injury a change in morphology was
observed. From as early as Day 1 post-injury, hypertrophy and ramification was
observed but with little overlapping of domains. Differences in reactivity were observed
between the distraction groups at this time point. For instance, at 10% distraction,
alongside non-reactive cells which were small and rounded there were astrocytes which
were hypertrophied and extended a number of processes. At 30% distraction astrocytes
were observed to be more hypertrophied compared to those at 10% distraction, with
more processes.
As time progressed, the extent of ramification increased and the majority of
GFAP-positive cells appeared morphologically reactive. There was also evidence of
astrocyte process beading and fragmentation (Figure 5.6 inset). At Day 14 post-injury,
astrocytes were observed to possess a higher density of processes (although not
quantified), which were finer and in some cases extended over longer distances compared
to astrocyte processes on Day 1. Further, increased domain overlapping was observed on
Day 14 which contrasts to astrocytes at the earlier timepoints where, although they were
hypertrophied and ramified, there were fewer finer processes and less interdigitation.
Three-dimensional image analysis was performed to measure the volume of GFAP
expressed per cell (Figure 5.7). The mean volume of GFAP expressed per cell for astrocytes
in the control group remained stable throughout the 14-day time period, with no significant
changes (mean volume 587.76 ± 30 µm3 across all time points).
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Figure 5.7: Volume of GFAP expression in astrocytes following simulated
distraction injury at 100 mm.s−1. Data presented as the mean ± SEM and analysed
by two-way ANOVA. All experimental groups were significantly greater than the control
group at each time point (Dunnett’s post-hoc, p<0.05). Significance levels * p<0.05 (20%
vs. 30%, Tukey’s post-hoc); # p<0.05 (10% vs. 30%, Tukey’s post-hoc); † p<0.05 (vs.
TGF-β1, Tukey’s post-hoc). N=3.
At Day 1 post-injury, the GFAP volume of astrocytes in all distraction injury groups
was significantly greater than the control. The mean volume of GFAP expressed per cell
increased significantly from 1134.42 ± 30 at 10% to 1781.22 ± 90 µm3 at 30% distraction.
The GFAP volume of astrocytes in the TGF-β treated group was significantly higher
compared to the control, but significantly lower than the 20 and 30% distraction groups.
At Day 7 post-injury, the volume of GFAP expressed per cell was significantly higher
than the control in all of the experimental groups. Further, there was no significant
difference between any of the experimental groups, with a mean volume of 1671.22 ± 40
µm3 across all groups. A similar trend was observed at Day 14 post-injury as at Day 7:
GFAP volume was significantly higher than the control in all of the experimental groups.
GFAP volume was slightly higher in the 20 and 30% distraction groups but there was no
statistically significant difference between any of the experimental groups.
Considering each displacement group individually, over time, GFAP volume of
astrocytes in the 10 and 20% distraction, and TGF-β1 treated groups increased
significantly at each time point. At 30% distraction, there was no significant change in
GFAP volume between Days 1 and 7 (1781.22 ± 90 µm3 vs. 1773.31 ± 60 µm3, p>0.05),
but there was a significant increase between Days 7 and 14. Astrocyte GFAP volume
was greatest on Day 14 for all experimental groups, with an overall mean volume of
2279.16 ± 60 µm3 across all experimental groups.
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5.4.2.2 Sphericity
The sphericity of the astrocytes, how closely the shape of each cell resembled a perfect
sphere, was another morphological measurement used to describe the reactivity of the cells
in response to distraction injury (see Chapter 4 Section 4.3.6.2 and Equation 4.3). Figure
5.8 illustrates the sphericity of astrocytes, following simulated distraction injury at 100
mm.s−1 and distraction lengths of 10, 20, and 30%, over a 14-day time period. Sphericity
of astrocytes in the control group significantly decreased between Days 7 and 14 (from 0.45
± 0.02 to 0.37 ± 0.02 AU), although remained significantly higher than the experimental
groups.
Figure 5.8: Astrocyte sphericity following simulated distraction injury at 100
mm.s−1. Data presented as the mean ± SEM and analysed by two-way ANOVA. All
experimental groups were significantly lower than the control group at each time point
(Dunnett’s post-hoc, p<0.05). Significance levels * p<0.05 (10% vs. 20%, Tukey’s post-
hoc); # p<0.05 (20% vs. 30%, Tukey’s post-hoc); † p<0.05 (10% vs. 30%, Tukey’s
post-hoc); ‡ p<0.05 (vs. TGF-β1, Tukey’s post-hoc). N=3.
At Day 1 post-injury, the sphericity of astrocytes in all experimental groups was
significantly lower than those in the control group. As the distraction length was
increased, there was also a significant step wise reduction in sphericity, from 0.35 ± 0.02
AU at 10% distraction to 0.26 ± 0.01 AU at 30% distraction. Although sphericity of
astrocytes in the TGF-β1 treated group was significantly lower compared to the control
group, it remained significantly greater compared to the experimental distraction injury
groups (mean 0.40 ± 0.02 AU).
At Day 7 post-injury, the sphericity of astrocytes was significantly reduced to a
similar level, compared to the control group and there were no significant differences in
sphericity between any of the experimental groups. The overall mean sphericity was 0.33
± 0.01 AU across all of the experimental groups. Similarly, sphericity of astrocytes was
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reduced to a similar level in all experimental groups at Day 14 post-injury, with a mean
of 0.24 ± 0.01 AU across all experimental groups.
Considering each experimental group over time, it was observed that the sphericity
of astrocytes in the TGF-β1 treated group significantly decreased at each time point,
from 0.40 ± 0.02 on Day 1 to 0.23 ± 0.01 on Day 14. Conversely, there was no change
in sphericity between Days 1 and 7 at 10 and 20% distraction, and sphericity actually
increased significantly at 30%. Between Days 7 and 14, astrocyte sphericity significantly
decreased in all experimental groups. Further, sphericity was at its lowest on Day 14,
suggesting reactivity was maximal at this time point.
5.4.3 Primary Astrocyte Viability Following Simulated Distraction
Injury
Astrocyte viability was evaluated over 14 days using the
LIVE/DEAD™Viability/Cytotoxicity Assay in order to determine whether tensile forces
resulted in alterations to cell viability. Viability was calculated as the percentage of live
cells out of the total number of live and dead cells counted (Figure 5.9).
Astrocytes in the control group remained viable and viability was stable across the
14-day time period, with an overall mean viability of 82.67 ± 1%. TGF-β1 treatment
had no effect on astrocyte viability over the 14-day time period, with viability being
non-significant compared to the control. The mean viability of astrocytes in this group
was 81.67 ± 1%, across the 14-day time period. Treatment of astrocytes with 70% (v/v)
methanol (positive cell death control) successfully resulted in a significant reduction in
viability compared to the control.
153
Chapter 5. Astrocyte Responses to Distraction SCI In Vitro Section 5.4
Figure 5.9: Astrocyte viability following simulated distraction injury at 100
mm.s−1. Data presented as the mean ± SEM and analysed by two-way ANOVA.
Significance levels * p<0.05 (vs. ctrl, Dunnett’s post-hoc); # p<0.05 (vs. 10%, Tukey’s
post-hoc). N=3.
At Day 1 post-injury, viability was significantly reduced in all distraction injury
groups compared to the control. Viability was lowest in the 10% distraction length
group (54.03 ± 1%); however, there was no significant difference in viability between the
different distraction lengths. At Day 7 post-injury, viability remained significantly lower
than the control at 20 and 30% distraction, but not at 10%. No significant difference
was observed in viability between 20 and 30%, with mean viabilities of 64.17 ± 3% and
63.85 ± 4%, respectively. At Day 14 post-injury, the viability of astrocytes in all of the
experimental distraction injury groups were not significantly different compared to the
control. There were also no significant differences in viability between the distraction
groups.
The viability of astrocytes at each distraction length, over time, was also evaluated.
At Day 1 post-injury, viability in the 10% distraction group decreased significantly but
subsequently recovered to a value which was not significantly different to the control at
Day 7 (75.85 ± 3%). Viability increased significantly by Day 14 (85.76 ± 1%, p<0.05) but
was at a similar level to the control (p>0.05). At 20 and 30% distraction lengths, viability
remained significantly less than the control at both Days 1 and 7 post-injury. Further,
there was no significant change in viability in those groups between Days 1 and 7. At Day
14 post-injury, viability in all distraction injury groups had recovered to values within the
range of the control group.
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5.4.3.1 Primary Astrocyte Metabolic Activity Following Distraction Injury
The ATP content of astrocytes was measured following distraction injury using the
ATPlite™Luminescence Assay System, as described in Section 5.3.7. Metabolic activity
of astrocytes in the control group was observed to increase over time, with activity
significantly increased between Days 1 and 7, but not between Days 7 and 14 (Figure
5.10). Treatment of the cells with 70% (v/v) methanol (positive cell death control)
successfully resulted in a significant reduction in ATP content compared to the control.
Figure 5.10: Astrocyte metabolic activity following simulated distraction
injury at 100 mm.s−1. Data presented as the mean ± SEM and analysed by two-
way ANOVA. Significance levels *p<0.05 (vs. ctrl, Dunnett’s post-hoc); # p<0.05 (10%
vs. 20%, Tukey’s post-hoc); † p<0.05 (20% vs. 30%, Tukey’s post-hoc); ‡ p<0.05
(10% vs. 30%, Tukey’s post-hoc); ∆ p<0.05 (vs. TGF-β1, Tukey’s post-hoc). TGF-
β1 (positive astrogliosis control) and +ve (positive cell death control; 1 hour 70% v/v
methanol treatment). N=3.
At Day 1 post-injury, the ATP content of astrocytes in all of the experimental
distraction injury groups was significantly greater compared to the control. Additionally,
there was a significant step-wise increase in ATP content as the distraction length was
increased. There was no significant difference in ATP content between the control and
TGF-β1 treated groups. At Day 7 post-injury, metabolic activity of astrocytes was
significantly increased at distraction lengths of 20 and 30%, but not 10%. There was no
significant difference in metabolic activity between 20 and 30%, and both groups were
significantly greater than 10% distraction and the TGF-β1 treated groups. At Day 14
post-injury, there was no significant difference in metabolic activity between any of the
distraction groups compared to the control. Astrocytes in TGF-β1 treated gels exhibited
greater metabolic activity than the control and distraction injury groups.
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Over time, astrocyte metabolic activity significantly increased in the TGF-β1 treated
group, from 2.30 x 105 ± 8 x 104 to 5.72 x 105 ± 2 x 104 CPS. On the other hand, metabolic
activity of astrocytes in all distraction injury groups significantly decreased between Days
1 and 7. Activity then plateaued between Days 7 and 14, with no significant change
when comparing each distraction group against time. Metabolic activity of astrocytes
in the distraction injury groups was greatest on Day 1, with the 30% distraction group
exhibiting the greatest activity overall (mean 7.5 x 105 ± 2 x 104 CPS).
5.4.3.2 Chondroitin Sulfate Proteoglycan Expression
Whilst astrocyte morphology has been extensively investigated in vitro in response to
mechanical trauma, CSPG expression has been less frequently evaluated, particularly when
comparing between injury mechanisms. In this study, CSPG expression was evaluated
following distraction injury at 100 mm.s−1 to various distraction lengths. Figure 5.11
illustrates representative images of CS-56 labelling in astrocyte-seeded hydrogels 14 days
following distraction injury at 100 mm.s−1. Quantification of the area of CS-56 labelling
















5.4Figure 5.11: CSPG deposition increases with increasing distraction length but not time at 100 mm.s
−1. Representative maximum intensity
projection images (36 µm depth) of primary rat cortical astrocyte-seeded collagen gels (5 x 105 cells.ml−1) subjected to distraction injury at 100 mm.s −1
and distraction lengths of 0, 10, 20, and 30% of the gauge length, and incubated for 14 days before labelling with a monoclonal antibody against CS-56
(CSPGs, red). Nuclei were counterstained with DAPI in B (blue). Scale bar represents 50 µm.
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CSPG expression by astrocytes in the control group remained stable across the 14-
day time period and was significantly lower than all the experimental groups. Further,
there was no significant change in CSPG expression in the control group over time (mean
1131.18 ± 100 µm2). Astrocytes treated with TGF-β1 responded by expressing CSPG,
which was significantly greater than the control at all time points. As time progressed,
CSPG expression also increased significantly, and expression was maximal on Day 14
(mean 8954.9 ± 600 µm2).
Figure 5.12: CSPG expression by primary astrocytes following simulated
distraction injury at 100 mm.s−1. Primary rat cortical astrocyte-seeded hydrogels
(5 x 105 cells.ml−1) were subjected to distraction injury at 100 mm.s−1 and 10, 20, or 30%
displacement, with immunolabelling for CSPGs performed using a CS-56 antibody. Data
presented as the mean ± SEM and analysed by two-way ANOVA. All experimental groups
were significantly different from the control (Dunnett’s post-hoc, p<0.05). Significance
levels * p<0.05 (10% vs 20%, Tukey’s post-hoc); # p<0.05 (20% vs 30%, Tukey’s post-
hoc); † p<0.05 (10% vs 30%, Tukey’s post-hoc); ‡ p<0.05 (vs. TGF-β1, Tukey’s post-hoc).
TGF-β1 (positive astrogliosis control). N=3.
At Day 1 post-injury, astrocytes in all experimental distraction injury groups
expressed significantly more CSPG compared to the control. As displacement increased,
CSPG expression also increased significantly, from 4156.61 ± 400 µm2 at 10%
distraction to 13367.70 ± 700 µm2 at 30% distraction. CSPG expression in the TGF-β1
treated group was significantly higher than the control group, but significantly lower
than the 20 and 30% distraction groups.
A similar trend in CSPG expression in the distraction injury groups was observed at
Day 7 post-injury: as distraction length increased the mean CSPG area also increased
significantly, from 3808.83 ± 300 µm2 to 11745.02 ± 1000 µm2. The mean CSPG area of
the TGF-β1 treated group was similar to that at 20% distraction (6453.76 ± 200 µm2 vs.
6136.87 ± 600 µm2, respectively; p> 0.05).
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Again, at Day 14 post-injury, the mean CSPG area increased as distraction length
was increased from 10 to 30%, although the increase from 10 to 20% distraction was not
statistically significant (p> 0.05). The mean CSPG area expressed in the TGF-β1
treated group was significantly higher than the 10 and 20% distraction injury groups,
but was significantly lower than the 30% distraction injury group.
Interestingly, there was no significant change in CSPG area with time, when evaluating
each experimental distraction group over time (p>0.05). This contrasts with the TGF-β1
treated group where CSPG area increased over time. Expression was consistently highest
in the 30% distraction group, with an overall mean CSPG area of 12357.40 ± 600 µm2,
over the 14-day time period.
5.4.3.3 Summary of Primary Astrocyte Outcomes Following Distraction
Injury
Overall, mechanical trauma simulating distraction spinal cord injury induced changes in
astrocytes which differed to that of non-injured astrocytes (control). Distraction injury
at 100 mm.s−1 resulted in astrocytes which changed from small and rounded to
hypertrophied and more ramified, with some loss of individual domains. Distraction
length was observed to influence astrocyte reactivity mainly at Day 1 post-injury: as
distraction length increased, GFAP volume increased and sphericity decreased. However,
at the later time points, distraction length had little effect on these outcomes (Figure
5.7).
Similarly, astrocyte viability and metabolic activity was significantly altered in
response to distraction injury, with a significant reduction in viability and significant
increase in metabolic activity occurring at Day 1 post-injury. Distraction length had
little effect on the severity of cell death (Figure 5.9), but did scale with metabolic
activity at Day 1 post-injury (Figure 5.10).
A significant increase in CSPG expression was observed by astrocytes in response to
distraction injury and CSPG area scaled with distraction length at all time points (Figure
5.12). However, there was no change in expression area over time when considering each
distraction group individually. This suggests that although astrocytes in each distraction
group became morphologically more reactive over time (as measured by GFAP volume
and sphericity), this did not affect CSPG expression.
5.4.4 Comparison of Primary Astrocyte Outcomes Following Contusion
and Distraction Injury In Vitro
One of the aims of this research was to evaluate astrocyte behaviour in response to not
only differing biomechanical inputs, but also different mechanisms of TSCI in vitro. As
previous in vivo models of contusion and distraction TSCI have highlighted distinct
patterns of histopathology and behaviour, this research was proposed to determine
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whether mechanism specific differences could be observed at an individual cell
population level in an in vitro model. This could have positive implications for
developing biomechanically faithful models to improve screening of therapeutic
interventions, or to better inform in vivo studies.
Results from Chapter 4 showed that as contusion displacement increased- from 25%
to 75%- the calculated energy applied also increased. An increase in velocity from 100
to 1000 mm.s−1 also resulted in an increase in the energy applied. Similarly, results
here show that as distraction length was increased from 10% to 30%, the mean energy
applied increased from 0.057 to 0.143 mJ (Figure 5.5). It is difficult to compare like for
like the energy applied values between the two injury mechanisms. Limitations in the
mechanical strength of the hydrogel and capabilities of the BOSE meant that the input
velocity and distraction length (displacement) parameters were lowered to values which
did not result in failure of the gel. The distraction lengths used (10, 20, 30%), however,
represented absolute displacement values which were within the upper range of those used
in the contusion study (Table 5.1). Despite this, the calculated energy applied values for
distraction were significantly lower than those for contusion injury.
Table 5.1: Comparison of kinetic outputs between contusion and distraction
injury. The displacement and load data were used to calculate the peak displacement






25% 0.386 ± 0.01 0.150 ± 0.008
100 mm.s−1 50% 0.770 ± 0.01 0.506 ± 0.03
Contusion 75% 1.140 ± 0.05 0.945 ± 0.08
25% 0.361 ± 0.01 0.954 ± 0.05
1000 mm.s−1 50% 0.737 ± 0.02 1.836 ± 0.03
75% 1.159 ± 0.02 3.709 ± 0.1
10% 0.852 ± 0.005 0.057 ± 0.003
Distraction 100 mm.s−1 20% 1.656 ± 0.001 0.108 ± 0.006
30% 2.482 ± 0.0003 0.143 ± 0.01
Differences in the gel geometry, dimensions and injury setup will likely have affected
the mechanical strength of the resulting samples due to collagen’s viscoelastic and
anisotropic properties. For instance, gels prepared for contusion injury were comprised of
300 µL gel solution, which resulted in discs which had a mean thickness of 1.276 ± 0.1
mm. For distraction experiments, a lower volume of gel solution was used to prepare
individual samples for distraction experiments (150 µL). This generated samples which
were much thinner (thickness could not be measured accurately) and significantly harder
to handle due to its softness.
It was previously hypothesised that astrocyte reactivity would increase as energy
applied also increased. However, as described in Chapter 4, the scaled increase in energy
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applied with increasing input velocity and displacement did not result in a proportionate
increase in astrocyte reactivity. Here, a similar observation was made in response to
distraction injury. GFAP volume increased and sphericity decreased with increasing
distraction length, at Day 1 post-injury. However, there were no significant differences in
GFAP volume or sphericity between the distraction lengths at Day 7 and 14. GFAP
volume increased with time, reaching a maximum mean of 2279.16 ± 60 µm3 on Day 14
(across all distraction groups). Correspondingly, sphericity decreased with time,
reflecting the increased ramification of the astrocytes. On the other hand, at Day 1
post-contusion injury, GFAP volume significantly increased but there were no significant
differences between the groups, at both 100 and 1000 mm.s−1. At 100 mm.s−1, GFAP
volume scaled with displacement depth as time progressed.
A comparison between the mean energy applied and astrocyte reactivity (as measured
by GFAP volume per cell) for both contusion and distraction injury was made. This
showed that although less energy was applied to astrocytes which had been subjected to
distraction injury, a greater volume of GFAP was expressed per cell compared to contusion
injury at 100 mm.s−1 (Figure 5.13), although this could be due to the slightly higher
displacement values used for distraction injury. Contusion injury at 1000 mm.s−1 resulted
in greater energy being applied to the astrocytes compared to contusion and distraction
injury at 100 mm.s−1, which also translated into greater astrocyte reactivity.
Figure 5.13: The mean volume of GFAP expressed per cell does not scale
with energy applied. The displacement and load data were used to calculate the peak
displacement and energy applied values. Data presented as the mean ± SEM on a log 2
scale. N=12 (contusion); N=9 (distraction).
In response to both contusion and distraction, alterations in morphology were observed
which were indicative of astrogliosis. One observation was that increased process branching
was associated with increased injury severity and progression of astrogliosis. In response
to both contusion and distraction injury at 100 mm.s−1, there was a gradual progression
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of astrocytes from being small and rounded to increasingly hypertrophied and ramified.
Further, cells occupied distinct domains with little overlapping of processes at earlier
timepoints (Figure 5.14A and B). At later timepoints, however, the extension of a greater
number of and finer processes occurred which then began interdigitating (Figure 5.14D).
Contrastingly, in response to contusion injury at 1000 mm.s−1, astrocytes subjected to
distraction injury exhibited extensive ramification of processes with fine branches and
domain overlapping even at the lower displacement depths and from as early as Day 1
post-injury (Figure 5.14C).
Figure 5.14: Extensive astrocyte process branching develops in response
to increased injury severity. Representative immunofluorescent maximum intensity
projection images of astrocytes in response to contusion injury at 100 mm.s−1-75% Day 1
post-injury (A), distraction injury at 100 mm.s−1-30% Day 1 post-injury (B), contusion
injury at 1000 mm.s−1-50% Day 1 post-injury (C), and distraction injury at 100 mm.s−1-
20% Day 14 post-injury (D). Cells were labelled with a polyclonal antibody against GFAP
(astrocytes, green) and counterstained with DAPI (nuclei, blue). 36 µm depth. Scale bar
represents 50 µm and 10 µm (inset).
Astrocyte susceptibility to cell death was observed to be similar for both contusion
and distraction injury. Both contusion and distraction injury induced significant cell
death at Day 1 post-injury, whereby viability was reduced to overall grouped means of
65.88% (contusion, 100 mm.s−1), 58.19% (contusion, 1000 mm.s−1), and 57.62%
(distraction, 100 mm.s−1). Further, viability had recovered to a level similar to the
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control group for both injury mechanisms by Day 14. Contusion displacement and
distraction length did not have an effect on the extent of cell death.
Both contusion and distraction injury resulted in an increase in ATP content of gels,
suggesting increased metabolic activity. However, there were differences in the amount
of ATP measured over time. In response to contusion injury, in general there was little
change in the metabolic activity of astrocytes for the first 7 days (Figure 4.13).
Significant increases in ATP content were measured at Day 14, at both 100 and 1000
mm.s−1. Displacement depth had little effect on ATP content following contusion injury.
Contrastingly, in response to distraction injury, a significant increase in ATP content
was observed at Day 1 post-injury and this scaled with the distraction length.
Subsequently, metabolic activity decreased and by Day 14 was similar to the control.
Astrocytes expressed and released significantly higher amounts of CSPG in response
to both contusion and distraction injury. However, some differences in expression were
observed between the two injury mechanisms. In response to distraction injury,
astrocytes expressed CSPGs which increased significantly as the distraction length also
increased (Figure 5.12). However, there were no temporal differences in CSPG area. In
response to contusion injury, there was a trend for increased CSPG area with increasing
displacement depth, although this was generally not significant due to the high amount
of variation observed. In contrast to distraction injury, CSPG expression increased with
time (Figure 4.15).
Overall, both contusion and distraction injury induced an astrogliosis response in
primary astrocytes in this in vitro model of TSCI, and there were some similarities in
astrocyte responses. For instance, both injury mechanisms elicited significant cell death
at earlier timepoints (Day 1). However, there were also differences in astrocyte
behaviour which were mainly temporal. Displacement appeared to influence astrocyte
responses at earlier time points for distraction injury; whereas displacement had less of a
clear influence on astrocyte reactivity in response to contusion injury.
5.5 Discussion
The aims of this chapter were to apply the distraction injury protocol, developed in
Chapter 3, to primary astrocyte-seeded hydrogels and evaluate responses of the
astrocytes to a range of input displacement values in vitro. Over 14 days, astrocyte
responses were evaluated through a range of assays to evaluate astrocyte morphology,
viability, metabolic activity, and secretion of chondroitin sulfate proteoglycans (CSPG).
5.5.1 Biomechanics of Distraction Injury In Vitro
The input velocity and distraction lengths used in this study were successfully achieved
with accuracy and repeatability similar to that demonstrated in previous results
(Chapter 3). In this study, distraction of experimental samples at 10% resulted in a
mean peak velocity of 107.22 ± 2 mm.s−1. In Chapter 3, an undershoot in velocity was
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observed at 10% distraction with the gel (90.00 mm.s−1). This was significantly lower
than the velocity measured at 20 and 30% distraction, and lower than the velocity
measured in this study. One reason for this could be that misalignment of the
distraction mould pieces in the previous study may have introduced friction which could
have prevented the input velocity from being achieved experimentally. However, an
overshoot in velocity was achieved in this study. A higher error in displacement was also
calculated at 10% distraction compared to the other groups, which could be attributed
to the larger overshoot observed (Figure 5.3). Improved tuning may reduce the amount
of error in displacement.
The simple design of the hydrogel and mould meant it was suitable for distraction
studies using the BOSE and no issues were experienced with securing the mould into the
grips or maintaining security and alignment of the pieces during the experiment.
However, distraction injuries modelled in vivo are significantly more complex due to the
spinal cord being enclosed within a rigid spinal column. High variability has been
observed in animal outcomes following distraction injury in vivo. This is predominantly
due to the experimental setup, where clamps are used to hold the transverse processes,
and the distraction injury is applied indirectly to the cord (Chen et al., 2016; Choo et
al., 2007). Maintaining clamp-vertebrae integrity was shown to be difficult, with slippage
occurring on occasion.
The loads measured in in vivo distraction models were significantly higher than those
measured in this study, and were greater than loads measured for other injury
mechanisms such as contusion and dislocation. Choo et al., (2007) modelled contusion,
fracture-dislocation and flexion-distraction at 100 mm.s−1, in rats, and measured mean
loads of 2.0, 20.7, and 38.6 N, respectively. The displacement parameters varied between
each mechanism, all of which were aimed at producing a moderate injury. Chen et al.,
(2016) also modelled these three mechanisms in rats using an input velocity of 1000
mm.s−1 and observed the same pattern of load, whereby distraction injury resulted in
the greatest load measured out of the three mechanisms (mean 52.2 N). Notably in these
studies, load was applied to the vertebral column for dislocation and flexion-distraction
mechanisms, thus the loads measured were greater than the loads measured in this study.
There were no measurements of load or energy applied directly from the cord, so it is
difficult to compare to this study.
The energy applied parameter calculated in this study revealed that distraction
injury resulted in lower energies compared to contusion injury. Collagen hydrogels
exhibit viscoelastic and anisotropic properties which explains the differing responses of
the material under compression and tension. Strain stiffening occurs whereby the matrix
becomes stiffer under higher strain rates (Nam et al., 2016). As mechanosensitive cells,
astrocytes may have responded to this by altering their behaviour and becoming more
reactive.
One objective with this study was to use the same input parameters used in the
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contusion study for the distraction study here. This would have enabled a direct
comparison of the load and energy applied measurements and subsequently astrocyte
responses between the two injury mechanisms. However, results from Chapter 3 showed
that the gel was too weak to withstand tensile displacement of more than 35%. Further,
the BOSE was incapable of reaching a velocity of 1000 mm.s−1 so only a velocity of 100
mm.s−1 was used. The range of distraction lengths used in this study did, however,
represent absolute lengths which were within the range of displacement depths used in
the contusion study.
5.5.1.1 Astrocyte Behaviour
There is little research where the effects of pure tensile forces have been evaluated in the
CNS in vitro. Instead, stretch models have been extensively used, particularly in
modelling traumatic brain injuries (TBI). Stretch models involve the application of shear
strain to a specimen and has been applied to astrocytes in multiple studies in vitro
(Ahmed et al., 2000; Cullen et al., 2007; Floyd et al., 2001; McKinney et al., 1996).
Astrogliosis has been modelled extensively in vitro using various mechanical and chemical
means, but not using tensile loading. Results in this study show that distraction of
astrocyte-seeded gels resulted in significant alterations to astrocyte morphology. These
alterations were also observed in the same model in response to contusion injury
(Chapter 4), and is consistent with astrogliotic responses observed in other research
(Cullen et al., 2007; East et al., 2009; Kirk, 2018; Smith, 2016; Yu et al., 2012).
Cullen et al., (2007) applied different shear strain rates (10, 20, 30 s−1) to 3D
co-cultures of primary neurons and astrocytes at 0.50 strain and assessed reactivity,
viability and CSPG expression 48 hours following injury. Increased GFAP expression,
hypertrophy, and ramification was observed. However, process density was only
significantly higher than the control in the 10 s−1 and the TGF-β1 treated group as
there was high variation in the data. Other reasons could be the short timescale of the
analysis (48 hours) and relatively low strain rates which may not have induced a
significant change at earlier time points. Higher strain rates were used in this study
which resulted in an immediate (24 hours) increase in GFAP volume. The authors did
state that a significant increase in process density was observed at 5 days post-injury,
but data was not shown. Further, they reasoned that a high severity injury may have
necessitated a recovery period, after which process density increased significantly. The
results of this study do not support this argument, since significant increases in GFAP
volume were observed at all distraction lengths from Day 1 post-injury. Although
process density was not measured here, ramification was observed at Day 1 post-injury
which corresponded with a decrease in sphericity.
Fragmentation and beading of astrocyte processes was observed in some cells
following distraction injury, although this was not widespread (Figure 5.6). These
observations could be associated with clasmatodendrosis, which also include cytoplasmic
swelling and vacuolation (Duchen, 1992). The term has mainly been discussed in studies
regarding pathologies in the brain, such as Alzheimer’s and dementia (Sahlas et al., 2002;
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Tomimoto et al., 1997), and trauma (Sakai et al., 2013). Process beading and
fragmentation has also been observed in human astrocytes in vitro in response to
stretch-induced injury using a pressure pulse (Halford et al., 2017). Further, a lumbar
crush injury was performed to model compression injury in mice and histology results
showed evidence of disintegrating and beaded astrocyte processes in both the white and
grey matter, 3 days post-injury (Levine et al., 2016). As process damage was not
observed in all samples in this study, it may not be a prominent feature of astrogliosis in
response to distraction injury.
Cullen et al., (2007) also measured viability using the live/dead assay, and found
that viability was reduced to approximately 65% 48 hours following the highest shear
strain deformation (30 s−1). However, further analysis showed that astrocyte viability
was not significantly affected, suggesting the majority of cell death was not occurring in
the astrocyte population. In this study, viability of astrocytes was significantly reduced
at 24 hours post-injury (mean 54.03 – 62.47%) and subsequently recovered by Day 7
onwards. Different strain rates were used compared to this study, which may have
affected the susceptibility of astrocytes to deformation. Further, as viability was
measured at 48 hours by Cullen et al., (2007), it is unknown whether alterations in
astrocyte viability occur at a much more acute timeframe, and/or whether the presence
of neurons contributes to astrocyte cell survival.
In this study, ATP content significantly increased one day following distraction
injury, and subsequently decreased at the later timepoints. There was no significant
change in cell density suggesting proliferation was not significant, although it was
expected as a process which is part of astrogliosis. The increase in ATP content at Day 1
post-injury was thus not associated with proliferation. Ahmed et al., (2000) used an in
vitro model of stretch injury with astrocytes cultured on deformable silastic membranes
and observed a significant decline in ATP content 15 minutes following injury. However,
this had recovered by 24 hours. In an in vitro model of traumatic brain injury, Geddes et
al., (2003) cultured primary rat neurons on silicone substrate which were then subjected
to stretch injury (10 s−1, 0.30 strain). Intracellular ATP was quantified using a
luciferin/luciferase assay which revealed a reduction of ATP of up to 40% 60 minutes
post-injury- however, ATP levels had recovered by 24 hours. Although a different neural
cell type was used in the Geddes et al., (2003) study, both of these studies suggest that
ATP dynamics may occur at much more acute timescales (< 24 hours).
There is a complexity associated with metabolic activity in astrocytes following
induction of astrogliosis, and the ATPlite assay may be confounded by the variety of
astrogliotic responses, including increased protein expression (e.g. GFAP), cell damage,
death, proliferation, and inflammation that also occur over a range of timescales (Burda
and Sofroniew, 2014). This necessitates the use of assays which are more targeted. For
instance, analysis of proliferation could be achieved using a bromodeoxyuridine (BrdU)
cell proliferation assay, utilising a thymidine analog which is incorporated into newly
synthesised of actively proliferating cells. Additionally, markers of astrocyte damage
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could be evaluated, such as cell permeability and proteins released into the medium.
The results of this study showed that distraction injury induced an astrogliosis response
in an isolated culture of primary astrocytes in vitro. However, there is a need for more
quantitative measures of astrogliosis, such as gene expression, which would provide a
more detailed picture of the profile of astrogliosis. Other features of astrogliosis, including
inflammatory responses could be evaluated by measuring cytokine expression in the cell
culture medium. Cytokine expression by ELISA was not used in this study due to its
limited sensitivity for detecting measurable levels of cytokines in response to contusion
injury. Further, smaller gels were used and the size of the moulds necessitated the use
of larger well-plates, thus more cell culture medium was required to overlay the gels.
Therefore, the cytokines would have been further diluted.
5.5.1.2 Contusion vs. Distraction Injury
Limited data is available regarding the behaviour of astrocytes in a direct comparison of
contusion and distraction injury mechanisms. Cullen et al., (2011) compared astrocyte
viability 48 hours following bulk shear or compression at various strain rates in vitro
(0.50 shear/compressive strain; 1, 10, 30 s−1). Shear loading significantly reduced the
percentage of viable cells at 30 s−1, although there was no significant difference between
shear or compression. However, shear deformation induced significantly higher cell death
compared to compression at 10 and 30 s−1 strain rate. In this study, there was no
difference in astrocyte viability between contusion and distraction, with a similar
reduction in viability observed at Day 1 post-injury, which then subsequently recovered
by Day 14. Higher strain rates were used in this study which could have exceeded the
threshold(s) of cell death for both mechanisms.
Additionally, Cullen et al., (2011) observed that the extent of membrane damage was
not significantly different between shear and compression, but there were differences in
calcein uptake: more calcein was present in the cellular processes following shear
deformation compared to compression, suggesting that the processes could be more
susceptible to, and loading thresholds lower, for shear. Membrane damage was not
evaluated in this project and different displacements were used for each mechanism, but
there were differences in the volume of GFAP expressed between both mechanisms at
100 mm.s−1. For instance, displacement affected GFAP volume at Day 1 post-injury for
distraction but not for contusion injury. Conversely, displacement affected GFAP
volume at Days 7 and 14 for contusion but not distraction injury.
In this study, distraction injury induced increased CSPG release, which also
increased with increasing distraction length. However, there were no temporal
differences in CSPG area. Contrastingly, CSPG expression generally increased with
displacement (although not always significant) in response to contusion, which also
increased with time. Further, a higher contusion velocity (1000 mm.s−1) did not result
in greater CSPG expression compared to lower velocity (100 mm.s−1). This suggests
that there are potentially additional aspects of astrogliosis, which were not evaluated,
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influencing CSPG dynamics. Molecular and genetic analysis of astrocytes and their
products may provide more information on how astrocytes control CSPG expression.
Cullen et al., (2007) showed that CSPG expression was not significantly different from
the control, 48 hours following shear deformation. It was suggested that the injury was
too severe to induce astrogliosis mediated CSPG expression which does not agree with
the results of this study. CSPG expression has not been extensively evaluated in vivo,
with more focus on gross tissue damage and the analysis of neuronal pathologies as they
are common targets of therapeutic interventions.
There are also few studies showing the direct comparison of different SCI
mechanisms in vivo. Chen et al., (2016) used the UBC rig to model cervical contusion,
distraction, and dislocation in rats and results showed the lesion extent was greater
following distraction compared to contusion and dislocation injury. Another observation
made was that tissue damage was more diffuse at earlier time points in the study
following distraction injury: significant haemorrhage and plasma membrane compromise
was apparent as early as 5 minutes and 3 hours post-injury, whereas it was not as
apparent following contusion and dislocation injury. The injury mechanism was also
shown to affect different cell populations in different ways: contusion injury resulted in
the greatest loss of myelinated axons in the dorsal white matter, whereas distraction
injury spared the most myelinated axons. It would be interesting to investigate the
effects of different injury mechanisms on multiple cell types in vitro in the model used in
this study. The more diffuse injury caused by distraction injury could contribute to the
reason why astrocyte volume increased and sphericity decreased to a greater extent at
Day 1 post-injury, compared to contusion injury at the same velocity (100 mm.s−1), in
this study.
It is difficult to discuss the results in this study in the context of in vivo research as
different outcome measures were used and acute astrogliosis is not frequently evaluated.
However, the results here show that, in isolation, astrocytes do not respond in the same
way to different mechanisms of deformation. Taking into consideration the biomechanics
of injury in the design of a SCI model is important for understanding the heterogeneity
of pathophysiological mechanisms underlying SCI. As astrocytes are known to be key for
the survival and proper functioning of other cells, including neurons, cell-cell interactions
and downstream responses are likely to be influenced by these acute changes in astrocyte
behaviour and knowledge of this may aid predictions about the nature of the injury
microenvironment.
5.5.1.3 Experimental Model and Setup
The original design of the gel cavity of the distraction mould for this study was
developed previously in order to generate self-aligned Schwann cell-fibroblast, and
astrocyte-neuron seeded collagen type-I hydrogels (Phillips and Brown, 2011).
Treatment of astrocyte-seeded gels in this tethered mould with TGFβ1 was shown to
induce astrocytes to contract the matrix and elongate, arranging themselves along the
longitudinal axis of the gel. Alignment was not introduced into the model in this study
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as a baseline non-reactive state was required in order to measure the expression of GFAP
in response to mechanical injury. The addition of TGF-β1 to induce alignment would
have generated cultures which were reactive prior to application of a mechanical injury.
However, replicating the spatial organisation of cells in the CNS, including the organised
tracts of the spinal cord, would provide a model that is more representative of native
spinal cord. Further, Cullen and LaPlaca (2006) showed that bulk deformation of 3D
matrices resulted in localised cellular strain that was a function of cell orientation.
Distraction injuries observed in humans are typically biaxial; however, the apparatus
used in this study was limited to applying tensile forces uniaxially. Geddes-Klein et al.,
(2006) applied uni and biaxial stretch to embryonic rat cortical neurons cultured on an
elastic substrate and demonstrated increased membrane permeability and cytoplasmic
calcium levels were significantly higher (indicating neuronal dysfunction) in biaxially
stretched neurons compared to uniaxial. This highlights the sensitivity of cellular
responses to the type of injury modelled and that this can be demonstrated in vitro.
5.6 Conclusions
Mechanical trauma simulating distraction injury in vitro, using the BOSE 5110
Electroforce BioDynamic apparatus, resulted in morphological changes in astrocytes
which were characteristic of astrogliosis observed elsewhere in vitro and in vivo. Multiple
aspects of astrogliosis were modelled in vitro, with an isolated population of astrocytes in
a 3D hydrogel. Further, use of this model to simulate two different TSCI mechanisms,
contusion and distraction, revealed differences in astrocyte pathology which warrant
further investigation to probe the mechanisms behind this. This chapter addressed the
main objectives of the project, which were to evaluate the biological responses of
astrocytes to simulated contusion and distraction injury, and to investigate the
relationship between the primary mechanical input and responses of primary astrocytes
cultured in isolation (Chapter 1).
The specific objectives set out in this chapter were met with the following observations:
I. Verify the accuracy and precision of the BOSE 5110 Electroforce BioDynamic
(BOSE) under distraction forces:
• The input displacement and velocity parameters were achieved with high
precision and accuracy and matched the data from Chapter 3.
II. Calculate the kinetic outputs following distraction injury:
• Energy applied was calculated using the load displacement graphs, which
showed a significant step-wise increase in energy applied with increasing
distraction length.
III. Evaluate the responses of primary astrocytes to distraction injury:
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• Astrocytes responded to mechanical injury in a variety of ways which were
characteristic of astrogliosis. Morphologically, astrocytes became
hypertrophied, ramified, and overlapping of domains was observed, suggesting
a more severe reactive response.
• Reactive astrocytes in experimental groups expressed CSPGs at a greater level
compared to the control group.
• Significant cell death was observed at Day 1 post-injury and ATP content was
significantly increased at Day 1 post-injury.
IV. Compare the responses of primary astrocytes to distraction against TGF-β1:
• Astrogliotic related alterations in morphology occurred earlier in response to
distraction injury compared to astrocytes treated with TGF-β1 (positive
astrogliosis control).
V. Compare the behaviour of astrocytes in response to contusion and distraction injury:
• Temporal differences in the progression of astrogliosis was observed between
contusion and distraction injury.
Several null hypotheses were also postulated at the beginning of the study:
I. There is no statistical difference between the reactivity of astrocytes in response to
distraction injury compared to no injury (control):
• Mechanical simulation of distraction injury induced astrocyte changes which
were consistent with astrogliosis and which was not observed in the control
groups.
II. There is no statistically significant relationship between distraction length and
astrocyte reactivity:
• An increase in distraction length resulted in a corresponding increase in
astrocyte reactivity at Day 1 post-injury. At later timepoints, distraction
length did not affect the severity of astrogliosis.
III. There is no statistically significant relationship between astrocyte reactivity and time
following distraction injury:
• The astrogliosis response progressed over time, in terms of GFAP volume and
metabolic activity. At each distraction length, CSPG expression did not




Traumatic spinal cord injury (TSCI) remains a highly complex injury to manage and
treat effectively. Where a greater understanding of the epidemiology of TSCI has led to
improved implementation of injury prevention strategies, it is unlikely that the TSCI
itself can be completely eliminated. The unexpected and devastating nature of this high
energy event means time is of the essence when it comes to treating the cord injury,
whilst also managing the patient’s comorbidities, including maintaining the airway and
stabilising the vertebral column. Effective treatment(s) for TSCI with improved
neurological outcomes remains elusive despite the promising number of preclinical
studies (Tator, 2006; Varma et al., 2013). One important reason for this is the complex
and heterogeneous nature of human TSCI, which is under-represented in TSCI models,
and even a clinically relevant animal model reflects only a small proportion of TSCI
cases in humans.
Greater effort is being put into implementing a more coordinated approach to
understanding and treating TSCI, including a better understanding of the relationship
between injury mechanics and secondary pathophysiology (Mattucci et al., 2019). Since
the biomechanics of human TSCI cannot be measured at the point of injury,
experimental models were developed to replicate the clinical injury scenario in vivo and
in vitro (Sharif-Alhoseini et al., 2017; Slovinska et al., 2016). These models are
predominantly used to model specific aspects of the secondary pathophysiological
cascade, thus the input biomechanical parameters are tailored based on that. Less
emphasis has been placed upon how injury biomechanics itself contribute to the
secondary response, particularly for evaluating thresholds in different cell populations.
For instance, transection models were primarily developed to evaluate axon
regeneration and test therapeutic interventions (Spillmann et al., 1997). However,
transection injuries, particularly complete transection, are not commonly observed in
humans thus lacks clinical relevance. Further, as animal models are continually being
refined, more consideration is being placed upon using more accurate biomechanical
models as evidence emerges of mechanically distinct damage patterns and pathologies
(Bhatnagar et al., 2016; Chen et al., 2016; Choo et al., 2008, 2007). Decoupling of
biomechanical parameters, including velocity, displacement, and force has been a
challenge for those designing the tools to simulate trauma.
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The rationale for this research was that different mechanisms of TSCI result in different
biological responses, and it was hypothesised that this would be reflected at an individual
cell population level in vitro. Primary rat cortical astrocytes were selected as astrocytes
play a major role in the formation of the glial scar, which has been a therapeutic target both
through attenuating scar formation or modulating scar-associated inhibitory molecules
(Bradbury and Burnside, 2019).
6.1 In Vitro Modelling of TSCI
The rationale for using collagen hydrogels as an in vitro system to model TSCI was that
it is an easily available biomimetic substrate with intrinsic cell attachment motifs,
possesses proven cytocompatibility with neural cells, and astrocytes maintain a
non-reactive state over a prolonged period of time in them (East et al., 2007, 2009; Kirk,
2018; Smith, 2016). Here, astrocytes remained viable in three-dimensional (3D) culture
in collagen hydrogels over the 14-day time period of the study. The astrocytes were also
maintained in a non-reactive state in the non-injured samples. 3D culture systems, such
as hydrogels, were selected over 2D culture systems since stiff substrates, such as tissue
culture plastic, have been shown to induce an astrogliosis response (East et al., 2009;
Georges et al., 2006; Wilson et al., 2016). In vitro models also allow greater control of
experimental conditions compared to in vivo animal models of TSCI. Further, the
cellular complexity of the spinal cord means that it would be difficult to isolate specific
cellular effects, and cells may also influence each other behaviourally which is a
confounding factor.
The in vitro model used in this project was adapted and enhanced from previous
research at The University of Leeds to simulate clinically relevant contusion and
distraction injury events, using the BOSE 5110 Electroforce BioDynamic (BOSE)
materials testing machine, with independent control of input velocity and displacement
depth/length. Similar models of the BOSE 5110 have previously been used to
characterise the mechanical properties of hydrogels at low strain rates, and there is one
published study using the BOSE TestBench™system to model contusion injury in vivo
(Chapter 1; Section 1.8.2.1). However, the limitations of these studies are that the strain
rates used are not clinically relevant, or errors of up to 73% in the velocity were
measured for the in vivo study (Salegio et al., 2016).
Kirk (2018) used the BOSE 5110 to overcome the technical limitations associated
with the Infinite Horizons impactor in modelling contusion injury in vitro, namely the
lack of independent control over displacement and velocity, and variable output force
data. The aim of that study was to investigate the effects of extracellular matrix (ECM)
stiffness on neural cell behaviour, and modelled focal contusion injury on primary
astrocyte and microglia-seeded collagen hydrogels. Alterations in cellular metabolism
and GFAP expression were observed, indicating the appropriateness of the BOSE for
modelling TSCI in vitro. However, verification of the velocity and displacement
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parameters was not fully performed.
Building on from this, the results in Chapter 3 in this study demonstrate more
in-depth characterisation and verification of the accuracy and precision of the BOSE,
under compressive and tensile configurations. Under compressive and tensile strains, the
BOSE was accurate and precise, achieving the desired maximum input displacement
value. A velocity of 1000 mm.s−1 was achievable under compression, which demonstrated
that the input velocity of 3000 mm.s−1 used by Kirk (2018) was unlikely to have been
achieved. Distraction injury has not been previously modelled using the BOSE, and
work was undertaken to adapt an existing hydrogel mould which could be used to cast
the hydrogel and loaded into the BOSE rig to have the distraction load applied. The
distraction length range selected (10, 20, 30% of the gauge length, 8.25 mm) required a
maximum distraction length of 2.475 mm (30%). Results from Chapter 3 showed that a
maximum velocity of 300 mm.s−1 could be achieved at this distraction length. Because
both the tensile grips were coupled to the mould, the distraction injury was effectively
the entire stroke length available to accelerate. In contusion injury, only one platen was
coupled to the sample; thus, the working distance was increased to allow the actuator to
accelerate to the desired velocity. Therefore, although the velocity of both contusion and
distraction injury modelled was within the range of those measured in vivo (Chapter 1
Table 1.5), a limitation of the distraction study in Chapter 5 was that the velocity
modelled was towards the lower end of the range and only one velocity was tested.
Astrocytes, and other neural cells, are mechanosensitive cells and substrate stiffness
has been shown to affect their reactivity, as mentioned previously. The mechanical
properties of the collagen hydrogel used in this project (2 mg.mL −1, First Link UK Ltd.)
were previously evaluated by Smith (2016) at The University of Leeds (Chapter 1 Table
1.7). Using oscillatory rheometry, its elastic modulus was calculated to be 55.19 Pa (1%
strain, 1 Hz, 2 x 106 p.mL−1 primary astrocytes). Other mechanical analyses of collagen
hydrogels reported moduli ranging from 4 Pa to 1.5 MPa. There is large variation in
these values due to the different concentrations of collagen, testing method, and testing
parameters used such as strain and strain rate. The higher modulus values can also be
attributed to modifications to the collagen hydrogels, such as incorporating plastic
compression or functionalisation. The values for fully hydrated collagen hydrogels of the
same concentration used in this project are substantially softer than the reported
stiffness values of human (40.12 kPa – 1.40 MPa) spinal cord (Chapter 1 Section 1.3).
The effects of matrix stiffness on the progression of astrogliosis in vitro is not fully
known. Further, type-I collagen is not a major component of the CNS matrix, which is
predominantly composed of glycosaminoglycans (GAGs) and proteoglycans (Chapter 1
Section 1.2.2). However, the collagen hydrogels used in this study supported cell
attachment, low baseline astrocyte reactivity and survival, and similarly in other studies
as well (East et al., 2007, 2009; Georgiou et al., 2013; Phillips et al., 2005). In future,
however, a more biologically and mechanically relevant substrate should be evaluated.
One of the aims of this project was to evaluate the relationship between injury
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mechanisms and mechanics on astrocyte outcomes in vitro. Mechanical parameters did
influence astrocyte reactivity: an increase in contusion velocity from 100 to 1000 mm.s−1
resulted in an increase in astrocyte reactivity, as measured via GFAP volume, sphericity
and CSPG expression. Sparrey et al., (2008) and Maikos and Shreiber (2007) both
demonstrated velocity dependent disruption to the white matter and blood-spinal cord
barrier (BSCB), respectively. Further, an increase in contusion displacement depth
resulted in an increase in astrocyte reactivity at 100 mm.s−1 in this study, and other
studies have also shown displacement related increases in SC damage (Pearse et al.,
2005).
However, interactive effects between displacement and velocity has been
demonstrated by Lam et al., (2014), which the other studies have not shown as both
displacement and velocity were not varied independently. Lam et al., (2014) showed that
increasing contusion velocity from 8 to 800 mm.s−1 resulted in increased behavioural
deficit and reduced tissue sparing but only at the higher displacement depths (1.5 mm),
suggesting the lower displacement depth (0.9 mm) was below the threshold with which
significant differences in increased velocity would be observed. In this study, an increase
in contusion velocity resulted in increased astrocyte reactivity at all displacement depths,
suggesting the depths used were great enough to elicit significant changes in astrocyte
reactivity with increasing velocity.
Results from the contusion study here showed a step-wise increase in load with
displacement depth and velocity (Chapter 4 and Appendix E Table 6.10). Despite the
significant increase in load between 100 mm.s−1 – 75% and 1000 mm.s−1 – 25%, there
was no significant difference in the energy applied. However, differences in astrocyte
reactivity were observed between these two injury groups (Chapter 4 Table 4.2):
astrocytes in the 1000 mm.s−1 – 25% group expressed a significantly larger volume of
GFAP per cell. This could be attributed to the increased stiffness response of the
hydrogel at higher velocities due to the viscoelastic nature of collagen hydrogels
(Chandran and Barocas, 2004; Fratzl, 2008; Motte and Kaufman, 2013). At high strain
rates the elastic response dominates, and the gel exhibits an increased elastic modulus.
Since astrocytes are mechanosensitive cells, this increased stiffness may induce or
contribute to the initiation of astrogliosis.
For distraction injury, only one velocity was tested: 100 mm.s−1 so it is difficult to
determine whether velocity could be a dominant parameter. Load and energy applied
increased significantly with an increase in distraction length. Displacement length had
little influence on astrocyte GFAP volume and sphericity after Day 1 post-injury, but did
influence CSPG release at all time points. It is still unclear precisely how each
biomechanical parameter influences astrocyte reactivity and the interaction between
them in different injury mechanisms, thus more research is required which includes
testing more input velocities.
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6.2 Mechanistic Insights into Astrogliosis
Astrogliosis comprises a spectrum of alterations that appear to be induced by both the
type and severity of injury, and has been modelled using a variety of methods, including
mechanical trauma and chemical stimuli. In this project, results showed that mechanical
trauma induced a more severe astrogliosis response compared to TGF-β1 treated cells
(10 ng.mL−1), with more GFAP and CSPG being expressed particularly at the higher
velocities and displacements (Chapters 4 and 5). A difference in viability was also
observed between mechanically and chemically treated astrocytes: TGF-β1 treatment
did not significantly affect cell viability, whereas both contusion and distraction injury
induced a significant reduction in viability 24 hours post-injury.
Chemical induction of astrogliosis through the treatment of astrocytes with TGF-β1
has been used in multiple studies in vitro (Cullen et al., 2007; East et al., 2009; Kirk,
2018; Smith, 2016; Yu et al., 2012) and in vivo (Logan et al., 1994). All the studies
showed that TGF-β treatment resulted in astrocyte responses considered as
characteristic markers of astrogliosis, including increased GFAP expression, cellular
hypertrophy, and scar formation. Cullen et al., (2007) compared astrocyte-neuron
co-cultures which had been treated with TGF-β1 (10 ng.mL−1) or subjected to shear
deformation at various strain rates. Both mechanisms induced astrocyte hypertrophy
and increased GFAP and CSPG expression after 48 hours. However, viability was not
adversely affected by TGF-β1 48 hours following treatment, which agrees with the
results of this project. Other chemical inducers of astrogliosis, such as bacterial
lipopolysaccharides (LPS) have also been shown to induce astrogliosis, but not affect
viability (Acaz-Fonseca et al., 2019; Brahmachari et al., 2006; Guerra et al., 2011; Kirk,
2018). This suggests that some chemicals considered inducers of astrogliosis may not
activate cell death pathways, thus does not faithfully represent all aspects of astrogliosis.
Results in this project showed that an immediate morphological and biological
change in astrocytes was observed in response to mechanical trauma, with an increase in
GFAP volume occurring from Day 1 post-contusion and distraction. GFAP volume also
significantly increased in TGF-β1-treated astrocytes, although never to an extent that
was greater than mechanical injury. Other research has also suggested that astrocyte
activation can occur within a matter of hours following injury, as shown by the increase
in expression of multiple activation markers such as GFAP, CSPG, pSTAT3, and NF-κb
(Brambilla et al., 2005; O’Callaghan et al., 2014). However, other research has suggested
that severe injury results in delayed astrogliosis (Cullen et al., 2007). At the higher
strain rates (30 s−1), cell viability decreased but with no concomitant increase in CSPG
deposition or hypertrophic processes at 48 hours post-injury. One potential reason for
this conflicting result is the lack of cellular complexity of the model used in this project.
Signalling from other cell types, such as neurons and microglia could influence the
temporal progression of astrogliosis.
Mechanical trauma is known to induce a robust and well-studied astrogliosis response
and scar formation in vivo. However, few studies have directly compared astrocyte
175
Chapter 6. General Discussion Section 6.2
responses to different mechanisms of TSCI. Choo et al., (2008) modelled contusion,
dislocation and distraction mechanisms in rats and observed increased GFAP
immunoreactivity from 3 hours following injury. Although there was a trend for
increased GFAP area following contusion injury, this was not significantly different from
the other mechanisms. Reactive astrocytes were largely confined to the lesion epicentre
following contusion injury, whereas there was more rostral-caudal extension of reactive
astrocytes following dislocation and distraction injury. As the contusion injury modelled
in Chapter 3 was not a focal contusion, a defined lesion with a border was lacking and
this limited the evaluation of the distribution of reactive astrocytes. It is important to
note that although mechanical insult has induced multiple responses indicative of
astrogliosis, in an isolated population of astrocytes, this is not fully representative of the
whole process, which is a multicellular process.
It is also recognised that human SCI is likely to involve multiple types of strain- such
as shear and compressive strains experienced during a dislocation SCI- which compounds
the complexity of developing truly representative models of TSCI. Force and strain
distribution to the spinal cord varies depending on the injury mechanism and it is
difficult to directly compare physiological and behavioural outcomes of different injury
mechanisms as they will likely be of varying severity as well. It would be a challenge to
model different injury mechanisms with the same force distribution due to the
experimental setup, particularly the closed column nature of distraction injury compared
to the open nature (via laminectomy) of contusion in vivo. This has yet to be achieved,
although Park et al., (2016) attempted to accommodate for the differences of two
contusion SCI devices- the New York University (NYU) impactor and the Infinite
Horizon (IH) impactor- by determining their equivalent parameters.
Direct strain transfer to astrocytes in this study may be an initiating factor for
astrogliotic alterations via mechanotransduction: the process by which cells convert
mechanical stimuli into changes in intracellular signalling (Hamill and Martinac, 2001).
When mechanical force is applied directly to the hydrogel, the resulting strain can be
translated to the cells via focal adhesions which mediate cell attachment to the matrix
(Ahearne, 2014; Bowman et al., 1992). Mechanotransduction may be initiated in a
variety of ways, such as through deformation of ion channels, changes in the cytoskeletal
structure, and/or activation of integrin-mediated signalling pathways (Alenghat and
Ingber, 2002; Cullen et al., 2007). These signalling pathways can regulate changes in
gene expression which ultimately modify cellular behaviour, such as migration and
proliferation. Astrogliotic induction mechanisms may also involve biochemical processes,
such as autocrine and paracrine signalling involving factors like glutamate or ATP
(Ahmed et al., 2000; Cullen et al., 2007; Neary et al., 2003).
Astrogliosis has been depicted as a finely regulated collection of processes along a
gradient of severity, rather than an all-or-nothing event with a single threshold
(Sofroniew, 2015). It can be broadly categorised ranging from mild to moderate, where
cytoskeletal hypertrophy is initiated but with preservation of domains and without
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proliferation, to severe diffuse astrogliosis which is characterised by significant GFAP
upregulation, cytoskeletal hypertrophy, and some domain overlapping. Severe
astrogliosis with scar formation comprises predominantly newly-proliferated astrocytes
with extensive process overlapping to demarcate the area of damage (Khakh and
Sofroniew, 2015; Sofroniew, 2015). There was no evidence of significant proliferation in
this study, although this was not evaluated using a specific proliferation assay, and a
global contusion was administered so there was no lesion epicentre with a border. This
may suggest that the astrogliosis observed here was severe- as evidenced by GFAP
upregulation, hypertrophy and domain overlapping- but not as severe as the scar forming
level.
6.3 Heterogeneity of Astrocytes
Glial fibrillary acidic protein (GFAP) is one of the most commonly used markers for
astrocytes in vivo and in vitro, and it is widely accepted that upregulation of GFAP
occurs during astrogliosis (Eng and Ghirnikar, 1994; Hinkle et al., 1997; Pekny and
Nilsson, 2005; Sofroniew and Vinters, 2010). However, although upregulation of GFAP is
a sensitive marker of reactive astrocytes, many astrocytes do not express detectable
levels of GFAP in healthy tissue. Whilst this meant that there was not a way to verify
the identity of these GFAP-negative cells as actually being astrocytes, the distinction
between non-reactive and reactive astrocytes could be made through quantification of
the change in GFAP volume expression. Hinkle et al., (1997) modelled traumatic brain
contusion injury in rats and assessed GFAP and S100β expression 96 hours post-injury
(1 mm cortical displacement at 3.5 m.s−1). Results showed that all S100β-positive
astrocytes expressed largely undetectable levels of GFAP under native conditions.
However, following a mild contusion injury, these astrocytes began expressing GFAP.
This property of astrocytes was observed in this project, particularly of astrocytes that
were seeded in 3D into the collagen hydrogels. Immunolabelling of astrocytes using a
polyclonal antibody against GFAP revealed that the majority of astrocytes in the control
samples (no injury) were GFAP-negative, despite verification of GFAP immunoreactivity
in 2D.
GFAP does not appear to be essential for the normal appearance and function of
astrocytes in the CNS since GFAP-deficient mice develop normally (Pekny et al., 1995),
but it has been shown to be essential for the pathogenesis of astrogliosis (Sofroniew and
Vinters, 2010). The mechanisms governing GFAP expression and its role in astrogliosis
is not fully understood but since it is a key component for the assembly of intermediate
filaments in astrocytes, it is thought that GFAP upregulation is important for the
process of hypertrophy and ramification (Yang and Wang, 2015). The presence of
intermediate filaments may provide increased mechanical resistance, which is considered
unnecessary under non-injurious circumstances as protection is already provided by the
vertebrae, meninges and cerebrospinal fluid (CSF). However, the structural demands are
increased following trauma when reactive astrocytes undergo hypertrophy (Pekny et al.,
1999; Wilhelmsson et al., 2004).
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The lack of GFAP immunoreactivity in this research may have limited the complete
evaluation of astrocyte behaviour in response to mechanical trauma, as the population of
GFAP-negative astrocytes may provide useful insights into astrocyte biology and their
roles in astrogliosis. However, GFAP was deemed an appropriate structural marker in
this project to monitor changes in astrocyte reactivity and morphology following
mechanical injury. As a more broad marker of astrocytes, S100β could have been used
alongside GFAP to visualise the GFAP-negative population in the sample. Gene
profiling of mouse forebrain astrocytes, neurons, and oligodendrocytes have also
highlighted antigenic markers specific for astrocytes, such as Aldh1L1, with a broader
pattern of expression compared to GFAP (Cahoy et al., 2008). Other markers reported
to be broad pan-astrocyte markers are GLAST (EAAT1), and GLT-1 (EAAT2).
In this research, both contusion and distraction resulted in an increase in GFAP
volume per cell and values were of a similar magnitude, particularly between both injury
mechanisms at 100 mm.s−1 (Figures 4.7 and 5.7). This may suggest a similar level of
reactivity, but does not provide information on potential genomic or functional
differences. Differences in gene expression profiles have been observed between astrocytes
activated by inflammation or ischaemic stroke (Anderson et al., 2014; Zamanian et al.,
2012). Although there were genes that were altered in astrocytes in response to both
injury mechanisms, at least 50% of the genes were specific to the applied injury type
(Zamanian et al., 2012). Another consideration for this research is that astrocyte
heterogeneity exists between species as well. Human astrocytes have been shown to be
different to rodent astrocytes in terms of size and the complexity of processes, and it has
been suggested that increased astrocyte complexity has contributed to the increased
power and capacity of the human brain (Oberheim et al., 2009). These potential
functional differences in astrocytes between species may have implications for future
testing of therapeutic interventions.
6.4 Verification and Validation of In Vitro Models of TSCI
Validation of the in vitro model and results of this project is a challenge that must be
achieved in order to enable the accurate comparison of in vitro results with clinical
results. A robust and valid model could better inform the design of preclinical models in
vivo or even replace some aspects such as early stage testing of therapeutic interventions.
This is a challenge due to the biological heterogeneity between human patients and
animal models, the wide variety of outcome measures used even between animal models,
and robustness of the in vitro model including hydrogel system, source of materials, and
stability of components. In this project, verification of the output biomechanical
measurements was performed against the input parameters and found to be accurate
(Chapter 3). Reliability was established for the injury methodology since repeatable
results were obtained over time using the same methodology. However, robust reliability
testing would require another group to use the same methodology and evaluate the
reproducibility of the study, which has not yet been achieved.
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Validation relies on the establishment of the reliability of the methodology, and the
interpretation of test results against the real world human system. The data needs to be
interpreted in the context of human TSCI, since reliability does not guarantee its
applicability. TSCI is difficult to study in humans due to the typically unexpected
nature of the event, and practical and ethical limitations associated with human research.
Much of the knowledge of human TSCI pathophysiology has been derived from animal
models. As the most commonly used animal model of TSCI, there remain important
differences between rodent and human physiology, which contributes to the difficulties in
translating this research into effective treatments for humans. At a cellular level,
morphological and functional differences have been observed between astrocytes of
different species and even between and within different tissue regions of the same species
(Miller, 2018; Sofroniew and Vinters, 2010; Vasile et al., 2017). For instance, GFAP
expression has been shown to be higher in the adult spinal cord relative to the brain
(Yoon et al., 2017).
The primary astrocytes used in this project were derived from cortical tissue of
pre-weaner Wistar rats. The identity and purity of the astrocytes were verified using
qualitative analysis of morphology and immunocytochemical staining methods, with a
GFAP antibody (Chapter 3). However, since the expression of GFAP was shown to vary
between 2D and 3D culture further validation of the cells will be required, such as gene
or protein expression analysis. Further, although multiple aspects of astrogliosis were
observed following mechanical injury in this project, further validation of the model by
treating with interventions known to modulate the microenvironment and/or promote
repair in vivo is needed. Digestion of CSPGs was briefly investigated but this did not
appear to affect astrocyte morphology after 48 hours. CSPG modulation may be more
appropriate when neurons are present as CSPGs are known to be inhibitors of neurite
outgrowth (Siebert et al., 2014; Yiu and He, 2006; Yu et al., 2012).
Successful validation of the in vitro contusion and distraction models used in this
study provide the basis for developing more informed TSCI models where the
biomechanics and, therefore, pathophysiology of injury can be more faithfully replicated
within a single system. As such, these are useful tools for pre-clinical studies where
therapeutic interventions can be tested to better inform animal studies, addressing the
principles of the Three Rs to replace, reduce and refine the use of animals in research.
There is also scope for analysing astrocyte behaviour using multiple molecular and
genetic assays within a single hydrogel sample through splitting the sample into multiple
segments, which will provide a better understanding of the effects of injury biomechanics
on astrogliosis. The injury model protocols can be adapted and used with different
hydrogel systems or spinal cord tissue, or used to mechanically characterise and test
interventions such as spinal cord conduits, depending on the research question(s) posed.
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6.5 Future Investigations
The research in this project raised further areas of investigation, which could provide useful
insights into neural cell biology and their roles in TSCI.
6.5.1 Mechanisms of TSCI
Given the complexity of human SCI, no one model can encompass all aspects of injury.
Each model aims to generate a consistent and easily reproducible injury that replicates
SCI pathology in humans. The contusion and distraction injury mechanisms modelled in
this project were clinically relevant as they are commonly observed in humans. However,
as previously mentioned, human SCI is often represented by a combination of different
mechanisms and strain modalities. Contusion-compression mechanisms of injury are
likely more clinically relevant than pure contusion injuries- in which the impact is
transient- as persistent spinal canal occlusion and cord compression is common in
fracture dislocations and burst fractures, where bony vertebral fragments remain
impinging on the cord. Some of the contusion models are, in fact, contusion–compression
models that comprise an acute injury, followed by prolonged compression of the cord
(Joshi and Fehlings, 2002; Rivlin and Tator, 1978).
Modelling contusion-compression injuries in vitro using the current model would be
feasible as additional dwell steps can be incorporated into the waveform setup of the BOSE
software. Further, the capability of perfusing cell culture medium through the chamber
means the environmental conditions of the cells can be maintained during the experiment.
Dislocation SCI is considered the most common mechanism of TSCI, representing up
to 58% of mechanisms (Sekhon and Fehlings, 2001; Tator, 1983), thus this would be an
important mechanism to model. However, substantial adaptations to the BOSE and mould
designs would need to be considered in order to model this injury.
6.5.2 Increasing Model Complexity
One limitation of this research was the lack of cellular complexity in the in vitro model.
Whilst simplifying the biological milieu to include only one cell type enabled the
evaluation of the direct impact of mechanical trauma on astrocyte biology, this removed
important interactions between astrocytes and other cell types and their secreted
molecules, which are likely to contribute to the dynamics of astrogliosis. As such,
increasing the cellular complexity of the model will increase its biological relevance.
Initially, different neural cell types- neurons, microglia, and oligodendrocytes- could be
cultured in isolation to evaluate the effects of different TSCI mechanisms on their
pathophysiology, followed by incorporating different cell types into co-cultures.
Co-cultures of neural cells have previously been used to model mechanical trauma,
including neurons and astrocytes (Cullen et al., 2007; LaPlaca et al., 2005).
Astrocytes are known to influence neuronal survival and behaviour, through
providing trophic factors, regulating the synaptic environment, and supporting neurite
outgrowth (Fields and Stevens-Graham, 2002; Tsacopoulos, 2002). By co-culturing
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astrocytes in isolation, and with neurons in co-culture, the influence of astrogliosis on
neurons and vice versa could be evaluated. For instance, since neurite outgrowth is
impeded by the glial scar in vivo, the effects of different injury mechanisms and injury
severity on neurite outgrowth could be assessed (McKeon et al., 1991; Wanner et al.,
2008). Further, additional secondary injury events could be investigated, such as neurite
outgrowth. In addition to cellular complexity, cytoarchitecture plays an important role
in the functioning of the spinal cord. The spinal cord is highly organised, with the white
matter containing the myelinated axons of neurons organised into bundles called tracts.
Cellular alignment has been previously shown to guide axon outgrowth in vitro (East et
al., 2010), and can be achieved by tethering hydrogels at opposite ends. This causes the
gel to contract as cells remodel the matrix and align along the axis of principal strain
(Phillips et al., 2005). The moulds used in the distraction study (Chapter 5) were based
on the design by Phillips et al., (2005) although alignment was not generated as it
necessitated the use of TGF-β1, an inducer of astrogliosis but alignment would be a
useful feature when evaluating neuronal behaviour in response to mechanical injury
mechanisms.
6.5.3 Local Mechanical Changes Following Injury
An accurate in vitro model of TSCI would faithfully replicate not only the
pathophysiological alterations, but also any potential mechanical alterations that occur
following injury. Human tissues have a poor regenerative capacity and fibrosis often
takes place following damage, a pathological wound healing process which results in scar
tissue which has been found to be stiffer than healthy tissue (Swift et al., 2013). In the
CNS, damage also results in a scar (glial scar) through astrogliosis. Glial scars are
described as rich in glial cells, non-neural cells such as meningeal cells, and various ECM
components like CSPGs which create a dense network of cells and ECM chemically and
mechanically non-permissive to neuroregeneration (Fawcett and Asher, 1999; Silver and
Miller, 2004). Therefore, the concept of the glial scar being stiff was a natural
assumption to make.
However, evidence has been presented for a softening of the microenvironment
following injury, at the cellular level in vitro (Miller et al., 2009) and tissue level in vivo
(Moeendarbary et al., 2017). Moeendarbary et al., (2017) found that the increases
observed in GFAP, vimentin, laminin, and collagen-IV following rat cortical stab injury
and spinal cord crush injury was correlated with tissue softening. Since some differences
in GFAP and CSPG expression were observed between contusion and distraction injury
in this project, it would be interesting to evaluate whether there are mechanical
differences too. Bulk mechanical properties can be evaluated using tools such as
rheology, and local mechanical properties can be evaluated using AFM like
Moeendarbary et al., (2017). AFM would be more useful in contusion models, for
instance, in which a focal injury is inflicted as this enables the measurement of elastic
modulus in injured and uninjured regions of the same sample.
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6.5.4 Inflammation
Following TSCI, disruption of the blood-spinal cord barrier (BSCB) leads to the
recruitment of blood-borne leukocytes, as well as activation of the intrinsic glia,
including astrocytes and microglia (Okada, 2016). The inflammatory response plays a
major role in the pathophysiology of TSCI (Chapter 1) and astrocytes are also important
mediators of inflammation through the release of numerous pro- and anti-inflammatory
chemokines, cytokines and growth factors. Selective ablation of reactive astrocytes has
been shown to exacerbate inflammation following SCI, amongst other degenerative
effects (Bush et al., 1999; Faulkner et al., 2004) so astrogliosis does provide a protective
role despite also being inhibitory to repair. It is difficult to demonstrate the release of
cytokines, chemokines and ECM components specifically by astrocytes in vivo since
other cell types secrete similar molecules (Kang and Hébert, 2011). Thus, using isolated
cultures of astrocytes in vitro would be advantageous.
This study has demonstrated that astrocytes produce increased amounts of CSPGs
in response to mechanical trauma (Chapters 5 and 6). ELISA analysis of cytokines in
the cell culture medium was attempted, but detectable levels of the analyte could not
be measured. Cytokine profiling for different injury mechanisms would provide insight
into the potential differences in inflammatory response, which could indicate whether one
injury mechanism environment could be better targeted with a particular treatment. For
instance, if one injury mechanism results in the expression of significantly more IL-6, a
key pro-inflammatory cytokine known to be expressed by reactive astrocytes (Garcia et
al., 2016), a receptor-neutralising antibody to IL-6 could be tested (Okada et al., 2004).
Increasing the cell density of each sample could enable a detectable level of cytokines to
be measured, but this would increase the number of animals required. Cytokine arrays are
also available to test for a wider range of cytokines which would provide a more detailed
picture of the inflammatory profile of astrocytes in response to different injury mechanisms.
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6.6 Conclusions
The aim of this project was to model two distinct mechanisms of traumatic spinal cord
injury in vitro, contusion and distraction, using the BOSE Electroforce BioDynamic 5110
with a three-dimensional primary astrocyte-seeded collagen hydrogel, in order to evaluate
the effects of differing injury biomechanics on astrocyte behaviour:
• The BOSE Electroforce BioDynamic 5110 materials testing machine is an
appropriate tool for the application of clinically relevant strains and strain rates
representing more than one mechanism of TSCI.
• Protocols were designed to simulate compressive and tensile forces representing
contusion and distraction TSCI, using a range of different input velocities and
displacement depths/lengths, which resulted in accurate and reproducible injuries
being inflicted in vitro with hydrogels.
• A collagen hydrogel seeded in 3D with primary rat cortical astrocytes was developed
for the application of experimental injury representing contusion and distraction
TSCI.
• Contusion and distraction injury both induced a response in astrocytes which
reflected multiple processes of astrogliosis, including increased GFAP and CSPG
expression, astrocyte hypertrophy, ramification, and loss of domain preservation.
• Differences in astrocyte responses were observed in response to contusion and
distraction injury in vitro, particularly temporal differences in GFAP volume and
CSPG expression. Viability was reduced similarly for both injury mechanisms at
Day 1 post-injury.
• Further investigations are required to probe in more depth the interactions between
velocity and displacement and how these influence cellular behaviour and dynamics,
extending to more cell types of the CNS.
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Appendix A – Equipment and Reagents









Automatic pipette (Pipetteboy) Starlab UK Ltd., Milton
Keynes, UK
BOSE Electroforce BioDynamic 5110 TA Instruments, Newcastle,
UK
Centrifuge Harrier 15/80 MSB080.CX1.5 Sanyo, Watford, UK
Centrifuge, refrigerated 220R VWR International Ltd.,
Leicestershire, UK




Freezer (-80 °C) MDF-
U2086S
Sanyo Electric Biomedical Co.
Ltd., Tokyo, Japan
Fridge, sparkfree Labcold
Fume Hood Whiteley Fume Extraction
Ltd., York, UK
Haemocytometer Neubauer Sigma-Aldrich Ltd., Dorset,
UK




Hoshizaki Europe Ltd., Telford,
UK
Magnetic Flea
Orbital shaker, 10 mm  PSU-10i Grant Instruments Ltd.,
Cambridgeshire, UK
pH Meter Jenway 3510 Wolf Laboratories Ltd., York,
UK
Continued on next page
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Hidex LabLogic Systems Ltd.,
Sheffield, UK







Spatula Various Sizes VWR International Ltd.,
Leicestershire, UK
Water Bath Grant Instruments Ltd.,
Cambridgeshire, UK
Dissection Equipment
Dissecting Scissors, Curved (10 cm) World Precision Instruments
Ltd., Hertfordshire, UK
Dumont Tweezers (11 cm) #55 World Precision Instruments
Ltd., Hertfordshire, UK
Dumont Tweezers, Curved (11.5
cm)
#7 World Precision Instruments
Ltd., Hertfordshire, UK
Fine Scissors ToughCut, Straight (9
cm)
Interfocus Ltd., Linton, UK
Mayo Scissors ToughCut, Straight
(17 cm)
Interfocus Ltd., Linton, UK
Scalpel Handle (95 mm) #3 Scientific Laboratory Supplies
Ltd., Nottingham, UK




Vannas Spring Scissors Straight (2.5
mm cutting edge)
Interfocus Ltd., Linton, UK
Surgical Scissors (16 cm) World Precision Instruments
Ltd., Hertfordshire, UK
Tweezers (11 cm) #4, #5 TAAB Laboratories Equipment
Ltd., Berkshire, UK
Microscopy
Olympus Inverted Light Microscope CK40 Olympus Optical Co. Ltd., UK
Zeiss Axio Imager.Z2 Upright
Microscope (confocal scanning laser
microscope)
LSM880 Carl Zeiss Ltd., Cambridge, UK
Zeiss Axio Upright Fluorescent
microscope
Zeiss, Cambridge, UK
Continued on next page
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Table 6.1 – Continued from previous page
Equipment Model Supplier
Software
(Fiji Is Just) ImageJ v1.52k National Institutes of Health,
USA
GraphPad Prism 7 v7.01 GraphPad Software, USA
MikroWin 2000 v4.43 Mikrotek Laborsysteme GmbH
rSpace Rheology Software Malvern Instruments Ltd.,
Malvern, UK
Volocity 3D Image Analysis
Software
PerkinElmer; MA, USA
WinTest v7.2 TA Instruments, Newcastle,
UK
ZEN 2.3 SP1 FP1 (Black) 14.0.12.201 Carl Zeiss Microscopy GmbH,
Germany
ZEN 2.5 (Blue) 2.5.75.0 Carl Zeiss Microscopy GmbH,
Germany
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Table 6.2: List of Consumables Used
Consumable Supplier
Bijou (5 ml) Scientific Laboratory Supplies Ltd.,
Nottingham, UK
Blade removers, non-surgical VWR International Ltd., Leicestershire,
UK
Blue Roll Scientific Laboratory Supplies Ltd.,
Nottingham, UK
Cell Scrapers Fisher Scientific UK Ltd.,
Loughborough, UK
Cell Strainers (40 µm) Fisher Scientific UK Ltd.,
Loughborough, UK
Cryovial Tubes (2.0 ml) Sarstedt Ltd., Leicester, UK
Falcon Conical Centrifuge Tubes (15 ml, 50
ml)
Sarstedt Ltd., Leicester, UK
FFP3 Valved Respirator VWR International Ltd., Leicestershire,
UK
Glass Cover Slips (22 x 22 mm) Scientific Laboratory Supplies Ltd.,
Nottingham, UK
Maxisorp 96-well microplate (flat bottom) Thermo Fisher Scientific, Paisley, UK
Microplate 96-well (polypropylene round
bottom)
Fisher Scientific UK Ltd.,
Loughborough, UK
Nitrile Gloves, Ecoshield Appleton Woods Ltd., Birmingham, UK
OptiPlate, 96-well PerkinElmer Life & Analaytical Sciences,
Bucks, UK
Petri Dish (60 x 15 mm) Sigma-Aldrich Ltd., Dorset, UK
Petri Dish (90 x 16 mm) Fisher Scientific UK Ltd.,
Loughborough, UK
Pipette tips (2 µl, 20 µl, 200 µl, 1000 µl) Starlab, Ahrensburg, Germany
Plate Sealers, TopSeal-A PLUS PerkinElmer Life & Analaytical Sciences,
Bucks, UK
Serological pipettes (5 ml, 10 ml, 25 ml) Sigma-Aldrich Ltd., Dorset, UK
Scalpel Blades (#10) Fisher Scientific UK Ltd.,
Loughborough, UK
Single Edge Razor Blades (38.1 mm x 19 mm) VWR International, Poole, UK
Sterile Pots (60 ml, 150 ml, 250 ml) Fisher Scientific UK Ltd.,
Loughborough, UK
Superfrost Plus Slides Fisher Scientific UK Ltd.,
Loughborough, UK
Syringe (10 ml)
Syringe Filters (0.22 µm) Sigma-Aldrich Ltd., Dorset, UK
Tethering Bars (Plastic Mesh, 10-count) Darice, Amazon, UK
Continued on next page
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Table 6.2 – Continued from previous page
Consumable Supplier
Tissue Culture Flasks, Nunclon Delta (25
cm2, 75 cm2)
Thermo Fisher Scientific, Paisley, UK
Universal Tubes (30 ml) Scientific Laboratory Supplies Ltd.,
Nottingham, UK
Weighing boats Scientific Laboratory Supplies Ltd.,
Nottingham, UK
Well Plates, Nunclon Delta Surface Flat, (6,
48 well)
Thermo Fisher Scientific, Paisley, UK
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Table 6.3: List of Reagents Used
Reagent Supplier
General
Bovine Serum Albumin Sigma-Aldrich ltd., Dorset, UK
DAPI (4’,6-diamidino-2-phenylindole) Sigma-Aldrich Ltd., Dorset, UK
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich Ltd., Dorset, UK
Dulbecco’s Phosphate Buffered Saline (PBS) Sigma-Aldrich Ltd., Dorset, UK
Dulbecco’s Phosphate Buffered Saline (PBS)
Tablets
Fisher Scientific UK Ltd.,
Loughborough, UK
Ethanol Fisher Scientific, UK Ltd.,
Loughborough, UK
Hydrochloric Acid (37% w/w, d=1.18) Fisher Scientific UK Ltd.,
Loughborough, UK
OptiPrepTM Density Gradient Medium STEMCELL Technologies UK Ltd.,
Cambridge, UK
Paraformaldehyde (4%) Insight Biotechnology Ltd., Wembley,
UK
pH Buffer Solution (pH 4, 7, 10) Scientific Laboratory Supplies Ltd.,
Nottingham, UK
Sodium Azide (1% w/v) VWR International Ltd., Leicestershire,
UK
Sodium Hydroxide Pellets Fisher Scientific UK Ltd.,
Loughborough, UK
Triton X-100 Fisher Scientific UK Ltd.,
Loughborough, UK
Trypan Blue Solution Sigma-Aldrich Ltd., Dorset, UK
Trypsin (3000 - 20 000 U.mg−1) Sigma-Aldrich Ltd., Dorset, UK
Virkon Fisher Scientific, Loughborough, UK
General Cell Culture
Dulbecco’s Modified Eagle’s Medium
(DMEM) High Glucose
Lonza Biological, Cambridge, UK
Foetal Bovine Serum (FBS) Bio-Whittaker, Lonza, Verviers,
Belgium
Hank’s Balanced Salt Solution (HBSS) with
Ca2+ and Mg2+
Sigma-Aldrich Ltd., Dorset, UK
Hank’s Balanced Salt Solution (HBSS)
modified without Ca2+ and Mg2+
Sigma-Aldrich Ltd., Dorset, UK
Laminin from Engelbreth-Holm-Swarm
murine
Sigma-Aldrich Ltd., Dorset, UK
L-glutamine Sigma-Aldrich Ltd., Dorset, UK
Penicillin/Streptomycin Solution Sigma-Aldrich Ltd., Dorset, UK
Poly-D-lysine hydrobromide Sigma-Aldrich Ltd., Dorset, UK
Trypsin-EDTA 1X Sigma-Aldrich Ltd., Dorset, UK
Continued on next page
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Table 6.3 – Continued from previous page
Reagents Supplier
Additional Primary Cell Culture Supplements
Collagenase Type IV Sigma-Aldrich Ltd., Dorset, UK
Cytosine β-D-arabinofuranoside Sigma-Aldrich Ltd., Dorset, UK
Deoxyribonuclease I (DNase) from bovine
pancreas (DNase), 2000 U.mg−1 Type IV
Sigma-Aldrich Ltd., Dorset, UK
5-Fluorodeoxyuridine MP Biomedicals Europe, Cambridge,
UK
Nerve Growth Factor (Recombinant Human
β-NGF, animal free) expressed in E.coli
Biolegend Ltd., London, UK
Pierce Protease and Phosphatase Inhibitor
Mini Tablets
Thermo Fisher Scientific, Paisley, UK
Soybean Trypsin Inhibitor from Glycine Max Sigma-Aldrich Ltd., Dorset, UK
Transforming Growth Factor β–1, human Cambridge Bioscience, Cambridge, UK
Uridine MP Biomedicals Europe, Cambridge,
UK
Assay Kits
ATPlite Luminescence System Perkin-Elmer Life & Analytical Sciences,
Buckinghamshire, UK
LIVE/DEAD Viability/Cytotoxicity kit Thermo Fisher Scientific, Paisley, UK
Rat IL-6 DuoSet ELISA kit Bio-Techne, Abingdon, UK
Reagent Additive 1 (21 mL) Bio-Techne, Abingdon, UK




Collagen Type-I rat tail, >2 mg.ml−1 in 0.6%
(v/v) acetic acid
First Link Ltd., Wolverhampton, UK
Minimum Essential Media, 10x (without
alkali)
First Link Ltd., Wolverhampton, UK
Neutralising Solution Lonza Biological, Cambridge, UK
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Table 6.4: Mean peak output displacement values under compression waveforms with or without the addition of a 100 ms dwell step
and with or without PID tuning. Output displacement values were recorded, under waveforms of various combinations of input displacement and
velocity parameters simulated in air. The peak output displacement values were selected and compared to the input displacement value. Data is
presented as the mean ± SEM (% error). N=4.
Input Displacement (mm) Mean Output Peak Displacement (mm)
100 mm.s−1 1000 mm.s−1 3000 mm.s−1
– Dwell – PID
1.000 0.642 ± 9.6 x 10−4 (35.85) 0.128 ± 4.1 x 10−4 (87.20) 0.064 ± 2.9 x 10−4 (93.65)
2.000 1.511 ± 1.2 x 10−3 (24.43) 0.471 ± 1.3 x 10−3 (76.44) 0.219 ± 6.5 x 10−4 (89.08)
4.000 3.571 ± 4.1 x 10−4 (10.73) 1.701 ± 5.8 x 10−4 (57.48) 0.699 ± 8.5 x 10−4 (82.52)
6.000 5.681 ± 8.5 x 10−4 (5.32) 3.470 ± 9.1 x 10−4 (42.17) 1.435 ± 4.8 x 10−4 (76.09)
8.000 7.659 ± 6.3 x 10−4 (4.26) 5.595 ± 4.8 x 10−4 (30.07) 2.601 ± 5.0 x 10−4 (67.49)
10.000 9.460 ± 6.3 x 10−4 (5.40) 7.763 ± 2.5 x 10−4 (22.37) 3.889 ± 7.5 x 10−4 (61.11)
+ Dwell – PID
1.000 0.999 ± 2.5 x 10−4 (0.13) 0.998 ± 4.8 x 10−4 (0.23) 0.999 ± 4.1 x 10−4 (0.10)
2.000 2.001 ± 6.3 x 10−4 (0.06) 2.001 ± 2.5 x 10−4 (0.04) 2.001 ± 4.8 x 10−4 (0.06)
4.000 4.002 ± 2.5 x 10−4 (0.04) 4.007 ± 4.1 x 10−4 (0.18) 4.007 ± 4.8 x 10−4 (0.18)
6.000 6.001 ± 5.0 x 10−4 (0.02) 6.014 ± 8.5 x 10−4 (0.24) 6.014 ± 2.5 x 10−4 (0.23)
8.000 8.004 ± 5.0 x 10−4 (0.04) 8.015 ± 4.8 x 10−4 (0.18) 8.038 ± 1.0 x 10−3 (0.47)
10.000 9.986 ± 5.0 x 10−4 (0.15) 9.989 ± 2.5 x 10−4 (0.11) 10.084 ± 7.5 x 10−4 (0.84)
+ Dwell + PID
1.000 1.089 ± 3.7 x 10−4 (8.92) 0.961 ± 5.1 x 10−4 (3.94)
2.000 2.001 ± 3.7 x 10−4 (0.06) 1.974 ± 5.1 x 10−4 (1.32)
4.000 4.069 ± 4.0 x 10−4 (1.72) 3.998 ± 4.0 x 10−4 (0.04)
6.000 6.001 ± 4.5 x 10−4 (0.02) 6.002 ± 3.2 x 10−4 (0.03)
8.000 8.003 ± 4.5 x 10−4 (0.04) 7.997 ± 5.8 x 10−4 (0.04)
10.000 9.993 ± 5.5 x 10−4 (0.07) 10.236 ± 6.0 x 10−4 (2.36)
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Figure 6.1: Comparison of input and output displacement profiles of a
simulated contusion regime with the addition of a 100 ms dwell step. Dashed
lines represent the output profiles; solid lines represent the input command. The simulated
waveform was programmed as follows: dwell (10 ms), ramp (100, 1000, or 3000 mm.s−1
to the defined displacement depth) in compression, dwell (100 ms), and ramp (100, 1000,
or 3000 mm.s−1) to 0.000 mm.
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Table 6.5: Mean peak output velocity values under compression waveforms with or without the addition of a 100 ms dwell step and
with or without PID tuning. Output velocity values were recorded, under waveforms of various combinations of input displacement and velocity
parameters simulated in air. The peak output velocity values were selected and compared to the input velocity value. Data is presented as the mean ±
SEM (% error). N=4.
Input Displacement (mm) Mean Output Peak Velocity (mm.s−1)
100 mm.s−1 1000 mm.s−1 3000 mm.s−1
– Dwell – PID
1.000 80.00 ± 0.00 (20.00) 45.00 ± 0.00 (95.50) 25.00 ± 0.00 (99.17)
2.000 91.25 ± 1.25 (8.75) 136.25 ± 1.25 (86.38) 77.50 ± 1.44 (97.42)
4.000 110.00 ± 0.00 (10.00) 365.00 ± 0.00 (63.50) 226.25 ± 1.25 (92.46)
6.000 112.50 ± 1.44 (12.50) 587.50 ± 1.44 (41.25) 420.00 ± 0.00 (86.00)
8.000 112.50 ± 1.44 (12.50) 795.00 ± 2.04 (20.50) 666.25 ± 1.25 (77.79)
10.000 113.75 ± 2.50 (13.75) 918.75 ± 1.25 (8.13) 897.50 ± 1.44 (70.08)
+ Dwell – PID
1.000 82.50 ± 1.44 (17.50) 110.00 ± 0.00 (89.00) 111.25 ± 1.25 (96.29)
2.000 90.00 ± 0.00 (10.00) 221.25 ± 1.25 (77.88) 226.25 ± 1.25 (92.46)
4.000 110.00 ± 0.00 (10.00) 440.00 ± 0.00 (56.00) 458.75 ± 1.25 (84.71)
6.000 111.25 ± 1.25 (11.25) 647.50 ± 1.44 (35.25) 703.75 ± 2.39 (76.54)
8.000 111.25 ± 1.25 (11.25) 810.00 ± 0.00 (19.00) 947.50 ± 1.44 (68.42)
10.000 111.25 ± 1.25 (11.25) 927.50 ± 1.44 (7.25) 1176.25 ± 3.15 (60.79)
+ Dwell + PID
1.000 117.00 ± 0.94 (17.00) 125.00 ± 0.00 (87.50)
2.000 94.00 ± 0.61 (6.00) 254.00 ± 0.61 (74.60)
4.000 118.00 ± 1.22 (18.00) 545.00 ± 0.00 (45.50)
6.000 108.00 ± 0.50 (8.00) 768.50 ± 0.61 (23.15)
8.000 107.50 ± 0.00 (7.50) 943.00 ± 1.22 (5.70)
10.000 110.00 ± 0.00 (10.00) 1031.00 ± 1.00 (3.10)
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Table 6.6: PID values determined for each combination of displacement and
velocity parameters.
Displacement (mm) Input Velocity (mm.s−1) P Value I Value D Value
1.000 100 0.658196 0.019039 -2.81748
1000 0.536222 0.004389 -2.17659
2.000 100 0.658196 0.009272 -2.81748
1000 0.536222 0.005305 -2.23762
4.000 100 0.322592 0.008357 -2.26814
1000 0.231037 0.004694 -2.57333
6.000 100 0.658296 0.009272 -2.81748
1000 0.627777 0.007441 -2.81748
8.000 100 0.658296 0.009272 -2.81748
1000 0.658296 0.007746 -2.81748
10.000 100 0.658296 0.009272 -2.81748
1000 0.505703 0.008051 -2.39022
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Table 6.7: Mean peak output displacement and velocity values under compression waveforms with or without the presence of a
hydrogel. Acellular gels 300 µl in volume were compressed to 25, 50, or 75% of their calculated height at 100 or 1000 mm.s−1 with the peak
displacement and velocities achieved reported. Control tests refer to the corresponding waveform simulated in air. Data is presented as the mean ±
SEM (% error). Two-way ANOVA with Tukey’s post-hoc test performed. N=4.
100 mm.s−1 1000 mm.s −1
Ctrl Gel Ctrl Gel
Peak Output Displacement (mm)
25% 0.376 ± 0.02 (0.05) 0.376 ± 0.02 (0.05) 0.351 ± 0.02 (0.04) 0.351 ± 0.02 (0.04)
50% 0.768 ± 0.02 (0.04) 0.770 ± 0.02 (0.06) 0.733 ± 0.06 (0.04) 0.717 ± 0.03 (0.02)
75% 1.018 ± 0.20 (0.03) 1.049 ± 0.10 (0.05) 1.152 ± 0.04 (0.06) 1.156 ± 0.04 (0.02)
Peak Output Velocity (mm.s−1)
25% 115.00 ± 0.00 (15.00) 115 ± 0.00 (15.00) 902.50 ± 32.56 (9.75) 900.00 ± 33.35 (10.00)
50% 115.00 ± 0.00 (15.00) 115.00 ± 0.00 (15.00) 955.00 ± 0.00 (4.50) 957.50 ± 1.44 (4.25)
75% 115.00 ± 0.00 (15.00) 115.00 ± 0.00 (15.00) 967.50 ± 1.44 (3.25) 966.25 ± 1.25 (3.38)
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B.2. Distraction
Table 6.8: Mean peak output displacement and velocity values under tensile loads with or without PID tuning in air. Data is
presented as the mean ± SEM (% error). Two-way ANOVA with Tukey’s post-hoc test performed. N=3.
100 mm.s−1 1000 mm.s −1
– PID + PID – PID + PID
Peak Output Displacement (mm)
2.000 mm 2.004 ± 3.3 x 10−4 (0.22) 2.008 ± 6.7 x 10−4 (0.42) 2.143 ± 6.7 x 10−4 (7.17) 2.022 ± 3.3 x 10−4 (1.08)
4.000 mm 3.997 ± 5.8 x 10−4 (0.08) 4.004 ± 3.3 x 10−4 (0.09) 4.189 ± 8.8 x 10−4 (4.73) 4.006 ± 5.8 x 10−4 (0.15)
6.000 mm 5.947 ± 6.7 x 10−4 (0.88) 5.995 ± 0.001 (0.08) 6.221 ± 8.8 x 10−4 (3.69) 6.008 ± 3.3 x 10−4 (0.13)
Peak Output Velocity (mm.s−1)
2.000 mm 111.67 ± 1.67 (11.67) 111.67 ± 1.67 (11.67) 253.33 ± 1.67 (74.67) 333.33 ± 1.67 (66.67)
4.000 mm 111.67 ± 1.67 (11.67) 111.67 ± 1.67 (11.67) 491.67 ± 1.67 (50.83) 628.33 ± 1.67 (37.17)
6.000 mm 110.00 ± 0.00 (10.00) 115.00 ± 2.89 (15.00) 703.33 ± 1.67 (29.67) 856.67 ± 1.67 (14.33)
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Table 6.9: Mean peak output displacement and velocity values under tensile
loads with or without collagen hydrogels. Gels were distracted to lengths ranging
from 10 – 30%, then repeated in air (ctrl) with peak displacement and velocity
calculated. Data is presented as the mean ± SEM (% error). Two-way ANOVA with
Tukey’s post-hoc test performed. N=3.
100 mm.s−1
Ctrl Gel
Peak Output Displacement (mm)
10% 0.857 ± 0.005 (3.84) 0.858 ± 0.005 (3.96)
20% 1.654 ± 6.7 x 10−4 (0.22) 1.658 ± 0.003 (0.46)
30% 2.480 ± 8.8 x 10−4 (0.22) 2.482 ± 5.7 x 10−4 (0.28)
Peak Output Velocity (mm.s−1)
10% 111.67 ± 1.67 (11.67) 90.00 ± 0.00 (10.0)
20% 111.67 ± 1.67 (11.67) 115.00 ± 0.00 (15.0)
30% 111.67 ± 1.67 (11.67) 115.00 ± 0.00 (15.0)
226
Appendix C – CAD Drawings of Distraction Mould
Figure 6.2: CAD drawing of the bottom piece of the distraction mould.
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Figure 6.3: CAD drawing of the top piece of the distraction mould.
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Figure 6.4: CAD drawing of the screw piece of the distraction mould.
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Figure 6.5: CAD drawing of the dowel piece of the distraction mould.
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Appendix D – Modelling Contusion SCI In Vitro
D.1. Kinetic Outputs







Peak Load (N) Energy Applied
(mJ)
100 mm.s−1
25% 0.386 ± 0.01 95.00 ± 1.0 115.42 ± 0.4 0.722 ± 0.02 0.150 ± 0.008
50% 0.770 ± 0.01 98.33 ± 0.7 115.00 ± 0.00 1.064 ± 0.07 0.506 ± 0.03
75% 1.140 ± 0.05 99.58 ± 1.0 115.00 ± 0.00 1.586 ± 0.1 0.945 ± 0.08
1000 mm.s−1
25% 0.361 ± 0.01 605.00 ± 26 825.00 ± 19 3.948 ± 0.3 0.954 ± 0.05
50% 0.737 ± 0.02 642.92 ± 29 871.67 ± 22 4.722 ± 0.2 1.836 ± 0.03
75% 1.159 ± 0.02 760.00 ± 4 967.08 ± 0.7 5.562 ± 0.05 3.709 ± 0.1
231
D.2. Astrocyte Responses Following Contusion Injury
Table 6.11: Mean volume of GFAP expressed per cell following simulated contusion injury in vitro. Data presented as the mean ± SEM.
N = 3.
Mean volume of GFAP per cell (µm3)
Ctrl 25% 50% 75% TGF-β1
100 mm.s−1
Day 1 427.67 ± 41 758.73 ± 41 959.92 ± 71 979.40 ± 56 901.40 ± 47
Day 7 873.92 ± 31 939.13 ± 97 1452.22 ± 78 1564.38 ± 117 1435.41 ± 78
Day 14 867.08 ± 48 1064.99 ± 79 1386.62 ± 83 1834.90 ± 128 1983.05 ± 133
1000 mm.s−1
Day 1 787.73 ± 47 2455.26 ± 221 2738.87 ± 158 2579.48 ± 183 904.91 ± 60
Day 7 1157.70 ± 104 3041.29 ± 243 2872.04 ± 259 2844.02 ± 193 1381.26 ± 57
Day 14 859.17 ± 54 2650.82 ± 132 2808.04 ± 108 3110.02 ± 232 1886.33 ± 150
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Appendix E – Modelling Distraction SCI In Vitro
E.1. Kinetic Outputs
Table 6.12: Kinetic Outputs Following Simulated Distraction Injury. Data












10% 0.852 ± 0.005 107.22 ± 2 0.127 ± 0.009 0.057 ± 0.003
20% 1.656 ± 0.001 115.56 ± 1 0.146 ± 0.007 0.108 ± 0.006
30% 2.482 ± 0.0003 115.56 ± 1 0.196 ± 0.03 0.143 ± 0.01
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E.2. Astrocyte Responses Following Distraction Injury
Table 6.13: Mean volume of GFAP expressed per cell following simulated distraction injury in vitro. Data presented as the mean ± SEM.
N = 3.
Mean volume of GFAP per cell (µm3)
Ctrl 10% 20% 30% TGF-β1
100 mm.s−1
Day 1 546.77 ± 61 1134.42 ± 36 1322.40 ± 61 1781.22 ± 86 874.37 ± 61
Day 7 535.50 ± 44 1568.49 ± 89 1754.67 ± 54 1773.31 ± 61 1606.30 ± 69
Day 14 700.91 ± 40 2120.09 ± 101 2400.30 ± 108 2408.57 ± 119 2142.00 ± 94
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